Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,double-stranded RNA binding (GO:0003725),0.7074664466637549,2.0874690330364003,0.0,0.0,0.0,18/70,5.02%,DDX60;OAS3;ZBP1;OASL;EIF2AK2;OAS2;IFIH1;DHX58;ACTN1;ADAR;DHX33;AGO2;ZFR2;TARBP2;ILF3;DHX36;HSP90AB1;TLR8
prerank,adenylyltransferase activity (GO:0070566),0.7932206086697204,1.9496070340133915,0.0,0.010797594122912799,0.02,4/21,0.82%,OAS3;OASL;OAS2;TENT4A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.7382639366654313,1.884564723767252,0.0,0.038048665004549856,0.093,6/25,4.18%,PARP14;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,chemokine activity (GO:0008009),0.7006481291054569,1.8502570796269577,0.0,0.06015802439908559,0.175,6/31,5.48%,CXCL10;CXCL9;CCL7;CXCL16;CCL5;CX3CL1
prerank,CXCR chemokine receptor binding (GO:0045236),0.8521991785780315,1.8430813828165855,0.0,0.05511914714172629,0.198,2/11,0.33%,CXCL10;CXCL9
prerank,pentosyltransferase activity (GO:0016763),0.6764185375844228,1.8300961800996085,0.0,0.05724438788972817,0.235,6/36,4.18%,PARP14;PARP10;PARP9;PARP11;ZC3HAV1;ART4
prerank,glutamate receptor binding (GO:0035254),-0.6180632771214877,-1.8198165644383877,0.011857707509881422,0.6627684202123413,0.493,10/17,22.44%,DLG4;HOMER1;HOMER3;SHISA6;SHANK3;NSF;GNAS;SHISA7;CAMK2A;SHANK1
prerank,single-stranded RNA binding (GO:0003727),0.6573860616556078,1.818173686999912,0.0,0.060672195547795724,0.281,14/43,12.58%,DDX60;IFIH1;DHX58;POLR2G;AGO2;ZFR2;ILF3;TLR8;SRA1;DHX9;EIF4H;LONP1;HNRNPA1;DDX11
prerank,CARD domain binding (GO:0050700),0.8079084009484325,1.8083646396326232,0.0,0.06272888014263625,0.319,4/14,1.42%,IRGM;CASP4;NOD2;NOD1
prerank,channel activity (GO:0015267),0.6432795194122072,1.7856999842861703,0.0,0.08352424660157942,0.458,11/41,12.84%,TRPM5;AQP11;PANX2;ASIC4;AQP4;TMEM120B;PDPN;TMEM266;PANX1;KCNK3;TRPV4
prerank,chemokine receptor binding (GO:0042379),0.6547629157162305,1.7737752570088554,0.0,0.09100829332169358,0.519,6/35,5.48%,CXCL10;CXCL9;CCL7;CXCL16;CCL5;CX3CL1
prerank,water transmembrane transporter activity (GO:0005372),0.8193795897448412,1.7503558426380321,0.0,0.11517433731106985,0.635,3/11,9.06%,AQP11;AQP4;PDPN
prerank,cytokine activity (GO:0005125),0.5368063952712225,1.659084264794194,0.0,0.35460670222708857,0.956,17/131,11.09%,CXCL10;CXCL9;WNT11;IL15;CRLF1;CCL7;WNT5A;GDF9;CXCL16;KITLG;CCL5;CX3CL1;WNT7B;CSF1;HMGB1;IL17D;CCL14
prerank,ubiquitin binding (GO:0043130),0.5582763688156932,1.65321264823909,0.003218884120171674,0.3523258917469128,0.971,30/73,16.35%,UBE2L6;ILRUN;CXCR4;AUP1;BIRC2;UBAP1;FBXO7;RBCK1;USP25;RNFT1;MVB12A;FBXW7;UBXN1;GGA3;NBR1;N4BP1;RAE1;UCHL3;RNF19B;RNF31;UBXN2B;UBXN11;FAF2;VPS28;RNF185;USPL1;SHARPIN;ASCC2;SPRTN;OTULINL
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.7101870257932084,1.6486278417775884,0.017980636237897647,0.3436866864021019,0.976,3/14,5.90%,RSAD2;EXO5;NFU1
prerank,ATP hydrolysis activity (GO:0140603),0.5902836582507494,1.6475909885286801,0.003500583430571762,0.323927823687384,0.977,8/41,9.47%,RNF213;HSPA1B;TOR3A;CLU;KIF26A;CHD1L;DHX9;ABCD1
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.652139683649848,-1.628538425645323,0.028662420382165606,1.0,0.951,8/10,27.54%,DLG4;SHISA6;SHANK3;NSF;GNAS;SHISA7;SHANK1;IGSF11
prerank,peptidoglycan binding (GO:0042834),0.7626857237839009,1.6146712415998337,0.030656934306569343,0.4341532636921187,0.995,5/10,15.46%,NOD2;NOD1;RNASE7;HK1;TLR2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.7503120141297098,1.6031901401799333,0.022900763358778626,0.4609998028611677,0.997,1/11,0.46%,CNGB1
prerank,receptor antagonist activity (GO:0048019),0.6675069475632323,1.5926443016540859,0.030789825970548863,0.48137845544795366,0.998,4/17,10.76%,ESR2;CCL5;LRPAP1;DKK3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.6725715952607998,1.5702779083270348,0.023968042609853527,0.5663459894845088,0.998,2/16,2.10%,BCO2;ETHE1
prerank,regulatory RNA binding (GO:0061980),0.5723148421268025,1.566806532441734,0.01652892561983471,0.5562303486746222,0.998,13/38,16.69%,PNPT1;ZC3H7A;AGO2;TARBP2;DHX9;HNRNPA2B1;ZC3H12A;HNRNPA1;MATR3;ZC3H7B;SOX2;TUT7;DICER1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5445986270911611,-1.5643950400819233,0.0311284046692607,1.0,0.996,5/15,10.01%,CYB5A;COX15;COX10;NDUFA4;COX8A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.7007204939800201,1.5612938323882506,0.03299856527977044,0.5609362389023406,0.998,5/12,8.54%,CANT1;ENTPD3;ENTPD6;NUDT5;ENTPD5
prerank,semaphorin receptor activity (GO:0017154),0.7193532256612098,1.5480270004587096,0.04148148148148148,0.6060675558341444,1.0,4/11,4.61%,PLXNA3;PLXNB2;NRP2;PLXNB3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.5164030119580092,-1.52916159202559,0.038834951456310676,1.0,1.0,5/15,15.71%,CCR5;CX3CR1;CCR2;CMKLR1;CCR1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.7051561036360593,1.5211432397659943,0.05,0.7334316107340023,1.0,3/11,6.29%,THAP7;MBD2;ZXDC
prerank,alpha-actinin binding (GO:0051393),-0.46224686906518475,-1.510825332135176,0.07017543859649122,1.0,1.0,7/24,14.64%,PDLIM5;PPARG;LDB3;RARA;PDLIM1;PKD2L1;PDLIM7
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.7119784670985443,1.4994968712883336,0.06151645207439199,0.8425122747572791,1.0,3/10,9.80%,CXCL10;PRKAR2B;PRKAG1
prerank,miRNA binding (GO:0035198),0.5762568051637639,1.4994676191987342,0.03850931677018633,0.8091408533021625,1.0,10/30,16.29%,PNPT1;ZC3H7A;AGO2;HNRNPA2B1;ZC3H12A;HNRNPA1;MATR3;ZC3H7B;SOX2;TUT7
prerank,ribosomal small subunit binding (GO:0043024),0.6395016185906123,1.494051143171718,0.054775280898876406,0.8131814474984876,1.0,11/17,20.51%,ERAL1;LARP1;MTIF3;ABCE1;EIF4H;NPM1;PIM1;EIF1B;CPEB2;EIF4B;DDX3X
prerank,MHC protein binding (GO:0042287),0.6014847802432686,1.4940033803212402,0.05614973262032086,0.7834063968754614,1.0,4/20,6.77%,FCRL6;LAG3;TAPBP;ABCB9
prerank,N-acetyltransferase activity (GO:0008080),0.5953247795734012,1.4789506975516644,0.06967213114754098,0.8500718148603389,1.0,4/19,6.22%,SATL1;SAT1;NAA50;SMARCE1
prerank,chemoattractant activity (GO:0042056),0.576324754391023,1.4725623121842943,0.035526315789473684,0.8626728072979394,1.0,6/26,11.22%,CXCL10;CCL5;CX3CL1;GDNF;HMGB1;VEGFD
prerank,mRNA 5'-UTR binding (GO:0048027),0.5916307363143024,1.4669596700307175,0.048284625158831,0.8677495086398016,1.0,5/24,4.84%,IGF2BP1;IGF2BP3;LARP1;RSL1D1;DHX36
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.6759149698457757,1.4653334675921967,0.06351550960118169,0.8506049416274346,1.0,4/11,6.12%,CASP4;CASP7;CASP6;CFLAR
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5851553265870951,-1.4650512974982257,0.06070287539936102,1.0,1.0,5/11,21.12%,KCND2;KCND1;KCND3;KCNT2;KCNT1
prerank,hexosaminidase activity (GO:0015929),0.6674962622087521,1.4596797449329177,0.06259314456035768,0.8613973525734451,1.0,4/12,8.19%,SPAM1;HYAL1;HYAL4;HEXD
prerank,ligand-gated calcium channel activity (GO:0099604),0.596925878456182,1.4585775915715204,0.05570291777188329,0.8421811796993975,1.0,5/19,8.96%,TRPM5;TRPM2;GRIN2D;ITPR1;P2RX4
prerank,mRNA 3'-UTR binding (GO:0003730),0.4862338020612435,1.4573222815447469,0.02569593147751606,0.8247910132544314,1.0,21/79,17.11%,IGF2BP1;ZFP36;IGF2BP3;TARDBP;RNF40;DDX5;LARP1;RSL1D1;ILF3;DHX36;AUH;RBMS2;HNRNPA2B1;ZC3H12A;ZFP36L1;RNPS1;SECISBP2;EXOSC9;DAZAP1;MEX3D;PCBP4
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5367905575087896,-1.4547015411644537,0.08783783783783784,1.0,1.0,11/13,46.36%,BMP6;SRC;BMP5;BMP3;BMP2;BMP4;CDH5;BMP7;GDF15;PYCARD;BMP8B
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.6843154065598175,1.4499434576178585,0.0684931506849315,0.8452679872709613,1.0,4/10,6.12%,CASP4;CASP7;CASP6;CFLAR
prerank,calcium activated cation channel activity (GO:0005227),0.6196417971506067,1.4469326690180266,0.06619718309859154,0.8393844002692925,1.0,2/17,0.73%,TRPM5;KCNMB3
prerank,BMP receptor binding (GO:0070700),-0.536819637139808,-1.4411023597501462,0.0975609756097561,1.0,1.0,11/12,46.36%,BMP6;SRC;BMP5;BMP3;BMP2;BMP4;CDH5;BMP7;GDF15;PYCARD;BMP8B
prerank,four-way junction DNA binding (GO:0000400),0.5982736198896906,1.4384489190949008,0.07816711590296496,0.8653917328317523,1.0,7/17,15.01%,MSH2;RAD51C;XRCC3;HMGB1;MEN1;HMGB3;GEN1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.45011313121491175,1.4350390610236237,0.0010050251256281408,0.863645159996589,1.0,57/269,12.75%,STAT1;STAT2;HSPA1B;PARP9;ISG15;PML;UBE2L6;DTX3L;BLZF1;TRIB3;CXCR4;AUP1;DAXX;CLU;TPI1;UBE2W;DDRGK1;CD40;CHEK2;HLTF;CUL5;FBXO7;RNF40;USP25;SUMO2;SUMO3;UBE2B;IKBKE;HSP90AB1;FBXW7;TRAF4;PSMA3;HERC2;UBXN1;GPR37;CAMLG;SLF2;DET1;SMAD2;PRKAR2B;RNF31;RBX1;HSPA8;TRAF3;ARRB2;ARIH1;SNX9;PRR7;TRAF5;FAF2;SMG5;NEK6;BAG1;PPARGC1A;MAP1LC3B;UBE2L3;RB1
prerank,SUMO binding (GO:0032183),0.6484181819808553,1.4346164829746721,0.09267563527653214,0.8435307291479935,1.0,8/13,15.55%,PML;RNF4;USP25;HERC2;UBA2;CBX4;USPL1;TDG
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.65291859400776,1.431094607148268,0.08997050147492626,0.8421609244723273,1.0,2/11,4.65%,TRPM2;ITPR1
prerank,ion channel inhibitor activity (GO:0008200),0.5227093141286718,1.4247749256938045,0.052503052503052504,0.8592176117738066,1.0,14/35,24.87%,CAMK2D;ITPR1;SLC30A1;STX7;STX8;RSC1A1;RACK1;VTI1B;SCN1B;ENSA;CALM2;WNK3;CFTR;COMMD1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.5041893966758901,1.4224083874710391,0.050400916380297825,0.8527406079655485,1.0,11/53,9.59%,MTHFR;ACOXL;XDH;CYB5R2;GFER;CYBB;ACADL;CYB5R3;DLD;LDHD;GSR
prerank,P-type ion transporter activity (GO:0015662),-0.5369886114624283,-1.4198281489096471,0.10703363914373089,1.0,1.0,6/12,27.65%,ATP6V1E1;ATP2A2;ATP2C1;ATP2A3;ATP2B2;ATP2B4
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.6588997813550588,1.4165178459402696,0.09565217391304348,0.8672034509082256,1.0,1/11,0.32%,CHRNA9
prerank,protein kinase regulator activity (GO:0019887),0.4721910613213474,1.4145011913091337,0.02127659574468085,0.8589229039202777,1.0,24/95,13.88%,CXCL10;WNT11;TAOK3;SOCS1;DAXX;CCNL1;CCNJ;CCND2;CCNL2;CCND1;CCNT2;CAB39;MT3;CSNK2B;CNPPD1;AGAP2;GMFB;PRKAR2B;NCK1;PRKAG1;NPM1;FGF13;DUS2;CCNI
prerank,thyroid hormone receptor binding (GO:0046966),0.5414702608834511,1.4114726923269394,0.07730061349693251,0.8566548378531896,1.0,3/28,2.03%,OASL;HMGN3;PRMT2
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6332473710722532,1.4088764572565284,0.08759124087591241,0.852518119828736,1.0,6/12,18.95%,SPPL2A;PSEN1;NAPSA;SPPL3;HM13;DDI2
prerank,cGMP binding (GO:0030553),0.6311566439256353,1.4082315229744107,0.09288824383164006,0.8383615278777096,1.0,2/11,8.10%,CNGB1;RAPGEF2
prerank,microtubule minus-end binding (GO:0051011),-0.5233296839921977,-1.4070062254115692,0.09090909090909091,1.0,1.0,6/13,11.67%,MACF1;TUBGCP3;TUBGCP4;TUBGCP6;HAUS4;TUBGCP2
prerank,sodium channel regulator activity (GO:0017080),0.516932239483793,1.404266555441064,0.06493506493506493,0.8430264459059892,1.0,9/37,16.17%,CAMK2D;SGK3;SGK2;FXYD4;FXYD6;RSC1A1;FXYD5;FGF13;SCN1B
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.5216309953412764,1.3959833951692824,0.08303249097472924,0.8725589326498454,1.0,13/34,21.47%,IRGM;SPRY2;ETAA1;CCNT2;CAB39;MTCP1;MAP2K2;CALM3;CCNK;CAB39L;STK3;DDX3X;CKS2
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4788027297788205,1.395322171826479,0.0405982905982906,0.8590565884189422,1.0,24/74,14.55%,ETNK1;GLYCTK;PIK3CD;TRPT1;HYKK;FCSK;PGM2L1;NOL9;IDNK;NT5C3A;FAM20B;NADK;NMRK1;PI4KB;HK1;DGKB;SPHK2;DGKK;FGGY;GNE;PIK3CB;GALK2;PANK2;FAM20C
prerank,disordered domain specific binding (GO:0097718),0.5521529943642309,1.3923732547180214,0.09523809523809523,0.8576374760485023,1.0,10/23,24.43%,TEAD2;HSP90AB1;SMAD2;RB1;FYN;HSP90AA1;CALM3;NUMA1;BCL2L2;CALM2
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6384664772088025,1.3908249289739234,0.103397341211226,0.8503204250860888,1.0,4/12,11.44%,STAT1;TRAF4;TRAF3;TRAF5
prerank,sequence-specific mRNA binding (GO:1990825),0.6525874292212251,1.3866533933873362,0.11607142857142858,0.8556584021930896,1.0,3/10,15.28%,DHFR;DHX9;ETF1
prerank,filamin binding (GO:0031005),-0.5280236882002902,-1.3849927439061676,0.11746031746031746,1.0,1.0,5/11,13.56%,DPYSL3;FBLIM1;NEBL;CRMP1;CEACAM1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.650468468269085,1.3833507167879462,0.1224188790560472,0.8573899121620863,1.0,5/10,19.50%,NSD3;SETD3;ASH1L;SETD5;SMYD2
prerank,muscle alpha-actinin binding (GO:0051371),-0.4843753769436287,-1.3832757349406368,0.08846153846153847,1.0,1.0,5/15,14.64%,PDLIM5;LDB3;PDLIM1;PKD2L1;PDLIM7
prerank,RNA methyltransferase activity (GO:0008173),0.5664349165521644,1.3813282130831455,0.11328125,0.8524583702960402,1.0,6/19,9.82%,TRMT9B;BCDIN3D;MRM2;MEPCE;TRMT13;TGS1
prerank,nucleotidyltransferase activity (GO:0016779),0.5712128849277677,1.3663384619190908,0.09762532981530343,0.9177587739369657,1.0,7/19,16.29%,TENT4A;PNPT1;CGAS;MOCS3;NUDT5;CRPPA;TUT7
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5288401384146093,1.3652627295554476,0.11152882205513784,0.9075030569269166,1.0,8/29,14.80%,SLC25A22;ABCC2;SLC26A1;SLC46A1;SLC19A1;SLC25A10;SLC26A2;SLC25A12
prerank,kinase activator activity (GO:0019209),0.5227347958584291,1.3609456876417036,0.10049019607843138,0.9156856257339152,1.0,7/30,13.05%,WNT11;DAXX;CAB39;MT3;AGAP2;MOB1B;FGF13
prerank,5'-3' exonuclease activity (GO:0008409),0.5889066219970476,1.3601691122621897,0.10296191819464035,0.9046100606510041,1.0,7/14,19.66%,XRN2;XRN1;DCP2;FEN1;DCLRE1A;TRIR;DCLRE1C
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.6182469892069009,1.3595513618668662,0.1240981240981241,0.8932352585775338,1.0,4/12,13.15%,TENT4A;TENT5A;PAPOLA;TENT5C
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.5858247750448262,1.3588297345478975,0.11978465679676985,0.8825874203137808,1.0,4/15,9.79%,RBBP5;KMT2A;SETD3;WDR5
prerank,MHC class I protein binding (GO:0042288),0.6024785000804482,1.3551553415086475,0.13012729844413012,0.8878077121615259,1.0,8/13,29.38%,TAPBP;ABCB9;TUBB4B;TAP1;ATP5F1B;PILRA;TUBB;LILRB1
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5041973413666186,1.3528113224563674,0.10235294117647059,0.8855985928021676,1.0,9/35,12.90%,STAT1;ZBTB17;AGO2;UBTF;TBPL1;NPM1;KLF10;NR3C1;TAF1B
prerank,cysteine-type peptidase activity (GO:0008234),0.45949380172187393,1.3511573212171073,0.07019438444924406,0.8799075139270098,1.0,13/73,9.04%,USP18;CASP4;CASP7;CTSS;USP50;USP25;CASP6;USP21;USP15;USP40;CTSC;CTSH;USP34
prerank,methyl-CpG binding (GO:0008327),0.5593398765353225,1.350882382232026,0.11688311688311688,0.8677310512139504,1.0,11/22,17.85%,LRWD1;MECP2;MBD2;ZBTB38;CXXC4;CHTOP;ZBTB21;ZCWPW1;PRMT1;ZBTB4;CXXC5
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5717593010041502,1.3508377268325975,0.13881401617250674,0.8548640680342476,1.0,8/18,21.20%,SOCS1;AGAP2;SOCS5;SOCS2;WDR91;SOCS6;SOCS4;SOCS7
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.6425503233021651,1.348856264052407,0.12859304084720122,0.8515441642264747,1.0,2/10,1.77%,PML;DAXX
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5735868583986449,1.3463890191008052,0.13443072702331962,0.8508625150302039,1.0,4/17,5.53%,ATP10A;ABCA1;ABCG1;PITPNM1
prerank,receptor ligand activity (GO:0048018),0.42247192724487126,1.344382147389076,0.006018054162487462,0.8490381498802198,1.0,27/245,11.33%,CXCL10;CXCL9;WNT11;IL15;AGT;CRLF1;WNT5A;BDNF;GDF9;SEMA4D;KITLG;TGFA;SFRP2;CCL5;TAFA4;OSGIN1;CX3CL1;WNT7B;CSF1;NPPC;GDNF;HMGB1;LRPAP1;TAFA2;IL17D;VEGFD;FGF9
prerank,histone methyltransferase binding (GO:1990226),0.6164291010230528,1.3416694964051388,0.13131313131313133,0.8503068645283207,1.0,5/11,12.96%,HSP90AB1;CTNNB1;LCORL;LCOR;PRDM4
prerank,protein kinase activator activity (GO:0030295),0.4620435754466683,1.3393298444107324,0.09031556039173014,0.850149406079963,1.0,18/60,22.78%,WNT11;IRGM;SPRY2;DAXX;ETAA1;CAB39;MT3;AGAP2;MTCP1;MAP2K2;FGF13;CALM3;CAB39L;STK3;DDX3X;STK11;ERBB3;GPRC5B
prerank,O-methyltransferase activity (GO:0008171),0.6419405882988691,1.3391021787844064,0.13253012048192772,0.8395129430564701,1.0,4/10,14.92%,BCDIN3D;MEPCE;COQ3;COMT
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.46335356101172365,1.3375857506709523,0.08044692737430167,0.8351266405515491,1.0,12/60,9.96%,AXL;FLT1;KDR;ACVR1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;INSR;ROR2
prerank,RNA cap binding (GO:0000339),0.5735723468424987,1.3360156718155376,0.1426553672316384,0.8314564370168835,1.0,7/16,19.48%,AGO2;LARP1;NCBP2;CYFIP1;NCBP1;DCPS;SNUPN
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.461460975095919,1.335361781736325,0.0782122905027933,0.8233731106984591,1.0,12/60,9.96%,AXL;FLT1;KDR;NRP2;EPHA4;FGFR2;RET;EPHA6;LTK;MET;INSR;ROR2
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.422206190835864,1.3316295231502788,0.02834008097165992,0.830264627789539,1.0,44/181,17.26%,STAT1;PARP9;PITX2;TAF4B;DTX3L;DDRGK1;STAT3;RBL1;MTA3;MAD2L2;BHLHE40;NCOA1;CTNNB1;ARID1A;SMARCE1;TCF7L2;DHX9;TACC2;MDFIC;MTA2;DACT1;LMO2;MAPK14;PROX1;COMMD7;DUSP26;NPM1;SNW1;LDB2;LDB1;PPARGC1A;RB1;MIER1;RNF25;BUD31;ACTB;BBS2;PIAS1;MEF2A;PIAS2;PPARD;RBPJ;TRIP4;ANXA4
prerank,transferrin receptor binding (GO:1990459),-0.5340646106191635,-1.3301610609605852,0.16216216216216217,1.0,1.0,3/10,7.68%,CD81;SNX4;IKBKG
prerank,CoA-ligase activity (GO:0016405),-0.485567792254527,-1.3269982735132557,0.14873417721518986,1.0,1.0,6/14,21.70%,ACSS3;AACS;ACSL1;ACSS1;ACSBG1;SLC27A2
prerank,chemorepellent activity (GO:0045499),-0.40541682104391186,-1.3223423331408308,0.14150943396226415,1.0,1.0,16/25,29.01%,SEMA4C;SEMA4G;SEMA4A;EPHA7;SEMA6A;SEMA4B;DPP4;SEMA3E;SEMA5B;SEMA6D;SEMA4F;NRG3;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4803942278172978,1.3222932759903285,0.12023121387283237,0.8643951540029783,1.0,4/38,9.06%,AGT;SERPINC1;SLPI;APP
prerank,cysteine-type endopeptidase activity (GO:0004197),0.4475059391143982,1.3192866801886511,0.08577633007600434,0.8686460121811423,1.0,16/78,13.04%,USP18;CASP4;CASP7;CTSS;GPAA1;USP25;CASP6;USP15;USP40;CFLAR;CTSC;CTSH;USP34;USP14;CAPNS1;CAPN1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5939516715116044,1.3173689507259103,0.1440922190201729,0.8667363528320056,1.0,2/12,7.62%,STAT1;TBPL1
prerank,neurexin family protein binding (GO:0042043),-0.5370535937869206,-1.3163527484633473,0.16510903426791276,1.0,1.0,4/10,14.60%,SYTL2;NLGN2;SYTL5;CPE
prerank,frizzled binding (GO:0005109),0.48908134731012676,1.3158138367818517,0.14774114774114774,0.8634733185863623,1.0,5/34,8.51%,WNT11;WNT5A;WNT7B;MYOC;BAMBI
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.428098725733009,-1.3153860626471499,0.12142857142857143,1.0,1.0,3/17,2.89%,BLVRA;TECR;LBR
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5539114311716119,1.3153289811622297,0.15405777166437415,0.8550856636808297,1.0,5/18,15.90%,NOL3;BIRC2;MT3;BIRC3;CD27
prerank,NAD binding (GO:0051287),0.5123425679727808,1.3141895199101383,0.13283208020050125,0.8500001533761982,1.0,4/26,1.99%,PARP9;ZC3HAV1;SORD;GRHPR
prerank,calcium-activated potassium channel activity (GO:0015269),0.6105990379935566,1.313720348863181,0.14564564564564564,0.8420017172612208,1.0,1/11,0.73%,KCNMB3
prerank,glutathione transferase activity (GO:0004364),-0.396960414136515,-1.3137125953906448,0.1085972850678733,0.9755927197253931,1.0,13/23,40.07%,LTC4S;ALOX5AP;GSTO1;GSTA3;PTGES;GSTM1;GSTA4;HPGDS;GSTM5;LANCL1;GSTT1;GSTP1;GSTT2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.5773790493737697,1.311993071084458,0.1565217391304348,0.8402046256731872,1.0,5/14,17.54%,MTHFR;DHFR;AASS;BLVRB;MTHFD1
prerank,ADP binding (GO:0043531),0.514793226493052,1.3105756810567357,0.13114754098360656,0.8366592931811287,1.0,11/25,19.78%,MSH2;ABCG1;ABCD1;PRKAG1;LONP1;MYO6;GLUD1;GCLC;MYH9;ERN1;TAP1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5046456561915562,1.3087889213660766,0.14470284237726097,0.835097647785279,1.0,6/28,11.44%,STAT1;TNFSF9;FEM1B;TRAF4;TRAF3;TRAF5
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5949408761821996,1.3087102032498725,0.16865671641791044,0.8259125251717666,1.0,6/12,18.02%,AGO2;LARP1;NCBP2;CYFIP1;NCBP1;DCPS
prerank,DNA polymerase binding (GO:0070182),0.5479896237671716,1.3052852311609655,0.156,0.8316835187465658,1.0,8/18,17.24%,HSP90AB1;POLG2;CDT1;RTEL1;HMGB1;LONP1;HSP90AA1;PTGES3
prerank,kinase activity (GO:0016301),0.4304572733102264,1.3022274772730027,0.06444906444906445,0.8359960701713319,1.0,30/109,16.76%,PKMYT1;ETNK1;GLYCTK;TRIB3;PIK3CD;ITPKC;HYKK;FCSK;PKN2;PGM2L1;EPHA4;IDNK;PPIP5K1;SEPHS1;LYN;NADK;NMRK1;PI4KB;DGKB;CERKL;SPHK2;DGKK;BCKDK;PIK3CB;PANK2;MASTL;MTOR;IRAK1;STK39;DGKA
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.5176668546600474,1.3016339614562862,0.14583333333333334,0.8294494710736602,1.0,10/22,23.55%,ZFP36;ILF3;DHX36;ZC3H12A;ZFP36L1;EXOSC9;MEX3D;CPEB2;EXOSC4;ZFP36L2
prerank,histone deacetylase binding (GO:0042826),0.4313704081586321,1.300166438041629,0.08924731182795699,0.8269115122387691,1.0,35/88,25.29%,HSPA1B;THAP7;MEF2B;MTA3;PKN2;NACC1;DHX36;HSP90AB1;CCND1;USF1;MTA2;DACT1;SMG5;LCOR;MIER1;ZMYND15;HSP90AA1;CAMTA2;MEF2A;HDAC1;BCOR;ANKRA2;GLI3;PRDM1;HDAC2;NACC2;RAD9A;KCTD21;HDAC4;HDAC6;NCOR2;KAT2B;TFAP4;YWHAE;SIRT2
prerank,ligand-gated cation channel activity (GO:0099094),0.4332983569430743,1.2999997512245938,0.09635974304068523,0.8186275345485378,1.0,9/75,10.12%,CHRNA9;TRPM5;TRPM2;GRIN2D;GRIK3;ASIC4;GRIA2;P2RX4;CCDC51
prerank,leucine zipper domain binding (GO:0043522),0.6120670594467937,1.2986926467800173,0.1641337386018237,0.8157518779557285,1.0,2/10,7.91%,DAPK3;MRTFA
prerank,neuropeptide receptor binding (GO:0071855),0.5661405486900384,1.2957325763705163,0.17348377997179126,0.8197529082190727,1.0,1/14,0.59%,GAL
prerank,ubiquitin-protein transferase activity (GO:0004842),0.40363822570416735,1.2942411930025395,0.01001001001001001,0.8182032551063757,1.0,92/346,18.78%,RNF213;PML;TRIM14;IRF2BP1;UBE2L6;DTX3L;RNF214;TRIM25;TRIM45;UBE2W;BIRC2;NFX1;KLHL20;RNF4;TMEM129;HLTF;CUL5;FBXO7;RBCK1;RNF40;TRIM21;RNFT1;RNF5;BFAR;CNOT4;SIAH1;UBE2B;TNFAIP1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;TRIM39;UBE2M;VPS11;RNF114;AMFR;RSPRY1;KLHL13;FBXW8;ANAPC4;RNF19B;RNF31;RBX1;UBE2E3;BARD1;PPP1R11;UBE2E1;RING1;TRAF3;ARIH1;BTRC;RNF122;RNF103-CHMP3;TRAF5;TRIM26;RNF149;SMURF1;FBXL14;KLHL9;UBE2L3;NEURL1B;NEURL3;RNF185;KCMF1;SHARPIN;MYLIP;RNF25;BIRC3;NSMCE1;UBE2Q1;DZIP3;MYCBP2;NHLRC3;RNF103;UBR4;LMO7;GID4;RNF166;MIB2;FBXL5;UBE2K;HECTD1;CBLL1;BIRC6;TRIM2;TRIM62;WWP1;RFFL;MGRN1;ASB1
prerank,acetyltransferase activity (GO:0016407),0.4837458180097203,1.293176220243264,0.1473551637279597,0.8141900139824959,1.0,5/31,6.22%,SATL1;SAT1;PAFAH1B3;NAA50;SMARCE1
prerank,glycine binding (GO:0016594),-0.51418922730845,-1.2901839779672493,0.17791411042944785,1.0,1.0,5/11,11.69%,GRIN2B;SRR;GRIN1;GLRB;GLRA3
prerank,lipoprotein particle receptor binding (GO:0070325),0.5069157576838569,1.2888151053900099,0.14102564102564102,0.8255574369557834,1.0,11/27,26.66%,CLU;AP2A1;LDLRAP1;LRPAP1;APOE;APBB1;ANKRA2;HSP90B1;SNX17;LRP1;DNAJA1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4782282792617433,1.2886684962402328,0.1503030303030303,0.8175426197378611,1.0,8/35,7.11%,TRMT9B;TRPT1;BCDIN3D;TRMT13;PTRH2;NT5C3A;ALKBH1;AARS1
prerank,ion channel activity (GO:0005216),0.4332513157462757,1.2885426615632793,0.10741138560687433,0.8097728163867589,1.0,18/80,16.24%,TRPM5;CNGB1;TRPM2;GRIN2D;GRIK3;TMC1;TRPM6;ASIC4;GRIA2;CALHM6;TMEM120B;TRPM3;KCNK3;TRPV4;CHRNB2;TRPM7;GRID1;GRIA4
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.40634239690344653,-1.2856635934217389,0.1487603305785124,0.9933892791570208,1.0,4/21,5.01%,ACBD3;PRRC1;AKAP1;GSKIP
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4323418128771101,1.2829157055177693,0.09503695881731784,0.8263244530920552,1.0,21/83,15.13%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;USP39;ZRANB1;USP45;MINDY3;USP37
prerank,damaged DNA binding (GO:0003684),-0.3392482693982829,-1.2826127240291745,0.07534246575342465,0.9594704010765319,1.0,19/44,19.73%,RPA1;RAD18;NBN;CRY2;APTX;ERCC3;XPC;ERCC2;DCLRE1B;SMC6;PNKP;OGG1;NEIL3;FANCG;RAD1;ERCC1;RPA3;XPA;POLD1
prerank,single-stranded DNA helicase activity (GO:0017116),0.5325718350674371,1.281166945414029,0.19724137931034483,0.8258097728629997,1.0,6/19,11.64%,MCM2;MCM7;HELQ;RFC4;DHX9;POLQ
prerank,neuropeptide receptor activity (GO:0008188),0.4901077075953809,1.273968758575384,0.16831683168316833,0.8492494290734665,1.0,4/29,11.44%,GAL;TACR1;GPR37;GALR1
prerank,ATPase binding (GO:0051117),0.42839779386188737,1.2738322097293915,0.11434735706580366,0.8416432589565871,1.0,11/71,6.54%,CHMP4A;NR1H2;ABCA1;TOR1AIP2;TOR1AIP1;METTL21A;ATP1B3;USP25;SNX10;ANK1;UBXN1
prerank,protein phosphatase regulator activity (GO:0019888),0.4543515868667014,1.2731449889068274,0.12965050732807215,0.8364081403507974,1.0,21/53,24.43%,EIF2AK2;RCAN1;ARPP19;ANKLE2;PPP2R5C;IGBP1;PPP6R3;PPP2R5D;PPP4R2;CALM3;PHACTR4;MGAT5;PPME1;PPP2R2A;PPP1R7;SET;PPP2R5A;PPP2R3A;CABIN1;ENSA;CALM2
prerank,omega peptidase activity (GO:0008242),0.4252574071774881,1.2721963157872769,0.10020876826722339,0.8326046864084433,1.0,22/89,15.13%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;GGT7;USP39;ZRANB1;USP45;MINDY3;USP37
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5205376633706081,1.2713679357308012,0.1834862385321101,0.8280774856688838,1.0,9/22,23.72%,CLU;AP2A1;LDLRAP1;LRPAP1;APOE;APBB1;ANKRA2;HSP90B1;SNX17
prerank,3'-5' DNA helicase activity (GO:0043138),0.5443524573040326,1.2712150329331082,0.18549511854951187,0.820876641584647,1.0,5/16,7.25%,ASCC3;MCM2;MCM7;HELQ;DHX9
prerank,voltage-gated ion channel activity (GO:0005244),-0.4585118090629967,-1.2702487732842986,0.16776315789473684,0.9640267930361327,1.0,4/14,11.64%,VDAC1;KCND2;GPR89B;GPR89A
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5003013219743613,1.2678801829395896,0.1736842105263158,0.827272813210787,1.0,4/24,5.94%,CAMK2D;CAMK2B;PNCK;MKNK1
prerank,hexosyltransferase activity (GO:0016758),0.4142977147797557,1.2666335121468912,0.09926854754440961,0.8247776941960729,1.0,24/101,19.22%,EXT1;HAS3;HYAL1;DPY19L4;HAS1;TMTC1;POMT1;POMT2;PIGV;B4GALT4;B4GALT1;GCNT4;B4GALT5;CSGALNACT2;B3GLCT;MGAT4C;B3GALNT1;B4GALT2;TMTC4;DPY19L1;FUT9;GYG1;GBA2;PIGB
prerank,nucleoside-triphosphatase activity (GO:0017111),0.401263394183953,1.2660941228253197,0.0371859296482412,0.8198505709014775,1.0,73/248,22.51%,RNF213;GBP4;HSPA1B;TOR3A;IRGM;GBP5;CLU;RAB8B;ATL1;GBP3;KIF26A;RAB21;KIF3C;GBP2;RHOF;GPN2;SRPRA;GSPT1;CHD1L;RHEBL1;GBP7;RRAGC;RHOJ;GNA15;GNA14;LSG1;DHX9;RAB22A;AGAP2;GFM1;RAB43;RAB11B;RAB5C;RAP1GAP;ABCD1;GCH1;DNM2;RAB14;ARL1;RAB24;MYO6;SEPTIN9;RAC1;EFTUD2;TBCC;KIF2A;HSP90AA1;GPN3;GNL2;GPN1;RAB11A;RAB32;DYNC2H1;ATAD1;HBS1L;RHOT2;MYH9;PIN1;RAP2A;RAB5B;RAB1A;RND2;DDX3X;MTG2;RIT1;MMUT;RHOH;RHEB;SMCHD1;RRAGA;RUVBL2;ENTPD7;RAB2A
prerank,G protein-coupled receptor binding (GO:0001664),0.41149296791374373,1.2646270661620747,0.09044193216855087,0.8186253191616848,1.0,17/132,10.09%,HSPA1B;WNT11;CALCA;NPB;WNT5A;RTP4;S1PR2;CCL5;REEP2;GNA15;GNA14;WNT7B;TUB;MYOC;BAMBI;HSPA8;ARRB2
prerank,poly(U) RNA binding (GO:0008266),0.5160087647726261,1.2550281844953426,0.18193891102257637,0.8518071424872355,1.0,6/20,14.74%,PNPT1;HNRNPH1;RBMS2;ATXN1;DIS3L2;DAZAP1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.42171220825352845,1.2510526406547366,0.15075921908893708,0.8614960347574065,1.0,11/70,11.71%,EXT1;HAS3;HYAL1;HAS1;B4GALT1;GCNT4;CSGALNACT2;XXYLT1;B3GLCT;MGAT4C;B3GALNT1
prerank,double-stranded DNA binding (GO:0003690),0.38806892470517185,1.2498958251281413,0.009,0.8589634963793863,1.0,72/531,12.97%,DDX60;STAT1;ZBP1;IRF7;PITX2;SYCP1;LMX1A;MSH2;USF2;ETV3;MEF2B;AIM2;TFAP2C;GMEB2;ESRRB;RARG;BBX;TARDBP;TEAD2;ZBTB2;NFKB2;MECP2;CGAS;BATF3;ELK3;CGGBP1;BHLHE40;NKX6-2;KLF15;JUNB;POLG2;ZNF23;SOX9;ZNF76;TCF4;ZBTB43;BCL6;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;FEN1;SMAD2;MEIS3;ATF6B;HOXA9;NFIB;POU3F1;HMGB1;ELF4;IRF9;MEN1;NR2C1;PROX1;FOXK1;MAX;XBP1;HMGB3;KLF10;CUX1;TEF;MAU2;PRKDC;HOXB6;NR3C1;DDX11;PRDM4;E2F4
prerank,histone acetyltransferase binding (GO:0035035),0.5132222480310397,1.2466816666993825,0.196870925684485,0.8657032565030508,1.0,10/21,25.37%,STAT1;ECD;KANSL1L;MEF2A;TRIP4;CITED2;GLI3;TAF7;SIRT2;EPAS1
prerank,potassium channel regulator activity (GO:0015459),0.4413359748333277,1.2446017846652029,0.16514806378132119,0.8674244579136055,1.0,17/49,25.68%,KCNMB3;SGK3;SGK2;ARPP19;KCNS3;AKAP9;DLG1;KCNS1;ABCC9;SUMO1;ENSA;FLNA;WNK3;YWHAE;DPP10;DPP6;CHP1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.4851799976587481,-1.2443480139989604,0.19435736677115986,1.0,1.0,8/11,46.83%,KCND3;KCNH2;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,DNA replication origin binding (GO:0003688),0.5023906546990377,1.243263512461192,0.1981981981981982,0.8656269046669213,1.0,7/23,12.58%,MCM2;MCM7;MCM4;MCM9;DHX9;ORC3;DDX11
prerank,NAD+ binding (GO:0070403),0.5600948872113801,1.2416349875055384,0.21782178217821782,0.8656202010013578,1.0,2/12,0.64%,PARP9;ZC3HAV1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3895227841959998,1.2414387543088876,0.05628140703517588,0.8591065364733883,1.0,51/254,13.20%,HSPA1B;ISG15;PML;UBE2L6;BLZF1;TRIB3;CXCR4;AUP1;DAXX;CLU;TPI1;UBE2W;CD40;CHEK2;HLTF;CUL5;FBXO7;RNF40;USP25;SUMO2;UBE2B;IKBKE;HSP90AB1;FBXW7;TRAF4;PSMA3;HERC2;UBXN1;GPR37;CAMLG;SLF2;DET1;SMAD2;PRKAR2B;RNF31;RBX1;HSPA8;TRAF3;ARRB2;ARIH1;SNX9;TRAF5;FAF2;SMG5;NEK6;BAG1;PPARGC1A;MAP1LC3B;UBE2L3;RB1;APBB1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5200853789461408,1.2405845754449532,0.21320495185694635,0.8555893609728069,1.0,3/18,11.74%,HSD17B7;HSD11B1;DHRS11
prerank,galactosyltransferase activity (GO:0008378),0.5804386234984847,1.239471128794505,0.2318181818181818,0.8533286368353445,1.0,4/11,12.34%,B4GALT4;B4GALT1;B4GALT5;B4GALT2
prerank,lipid phosphatase activity (GO:0042577),0.5457462257802872,1.23787923175031,0.22708039492242596,0.8523018967512316,1.0,9/14,25.46%,SGPP2;EPHX2;INPP5K;PLPP2;PLPP7;PLPPR2;PLPPR1;PLPP6;PLPP1
prerank,deubiquitinase activity (GO:0101005),0.4168504651239927,1.2378417407616225,0.13938753959873285,0.8455398231674687,1.0,21/88,15.13%,USP18;USP50;USP25;USP21;USP15;OTUD3;USP40;CYLD;UCHL5;UCHL3;USP34;VCPIP1;JOSD2;ZC3H12A;OTUD1;USP14;USP39;ZRANB1;USP45;MINDY3;USP37
prerank,RNA binding (GO:0003723),0.38127511647276235,1.2350288058763015,0.0,0.850538596963085,1.0,341/1321,19.64%,IFIT3;DDX60;OAS3;IGF2BP1;ZBP1;OASL;EIF2AK2;PARP12;NOL3;OAS2;IFIH1;SAMHD1;HSPA1B;ZNFX1;HELZ2;IFIT1;MCAT;RPS19BP1;MOV10;ZC3HAV1;APOBEC1;IFIT2;ASCC3;BST2;DHFR;DHX58;PWP2;POLR2G;MYBBP1A;PNPT1;KNOP1;CCDC86;CPNE3;TRIM25;TRMT9B;FNDC3A;ZFP36;NFX1;HTATSF1;CSRP1;XRN2;ZC3H7A;ACTN1;EIF4A2;ADAR;DHX33;IGF2BP3;AGO2;RBM14;TARDBP;SUGP2;MECP2;HLTF;SBDS;STAT3;DDX27;DDX18;MSI1;TDRD7;ZNF106;RPL36;YTHDF1;ZC3H12C;DDX5;MAGOHB;HARS2;ZFR2;SMG7;FLNB;PKN2;DDX49;ERAL1;HNRNPH1;SUMO2;TARBP2;DYNC1H1;LARP1;RBMX;CNOT4;SRPRA;MRPS30;SRRT;RSL1D1;NOP53;MTHFSD;ILF3;DHX36;HSP90AB1;COL14A1;NCBP2;KPNB1;GSPT1;TLR8;UBTF;TCOF1;MRPL12;RPL22;MRM3;CHERP;XRN1;HNRNPK;GPATCH1;NGRN;PRPF40A;RCC1L;SLPI;RPS21;MEPCE;WDR33;PIN4;LAS1L;TRMT1;RBMS2;TRNAU1AP;TFB2M;EDF1;FNDC3B;DDX20;CFAP65;DCP2;MRPL16;ALKBH1;HNRNPM;SEPSECS;AARS1;RRS1;PPAN;MRPS35;MRPS28;CCT4;BICC1;DHX9;SRF;CISD2;NUDT5;N4BP1;HNRNPA2B1;MAPRE1;GAR1;PPIA;SF3B6;GFM1;RO60;RAE1;TUFM;UCHL5;NOLC1;YTHDF2;RPL7L1;NONO;SLTM;RNMT;CLK3;BARD1;HMGB1;SRPK1;PPP1R10;HNRNPL;HSPA8;SLIRP;SSRP1;DIMT1;DHX30;NCOA5;G3BP2;EIF4H;STAU1;DUSP14;DDX24;ZC3H12A;NPM1;ZC3H4;PUM3;CCT3;PRR3;FAM98B;SNW1;ZFP36L1;DDX50;HNRNPDL;RNPS1;RBFOX1;HDLBP;TENT5A;RALY;MRPL42;EIF3A;LONP1;ABCF1;SMG5;HMGB3;HNRNPH3;NKAP;HNRNPA1;PRRC2B;CELF6;ILF2;NOP2;PPARGC1A;PRKDC;HOXB6;TRMT10C;DDX54;MRPL4;DDX11;UBE2L3;KTN1;GTF2E2;SECISBP2;EWSR1;ZC3H11A;RACK1;RPS6;MATR3;DENR;CHTOP;ALG13;SART1;EIF4G3;MRPS23;TIAL1;ZC3H7B;SPATS2;CLNS1A;SNRPD2;SNRPD1;KRI1;DUS2;DBR1;NOP16;ADAT1;EIF1B;WDR43;EIF2S1;DHX57;EXOSC9;EFTUD2;RPN1;DUSP11;RBM45;PCF11;RBM27;PATL2;RPS11;MAP4;CFAP20;DZIP3;DAZAP1;DDX39B;RPL30;HSP90AA1;RBM15;NOA1;SNRPG;MBNL2;ZC3H13;RBFOX3;RBM39;ETF1;NCBP1;RBM3;DDX19B;PRPF40B;TUBB4B;DHX16;NUDT16;TAF15;SNTB2;GNL2;RPL32;UBA1;SRSF7;BZW1;SF3B4;PRMT1;RPL23A;MEX3D;RPL11;SRSF4;TUT7;DHX40;DHX37;ZBED4;UPF1;DDX47;RTCB;PUS7;METAP2;YARS2;DICER1;METTL14;HNRNPA3;RPL10A;NUDT4;RPP30;PCBP4;NOL4;PRKRA;RRP1;RRP1B;TLR3;DDX46;RPS15A;MRPL13;LRRFIP1;CWC22;PELP1;ZMAT3;DDX23;SRBD1;ENDOV;RPP14;MYH9;LSM5;POLR1G;CAVIN1;TBRG4;CPEB2;CAPRIN1;RBPMS;RSL24D1;RPL24;RPL37A;FASTKD2;BUD23;EIF4B;ZCCHC3;RPL3;MRPS11;ESF1;DDX19A;MRPL40;MRPL22;RC3H2;RPP25L;HNRNPF;UTP3;SNUPN;DNAJC21;RBM28;EIF5
prerank,N-methyltransferase activity (GO:0008170),0.4979624671582768,1.231914019681323,0.21515561569688768,0.8570780578387057,1.0,8/20,16.55%,ZCCHC4;TRMT1;TFB2M;SETD3;RNMT;DIMT1;PRMT1;METTL15
prerank,solute:proton symporter activity (GO:0015295),0.5315314417283015,1.231401013243023,0.22465753424657534,0.8523570199657172,1.0,5/16,15.49%,MFSD3;SLC15A2;SLC11A2;CTNS;SLC2A9
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.42862334266164875,1.2311582726478374,0.1815028901734104,0.8466981812153149,1.0,25/49,25.93%,PARP10;UBQLN2;IKBKE;UBXN1;UBQLN1;TNIP1;ZRANB3;SHARPIN;ZRANB1;TNIP2;DZIP3;SPRTN;TNIP3;BABAM2;TAB3;ATRIP;ZFAND6;OPTN;UBQLN4;PSMD4;VCP;HDAC6;UBL7;RAD23A;ABRAXAS2
prerank,ribosomal large subunit binding (GO:0043023),0.5692907058087697,1.2294906255217868,0.24172661870503598,0.8467756105320007,1.0,5/11,18.42%,DHX33;NPM1;EIF6;RBM3;CPEB2
prerank,protein phosphatase binding (GO:0019903),0.4051983390035314,1.2291067931467454,0.12293388429752067,0.841622439804182,1.0,25/117,13.11%,MYOZ2;FCRL6;PPP1R3E;STAT3;ARPP19;ANAPC5;ANKLE2;SMG7;IKBKE;PPP1R3D;CTNNB1;ANK1;IGBP1;PPP6R3;ANAPC4;AKAP11;VRK3;MET;PPP1R11;MAPK14;TRAF3;CDC27;SMG5;RACK1;BAD
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.5330989734018701,1.2267438430597157,0.2530612244897959,0.844435143014699,1.0,6/15,21.20%,SOCS1;SOCS5;SOCS2;SOCS6;SOCS4;SOCS7
prerank,adenyl nucleotide binding (GO:0030554),-0.47665785978282826,-1.225471827055191,0.21311475409836064,1.0,1.0,8/11,24.36%,HSPH1;SIL1;GRPEL1;BAG4;BAG5;BAG3;GRPEL2;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.47665785978282826,-1.225471827055191,0.21311475409836064,1.0,1.0,8/11,24.36%,HSPH1;SIL1;GRPEL1;BAG4;BAG5;BAG3;GRPEL2;BAG2
prerank,DNA-binding transcription factor binding (GO:0140297),0.3896048881500573,1.2239357693644435,0.09504550050556117,0.8494656872575519,1.0,48/189,19.43%,STAT1;PITX2;DAPK3;USF2;ZBTB17;DDRGK1;STAT3;RBL1;MTA3;CGGBP1;MAD2L2;BHLHE40;CTNNB1;TCF7L2;DDX20;USF1;DHX9;SRF;MTA2;SMAD2;DACT1;LMO2;SCX;HMGB1;CRTC1;DUSP26;NPM1;SIK1;NEK6;LDB2;LDB1;RB1;MIER1;CRTC3;BBS2;PIAS1;MEF2A;PIAS2;PPARD;RBPJ;CHCHD2;ZBTB49;CXXC5;HDAC1;PRRX1;CTBP1;PSMD9;BEX1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5502223770378657,1.2234713434700608,0.22340425531914893,0.8448299401624498,1.0,3/12,7.48%,XDH;FXN;CISD2
prerank,chloride channel inhibitor activity (GO:0019869),0.5636051532497123,1.2234414494970276,0.25975975975975973,0.8385938138037945,1.0,5/10,24.80%,STX7;STX8;VTI1B;WNK3;CFTR
prerank,manganese ion binding (GO:0030145),0.4379910942784452,1.2230519171430572,0.20022497187851518,0.8338397934790974,1.0,16/48,21.67%,XYLT2;SOD2;HMGCL;FEN1;B4GALT1;XXYLT1;PIM1;DYRK2;PAPOLA;FAM20C;GALNT1;NUDT16;MGAT5;GYG1;MTPAP;ABL2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5109026096846122,1.219802547193159,0.21635883905013192,0.8404679683567594,1.0,5/20,6.96%,USP50;SENP3;USP25;USP21;SENP5
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5512926458610325,1.217147502005239,0.2298507462686567,0.8447680746499046,1.0,4/12,12.43%,IRS1;SOCS1;INSR;SOCS2
prerank,nuclear receptor binding (GO:0016922),0.39596788130764393,1.2168614598000864,0.15441176470588236,0.8398328926216346,1.0,19/111,13.61%,STAT1;OASL;HMGN3;DAXX;PRMT2;DDX5;NCOA1;CTNNB1;ARID1A;SMARCE1;TCF7L2;TACC2;MED12;PROX1;SNW1;PPARGC1A;DDX54;LCOR;BUD31
prerank,lysine-acetylated histone binding (GO:0070577),0.4916409250798538,1.2166877248471049,0.2243839169909209,0.8284147992513077,1.0,7/20,16.79%,THAP7;BRD2;PSME4;KMT2A;PHIP;MLLT3;BRD7
prerank,acetylation-dependent protein binding (GO:0140033),0.4916409250798538,1.2166877248471049,0.2243839169909209,0.8284147992513077,1.0,7/20,16.79%,THAP7;BRD2;PSME4;KMT2A;PHIP;MLLT3;BRD7
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.420773434831582,1.2164763824292077,0.18967452300785634,0.8233642963359097,1.0,14/55,16.66%,SLC38A2;SLC38A1;SLC46A1;SLC19A1;SLC38A3;SLC25A10;SLC38A6;PDPN;SLC7A6;ABCC1;SLC16A13;SLC16A14;SLC16A6;SLC36A4
prerank,translation initiation factor activity (GO:0003743),0.4535017675316127,1.2161937433556906,0.19327731092436976,0.8186917464866283,1.0,17/36,27.56%,EIF4A2;AGO2;MTIF3;EIF2B2;EIF3A;EIF4G3;EIF1B;EIF2S1;EIF3K;EIF2B5;EIF2B3;EIF5;EIF3I;EIF3C;EIF4E;EIF4E2;EIF2B4
prerank,syntaxin binding (GO:0019905),0.4196870493645749,1.2136086811873155,0.1829405162738496,0.8224493406741002,1.0,20/61,16.47%,ABCA1;CPLX1;STX7;VPS11;VPS54;BAIAP3;CACNA1A;SYT3;STX8;STX16;TMED10;VAMP1;SCFD1;VPS52;VAMP2;NAPB;NAPA;SNAP23;RAB11A;STXBP5L
prerank,mannose binding (GO:0005537),-0.4740543393255199,-1.2109441265988543,0.2408026755852843,1.0,1.0,4/12,23.46%,CLN5;CLEC4D;LMAN2L;CLEC6A
prerank,mannosyltransferase activity (GO:0000030),0.49221969186231157,1.2101769914737717,0.21973684210526315,0.8297931307645073,1.0,8/21,19.22%,DPY19L4;TMTC1;POMT1;POMT2;PIGV;TMTC4;DPY19L1;PIGB
prerank,protein homodimerization activity (GO:0042803),0.3752853211975526,1.2073186067237158,0.021,0.835378150068926,1.0,152/590,22.29%,STAT1;GBP4;TPST1;CLTRN;PML;CHMP4A;CHMP4B;TRIM14;AGXT;EXT1;MSH2;GBP5;BST2;DAPK3;USF2;PPCS;CAMK2D;XDH;NOD1;SPPL2A;DPY30;ABCG1;TPI1;GRHPR;PRMT2;B2M;CAMK2B;ACTN1;GBP3;CHEK2;CANT1;ACVR1;STAT3;RNF40;TRIM21;PAFAH1B3;GBP2;TARBP2;BHLHE40;ZHX3;PEX7;GOLGA5;CCL5;MZF1;HSP90AB1;DCK;TNNC1;KMT2A;FGFR2;SH3GLB1;ZBTB38;WDR54;USF1;TFAP2B;ABCB9;DUSP29;CSF1;IDH1;CPQ;SRF;ST6GAL1;CISD2;NUDT5;TPD52L1;CCDC88A;HSD11B1;CST7;GDNF;BANF1;NFS1;BARD1;RAP1GAP;VAPB;MKLN1;TMEM266;ABCD1;HOOK1;GCH1;SNX9;NPM1;ATIC;NECTIN3;IL17D;CEP131;SRGAP2;STARD3;LDB1;EPHX2;APOE;ENPP1;RACK1;MASP1;SHMT1;SPPL3;CRPPA;HSP90AA1;GEN1;STK25;BMPR1A;CCDC66;NRBP1;NUDT16;TDG;PGRMC1;DSCAML1;MIGA2;IRAK1;ZBTB4;YARS2;SNX1;BAX;PRKRA;LRRFIP1;CLCN1;GLB1;ABCB7;HM13;MYH9;ACOX1;TARS2;GYG1;PSMD7;RBPMS;TERF2;ERN1;TAP1;RIPK2;TYROBP;POU3F3;ABCG2;PSMF1;RPE;APPL2;TKT;LHPP;ZDHHC3;MCL1;MMUT;TPD52;MTPAP;GADD45A;TENM4;SMCHD1;S100A13;PON3;CHMP1A;SNX2;TSG101;STUB1;RRAGA;HMGCS1;IDE
prerank,ATPase activator activity (GO:0001671),0.4940797429541262,1.2070957650636922,0.25686813186813184,0.8304466873015416,1.0,5/20,9.81%,TOR1AIP2;TOR1AIP1;ATP1B3;DNAJB4;DNAJB6
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.48339715021028173,-1.2008685785533337,0.2514450867052023,1.0,1.0,8/10,51.68%,SLC6A11;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2;SLC6A1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5345845927716235,1.2001624255126655,0.2631578947368421,0.8518407246048251,1.0,4/14,29.21%,RDH11;RDH10;AKR1A1;DHRS3
prerank,anion transmembrane transporter activity (GO:0008509),0.5579147623600141,1.2000536495343552,0.24583333333333332,0.8465215855001974,1.0,5/12,20.40%,ABCC2;SLC19A1;SLC4A2;ABCG2;ABCC5
prerank,CCR chemokine receptor binding (GO:0048020),0.45927820588711143,1.199637792874729,0.22732919254658385,0.8422192898459646,1.0,5/28,13.94%,CCL7;CCL5;CX3CL1;CCL14;NARS1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.5286010596046246,1.1983980138088168,0.2802275960170697,0.8417913423916101,1.0,5/15,19.67%,SAP30L;RUBCNL;SH3PXD2B;PHLDA3;PLA2G4E
prerank,E-box binding (GO:0070888),0.4507010393122803,1.1982411236153858,0.2184873949579832,0.8367415605649224,1.0,7/34,11.42%,CIART;BHLHE40;TCF4;SNAI2;SCX;MAX;MITF
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.486034274703544,1.1924508633988915,0.2403718459495352,0.8534764353615899,1.0,6/21,11.64%,POLD4;POLE2;POLM;POLB;POLK;POLQ
prerank,growth factor activity (GO:0008083),0.40352246475725184,1.189507478342647,0.21366594360086769,0.8594438404788391,1.0,8/74,11.33%,AGT;BDNF;TGFA;OSGIN1;CSF1;GDNF;VEGFD;FGF9
prerank,nuclease activity (GO:0004518),0.4194864715535404,1.1875723835410295,0.2242152466367713,0.8611459380044066,1.0,12/52,14.13%,SAMHD1;XRN2;AEN;RNASEH2A;FEN1;N4BP1;RNASE7;ZC3H12A;ENPP1;RNASE1;DIS3L2;REXO1
prerank,protein phosphatase 2A binding (GO:0051721),0.470581195445364,1.1830957034012235,0.24872448979591838,0.8730158676781054,1.0,13/23,28.12%,ARPP19;ANKLE2;SMG7;IGBP1;SMG5;MASTL;PPME1;MFHAS1;STRN3;ENSA;GRIN3A;BOD1;CTTNBP2NL
prerank,phosphatidylinositol binding (GO:0035091),0.39060614061172516,1.1829933231236682,0.20442571127502634,0.8677550373618307,1.0,34/91,24.26%,GPAA1;THY1;PLEKHN1;GAP43;ITPR1;GRAMD2A;PITPNM1;SNX10;DENND1A;RUBCNL;CCDC88A;PLEKHF2;WDFY1;SNX9;ANKFY1;RUBCN;SNAP91;RPH3A;SNX1;SNX24;TULP3;NUMA1;DENND1B;PIGK;APPL2;TNFAIP8L3;SNX2;ESYT2;ZFYVE1;PITPNA;EEA1;SNX17;SNX12;WDFY3
prerank,DNA polymerase activity (GO:0034061),0.4784856891842364,1.1796107899369768,0.25857519788918204,0.8748292498412719,1.0,6/22,11.64%,POLD4;POLE2;POLM;POLB;POLK;POLQ
prerank,cytokine receptor binding (GO:0005126),0.3931270018586496,1.1786078732838268,0.21621621621621623,0.87310191021544,1.0,18/83,18.76%,CRLF1;TNFSF9;KITLG;USP15;CCL5;IL27;ERAP1;CSF1;SMAD2;TIMM50;VEGFD;SOCS2;JAK2;IL1RAP;PIBF1;IL18;CD300LF;SPRED1
prerank,bHLH transcription factor binding (GO:0043425),0.48237102215453065,1.177249463699414,0.26897470039946736,0.8730040340498266,1.0,5/19,9.11%,USF2;BHLHE40;USF1;LMO2;SCX
prerank,calcium channel inhibitor activity (GO:0019855),0.5312088635114276,1.1771365532193327,0.2838801711840228,0.867810950475182,1.0,2/11,5.28%,ITPR1;SLC30A1
prerank,chloride transmembrane transporter activity (GO:0015108),0.5015180767678585,1.1758288262857537,0.26788218793828894,0.8671239337422043,1.0,5/16,15.71%,SLC26A1;SLC12A5;CLCN6;SLC26A2;CLCN7
prerank,phosphoric ester hydrolase activity (GO:0042578),0.41863326956109603,1.1757798237197923,0.2409090909090909,0.861897751280672,1.0,14/49,21.42%,SAMHD1;DUSP3;PDXP;SBF1;DUSP28;EPHX2;DUSP10;DUSP16;DUSP11;ENPP6;DUSP8;SACM1L;LHPP;PGAM5
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.5359865122017022,1.17482058881816,0.29246676514032494,0.8601258104965809,1.0,4/12,13.11%,NOD1;CTSH;RACK1;BAD
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4468839069513726,-1.174763504760804,0.24358974358974358,1.0,1.0,4/11,32.11%,DDAH1;PADI4;DDAH2;ARG2
prerank,guanyl ribonucleotide binding (GO:0032561),0.37504081679894136,1.1747463931159843,0.16967871485943775,0.8551454809105818,1.0,43/196,16.75%,GBP4;CNGB1;GBP5;TUBD1;ARF3;TUBB2B;RAB8B;ATL1;GBP3;RAB21;GBP2;RHOF;RHEBL1;GBP7;RAB12;SLC19A1;RRAGC;RHOJ;LSG1;ARF5;RAB22A;AGAP2;RAB11B;RAPGEF2;SEPHS1;RAB5C;EIF2B2;INSR;TUBE1;GCH1;DNM2;RAB14;ARL1;ARL5C;RAC1;NOA1;TUBB4B;NUDT16;GNL2;GLUD1;ARF4;RAB32;RANBP17
prerank,tau-protein kinase activity (GO:0050321),-0.37631083492507567,-1.1733742414048978,0.23170731707317074,1.0,1.0,6/20,14.29%,DYRK1A;ROCK1;MARK4;GSK3B;TTBK1;TTBK2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3690356595801856,1.1733091152046335,0.13293051359516617,0.8555118172751762,1.0,71/232,23.21%,TRIM14;IRF2BP1;DTX3L;TRIM25;BIRC2;NFX1;TMEM129;HLTF;TRIM21;RNFT1;RNF5;BFAR;SIAH1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;TRIM39;VPS11;RNF114;AMFR;RNF19B;RBX1;PPP1R11;RING1;ARIH1;RNF122;CBX4;TRIM26;RNF149;SMURF1;NEURL1B;NEURL3;RNF185;KCMF1;MYLIP;RNF25;BIRC3;NSMCE2;NSMCE1;MYCBP2;NHLRC3;UBR4;PIAS1;PIAS2;GID4;RNF166;HECTD1;CBLL1;TRIM2;TRIM62;WWP1;RFFL;MGRN1;ASB1;RC3H2;RNFT2;VPS18;MKRN2;RNF180;TRIM13;MKRN1;RNF216;HUWE1;SMURF2;STUB1;UBR2;CUL3;PELI1;XIAP
prerank,RNA polymerase II complex binding (GO:0000993),0.4416184209218049,1.1726875926348794,0.24537607891491986,0.8524583702960402,1.0,11/32,16.93%,ESRRB;AGO2;UVSSA;SCAF1;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1
prerank,tRNA methyltransferase activity (GO:0008175),0.5007333896402181,1.1716220279734522,0.2719665271966527,0.8515107860957997,1.0,7/16,22.66%,TRMT9B;BCDIN3D;TRMT13;THUMPD3;TYW3;TARBP1;TRDMT1
prerank,methylation-dependent protein binding (GO:0140034),0.4090932333993224,1.170504062343097,0.25055187637969095,0.8504267644899445,1.0,18/57,23.71%,THAP7;LRWD1;RBBP5;MORC3;BPTF;WDR5;NCAPG2;CDYL;PYGO1;KDM8;ZCWPW1;KDM7A;KAT8;SGF29;SPIN1;ZCWPW2;ING5;CHD8
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.4554469759206424,-1.1697242339124048,0.26625386996904027,1.0,1.0,4/12,23.88%,SLC9A9;LETM1;SLC9A8;SLC9B2
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.47076926737540814,1.1647686352005404,0.2766233766233766,0.8665497759594779,1.0,3/21,15.11%,CHRNA9;P2RX4;CHRNB2
prerank,DNA binding (GO:0003677),0.3612385558869514,1.1632751101566041,0.035,0.8668073686059716,1.0,136/694,17.98%,DDX60;STAT1;ZBP1;OASL;IRF7;SAMHD1;SYCP1;SIM1;TAF4B;NR1H2;MSH2;ESR2;USF2;AIM2;POLR2G;MYBBP1A;TFAP2C;MCM2;ESRRB;RARG;TIMELESS;SAP30L;ZFPL1;RNF4;TARDBP;MECP2;STAT3;CGAS;TIGD2;ARID5B;SPATA24;CGGBP1;MCM7;NKX6-2;SRRT;ILF3;DHX36;TIPIN;RNF11;JUNB;TLR8;MCM4;POLG2;RFC1;SOX9;XRN1;ARID1A;SLPI;ZNF76;CDT1;TCF7L2;TCF4;BCL6;MCM9;BRIP1;USF1;NFATC2;TFAP2B;RAD51C;SNAI2;DHX9;FEN1;SMAD2;MEIS3;ERCC4;GTF3C5;DNMT3A;MPG;SLTM;NFIB;JRKL;POU3F1;BANF1;APP;SCX;DNMT1;HMGB1;ZMYM3;MEN1;BPTF;POGK;LIN9;NR2C1;TWNK;RORA;PROX1;ZC3H12A;MAX;CTCF;RYBP;XBP1;LONP1;POLQ;HMGB3;ZNF423;CUX1;TRIM26;HNRNPA1;ILF2;PPARGC1A;MAU2;PRKDC;DDX11;DNASE2;E2F4;ZNF35;STN1;ZBTB21;SMARCA1;IKZF1;SOX2;POU6F1;DCLRE1A;RTF2;CAMTA2;ERF;TDG;NHEJ1;MEF2A;SPRTN;CARF;ZMYM6;PPARD;GTF3C3;DENND4A;SREBF1;ZBTB4;RBPJ;CHCHD2;HMBOX1;LRRFIP1;ZBTB49;POU2F2;CXXC5;ZNF513;ENDOV
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4177237345354974,1.1628458552459326,0.2727272727272727,0.8635232234331488,1.0,8/42,7.52%,CCNL1;CCNJ;CCND2;CCNL2;CDKN2D;CCND1;CCNT2;CNPPD1
prerank,LRR domain binding (GO:0030275),0.508977489600773,1.1615789065969635,0.30503597122302156,0.8632242011613879,1.0,3/14,7.91%,DAPK3;ZXDC;MRTFA
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.40906055095591143,1.1584593831632277,0.2807215332581736,0.8695650509517198,1.0,14/48,23.71%,TRPM5;TRPM2;TRPM6;SLC46A1;CALHM6;TRPM3;DMAC2L;TRPV4;TRPM7;ATP6V1B2;TRPC1;ABCC9;PIEZO1;TMEM165
prerank,zinc ion binding (GO:0008270),0.3633425687307183,1.1575980829920514,0.15,0.8677782388195945,1.0,62/293,15.96%,IFIH1;SAMHD1;TNFSF10;ADAM33;DHX58;GALT;SORD;BIRC2;CSRP1;SAP30L;ZFPL1;ADAMTS3;ITGB1BP2;ASAH2;ZFP37;ADAM8;ENPP3;RNF5;SIAH1;RNF11;KPNB1;ZDHHC20;ZCCHC4;KMT2A;ZNF2;SLC30A5;ERAP1;MT3;SEC24D;CYLD;ATAD3A;SIRT6;DPP3;SEC23A;P2RX4;PAPPA;TK1;MNAT1;WDFY1;ARIH1;TIMP2;GCH1;CHORDC1;CTCF;MYRIP;NPEPPS;FBXL19;ENPP1;CXXC4;LIMS1;PITRM1;CA2;SHMT1;TET2;PAM;MYCBP2;TMEM163;SEC24A;ENPP5;ACER3;RPH3A;KDM7A
prerank,low-density lipoprotein particle binding (GO:0030169),0.4909833852529566,1.1563262102356986,0.29315068493150687,0.867660858441748,1.0,6/16,20.83%,STAB2;CDH13;LIPC;SORL1;LDLR;MSR1
prerank,ATP binding (GO:0005524),0.36323992887162976,1.156303983791715,0.13165829145728644,0.8627850637773031,1.0,64/266,21.18%,OAS3;OAS2;HSPA1B;MSH2;ABCA1;DAPK3;ABCG1;MLKL;ACVR1;HASPIN;STK38L;DHX36;HSP90AB1;PEAK1;NOL9;PFKM;MKNK1;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;AGAP2;ABCE1;EIF2B2;P2RX4;UBA2;INSR;SRPK1;ABCD1;HSPA8;PRKAG1;NUAK2;HSPA4;BCKDK;SIK1;LONP1;PIM1;ABCF1;NEK6;DYRK2;ENPP1;PAPOLA;HSP90AA1;MINK1;BMPR1A;TDG;OXSR1;TBCK;YARS2;SNRK;MYH9;HSPA14;MARK1;BRSK1;STK3;ERN1;TAP1;ACVRL1;ABCD4;TLK2;MAP4K2;MTPAP;STK11
prerank,WW domain binding (GO:0050699),0.4507917573500775,1.155325001139587,0.29078947368421054,0.8612308312355106,1.0,6/26,12.79%,DAZAP2;PMEPA1;TRAF4;RAPGEF2;TCEAL3;TCEAL6
prerank,alkali metal ion binding (GO:0031420),-0.4361358873506957,-1.1546498898140645,0.27124183006535946,1.0,1.0,2/13,1.80%,CAPN3;DRG1
prerank,chloride channel regulator activity (GO:0017081),0.5013477340946657,1.1523122444516518,0.2943722943722944,0.8669855142210966,1.0,4/14,13.51%,SGK3;STX7;STX8;VTI1B
prerank,mRNA binding (GO:0003729),0.36439640275962887,1.1521657419170763,0.16180904522613065,0.8627156382925045,1.0,60/249,19.30%,IGF2BP1;DHFR;ZFP36;DHX33;IGF2BP3;AGO2;RBM14;TARDBP;TDRD7;RNF40;YTHDF1;ZC3H12C;DDX5;LARP1;RBMX;RSL1D1;DHX36;NCBP2;HNRNPK;SLPI;AUH;RBMS2;HNRNPM;DHX9;N4BP1;HNRNPA2B1;SF3B6;YTHDF2;HNRNPL;G3BP2;ZC3H12A;PUM3;MARF1;ZFP36L1;RNPS1;RBFOX1;HDLBP;EIF3A;CELF6;SECISBP2;ZC3H11A;DENR;EIF4G3;SHMT1;PCF11;DAZAP1;RBM15;RBFOX3;ETF1;NCBP1;NUDT16;SRSF4;METTL14;PCBP4;MRPL13;SRBD1;CPEB2;RBPMS;MRPS11;RC3H2
prerank,ubiquitin protein ligase activity (GO:0061630),0.3622269954858956,1.1516467138129511,0.16314199395770393,0.8597056505014146,1.0,69/228,23.21%,TRIM14;IRF2BP1;DTX3L;TRIM25;BIRC2;NFX1;TMEM129;HLTF;TRIM21;RNFT1;RNF5;BFAR;SIAH1;RNF11;UBE3A;AREL1;LRSAM1;HERC2;TRIM39;VPS11;RNF114;AMFR;RNF19B;RBX1;PPP1R11;RING1;ARIH1;RNF122;TRIM26;RNF149;SMURF1;NEURL1B;NEURL3;RNF185;KCMF1;MYLIP;RNF25;BIRC3;UBE4B;NSMCE1;MYCBP2;NHLRC3;UBR4;GID4;RNF166;UBE2K;HECTD1;CBLL1;TRIM2;TRIM62;WWP1;RFFL;MGRN1;ASB1;RC3H2;RNFT2;VPS18;MKRN2;RNF180;TRIM13;MKRN1;RNF216;HUWE1;SMURF2;STUB1;UBR2;CUL3;PELI1;XIAP
prerank,transition metal ion binding (GO:0046914),0.36009891748546463,1.1498295445089959,0.116,0.8616480110084414,1.0,81/397,15.96%,IFIH1;SAMHD1;TNFSF10;LOXL2;ADAM33;XYLT2;DHX58;GALT;SORD;BIRC2;ETHE1;CSRP1;SAP30L;ZFPL1;ADAMTS3;SOD2;ITGB1BP2;ASAH2;ZFP37;ADAM8;ENPP3;RNF5;SIAH1;RNF11;KPNB1;ZDHHC20;ZCCHC4;KMT2A;ZNF2;SLC30A5;NFU1;ERAP1;MT3;HMGCL;SEC24D;SLC11A2;CYLD;ATAD3A;FEN1;B4GALT1;ABCE1;SIRT6;DPP3;SEC23A;P2RX4;PAPPA;SCD5;PRNP;TK1;MNAT1;WDFY1;ARIH1;TIMP2;GCH1;CHORDC1;XXYLT1;CTCF;PIM1;DYRK2;MYRIP;NPEPPS;FBXL19;ENPP1;CXXC4;LIMS1;PAPOLA;PITRM1;CA2;SHMT1;FAM20C;TET2;PAM;MYCBP2;TMEM163;SEC24A;ENPP5;GALNT1;NUDT16;ACER3;RPH3A;KDM7A
prerank,ubiquitin-specific protease binding (GO:1990381),0.4695126954530194,1.1493197315235784,0.296043656207367,0.8588305803714761,1.0,9/19,26.53%,AMFR;CHMP3;LCOR;SART3;SUMO1;VCP;DERL2;RAD23A;PTEN
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5081220307661486,1.1483883965335016,0.3184438040345821,0.8575357718652409,1.0,4/14,13.11%,NOD1;CTSH;RACK1;BAD
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3722272169071541,1.1477324412398051,0.22324159021406728,0.8552998236128365,1.0,35/134,22.21%,SLC25A22;ABCC2;SLC27A1;SLCO1C1;SLC38A2;SLC26A1;SLC38A1;SLC2A6;SLC25A1;SLC46A1;SLC19A1;SLC52A2;SLCO1B1;SLC38A3;SLC35B1;SLC38A6;PDPN;SLC25A25;ABCC1;SLC26A2;SFXN2;SLC35B4;CTNS;SLC35A3;SLC25A12;SLC36A4;SLC35D1;SFXN1;ABCG2;SLC25A15;ABCC5;SLC5A6;MFSD12;SLC6A6;SLC1A3
prerank,protein serine/threonine phosphatase activity (GO:0004722),-0.28731812586830396,-1.1431526005082993,0.18181818181818182,1.0,1.0,12/60,11.32%,TAB1;PPP3R1;PPM1E;PPM1G;CTDSPL2;PPP4C;CTDNEP1;LRRC40;PPM1L;LRRK1;CTDP1;CTDSPL
prerank,adenyl ribonucleotide binding (GO:0032559),0.35847660626766775,1.142586310658152,0.15562248995983935,0.8692957479638211,1.0,75/291,21.89%,OAS3;OAS2;HSPA1B;MSH2;ABCA1;DAPK3;ABCG1;MLKL;ACVR1;HASPIN;STK38L;DHX36;HSP90AB1;PEAK1;NOL9;SLC19A1;PFKM;MKNK1;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;AGAP2;RAPGEF2;ABCE1;EIF2B2;P2RX4;UBA2;INSR;SRPK1;ABCD1;HSPA8;PRKAG1;NUAK2;HSPA4;BCKDK;SIK1;LONP1;PIM1;ABCF1;NEK6;DYRK2;ENPP1;PAPOLA;MYO6;HSP90AA1;MINK1;BMPR1A;TDG;GLUD1;OXSR1;GCLC;TBCK;YARS2;SNRK;ACSS2;MYH9;HSPA14;MARK1;BRSK1;STK3;PDE4B;ERN1;TAP1;CNBD2;ACVRL1;ABCD4;TLK2;MAP4K2;MTPAP;STK11;PNPLA8;PDE4A;AKT3
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.3501029078690913,-1.136474187741552,0.2694063926940639,1.0,1.0,7/22,13.24%,ATP6V0A1;ATP6V1E1;ATP2A2;ATP6V1C1;ATP2C1;ATP6V1D;ATP6V1A
prerank,poly-pyrimidine tract binding (GO:0008187),0.45786773172394596,1.1354752704982938,0.3121761658031088,0.890349878320493,1.0,6/23,14.74%,PNPT1;HNRNPH1;RBMS2;ATXN1;DIS3L2;DAZAP1
prerank,ribonuclease activity (GO:0004540),0.396410723949879,1.1344695672187501,0.2952275249722531,0.8893668117737438,1.0,12/56,14.05%,SAMHD1;AGO2;NOB1;ZC3H12C;CNOT7;RNASEH2A;N4BP1;RNASE7;ZC3H12A;RNASE1;DIS3L2;EXOSC9
prerank,aminopeptidase activity (GO:0004177),0.4482307453098086,1.1344660096720527,0.31241997439180536,0.8846273369882811,1.0,10/26,24.10%,LAP3;MMP14;ERAP1;CTSH;NPEPPS;KDM8;METAP2;MMP15;TRHDE;RNPEP
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.35435274892803065,1.1334572296727317,0.135,0.8835976491525266,1.0,106/431,21.28%,OAS3;GBP4;OAS2;HSPA1B;MSH2;ABCA1;GBP5;DAPK3;TUBD1;ABCG1;ARF3;TUBB2B;ATL1;GBP3;MLKL;ACVR1;HASPIN;RAB21;STK38L;GBP2;RHOF;DHX36;HSP90AB1;PEAK1;RHEBL1;GBP7;NOL9;RRAGC;RHOJ;PFKM;MKNK1;LSG1;ARF5;RTEL1;PPIP5K1;ABCB9;AARS1;DHX9;RAB22A;AGAP2;RAB11B;SEPHS1;ABCE1;EIF2B2;P2RX4;UBA2;INSR;SRPK1;ABCD1;TUBE1;HSPA8;PRKAG1;GCH1;DNM2;NUAK2;HSPA4;RAB14;ARL1;BCKDK;SIK1;LONP1;PIM1;ABCF1;NEK6;DYRK2;ENPP1;ARL5C;PAPOLA;RAC1;HSP90AA1;NOA1;MINK1;BMPR1A;TUBB4B;NUDT16;TDG;GNL2;GLUD1;ARF4;OXSR1;RAB32;TBCK;YARS2;RANBP17;SNRK;RHOT2;MYH9;HSPA14;MARK1;BRSK1;MFHAS1;STK3;RAP2A;ERN1;TAP1;TGM2;ACVRL1;RND2;ABCD4;TLK2;MTG2;RIT1;MAP4K2;MTPAP;STK11;RHOH
prerank,titin binding (GO:0031432),0.508426134063012,1.133202213700722,0.3242467718794835,0.8798039655706725,1.0,2/13,3.83%,CAMK2D;ACTN2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.42466579975305496,1.1327345350970044,0.3062730627306273,0.8767375811411134,1.0,17/33,27.94%,ESRRB;AGO2;UVSSA;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1;SMYD2;RPRD2;ZNF326;SCAF8;AGO1;CDC73;HNRNPU
prerank,methylated histone binding (GO:0035064),0.391511397908963,1.1311647422420272,0.3014145810663765,0.8779135864782652,1.0,20/62,23.79%,THAP7;LRWD1;RBBP5;MORC3;BPTF;WDR5;NCAPG2;CDYL;PYGO1;KDM8;ZCWPW1;KDM7A;KAT8;SGF29;SPIN1;ZCWPW2;ING5;DPF2;CHD8;TAF7
prerank,cyclic nucleotide binding (GO:0030551),0.453004800156228,1.1287182391495245,0.33727034120734906,0.8820659615616993,1.0,3/21,8.10%,CNGB1;SLC19A1;RAPGEF2
prerank,death domain binding (GO:0070513),0.5233652400961362,1.126804632263782,0.33798449612403103,0.8845022525438028,1.0,5/11,21.05%,IRGM;RACK1;BAX;CRADD;MCL1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3752035253275705,1.1257641141119157,0.3147153598281418,0.8837011826279634,1.0,14/85,14.84%,AOAH;PNPLA2;ABHD2;PAFAH1B3;PLA2G12A;PTRH2;ABHD8;AARS1;LIPC;PGLS;LYPLA2;PNPLA6;CA2;ABHD3
prerank,sterol transfer activity (GO:0120015),0.4776858521616829,1.1220906085051094,0.31704095112285335,0.8925536522086026,1.0,7/17,19.17%,ABCA1;ABCG1;NPC2;GRAMD1C;OSBP;MTTP;OSBPL2
prerank,PDZ domain binding (GO:0030165),-0.2721457211041413,-1.1206198355186425,0.19148936170212766,1.0,1.0,24/61,29.29%,DOCK4;SDC2;SRR;TGFBR3;DLG4;TBC1D10A;CCDC88C;CIT;SYNJ2;NSF;GNG5;FZD7;F11R;CRIM1;CXADR;SLC26A6;SNTG2;FZD4;KIF14;GRID2;ATP2B2;ATP2B4;FZD2;PRKN
prerank,telomerase RNA binding (GO:0070034),0.4494407011132935,1.118089969911598,0.3363754889178618,0.9020713072569321,1.0,6/22,11.57%,SMG7;DHX36;XRN1;DCP2;GAR1;SMG5
prerank,clathrin adaptor activity (GO:0035615),0.4945224944544743,1.1178644252596126,0.32729805013927576,0.8983326869657022,1.0,6/15,17.70%,AP2A1;LDLRAP1;AP2S1;STON1;DAB2;STON2
prerank,transforming growth factor beta binding (GO:0050431),-0.34456834836952527,-1.1177104804019387,0.2761904761904762,1.0,1.0,4/23,6.24%,TGFBR3;LTBP1;ITGAV;TWSG1
prerank,glutamate receptor activity (GO:0008066),0.46328655843258915,1.1136533485315485,0.3481675392670157,0.9086598736740411,1.0,10/19,25.15%,GRIN2D;GRIK3;GRIA2;GRID1;GRIA4;GRIK4;GRM7;GRM4;GRIK5;GRIK2
prerank,RNA polymerase binding (GO:0070063),0.4602556291403571,1.1120874863365404,0.3302139037433155,0.9095920160397754,1.0,5/18,7.25%,ZFP36;PKN2;TCERG1L;CCNT2;DHX9
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5333811465485837,1.110506976357327,0.35766423357664234,0.9106588049034912,1.0,2/10,6.50%,SLCO1C1;SLCO1B1
prerank,nuclear receptor coactivator activity (GO:0030374),0.3876610591448375,1.107489633686161,0.33934611048478014,0.916611116159763,1.0,9/52,13.61%,HELZ2;ACTN1;RBM14;RNF4;NCOA1;SRA1;MED12;PPARGC1A;BUD31
prerank,microtubule plus-end binding (GO:0051010),-0.3486067854373679,-1.1071332645090206,0.27309236947791166,1.0,1.0,11/20,20.07%,STIM1;DST;CLIP1;CLASP2;FBXW11;APC;KIF18A;CLIP3;TTBK2;KNSTRN;CLASP1
prerank,amyloid-beta binding (GO:0001540),0.36960659187410205,1.1062481535643411,0.32696390658174096,0.9166093432431377,1.0,21/79,18.10%,ITGA2;CLU;CLSTN1;PFDN5;EPHA4;GRIA2;CACNA1A;INSR;PRNP;LDLRAP1;LRPAP1;SORL1;PFDN4;APOE;FCGR2B;APBB1;TLR2;PGRMC1;GRIA4;ITM2C;LDLR
prerank,MAP kinase phosphatase activity (GO:0033549),0.5029486913721419,1.1061780559407004,0.34873323397913564,0.9123675754639139,1.0,5/12,18.46%,DUSP3;DUSP29;DUSP10;DUSP16;DUSP8
prerank,GTP binding (GO:0005525),0.3551481247641608,1.105735690964772,0.29797979797979796,0.9093368809619448,1.0,37/172,16.75%,GBP4;GBP5;TUBD1;ARF3;TUBB2B;ATL1;GBP3;RAB21;GBP2;RHOF;RHEBL1;GBP7;RRAGC;RHOJ;LSG1;ARF5;RAB22A;AGAP2;RAB11B;SEPHS1;EIF2B2;INSR;TUBE1;GCH1;DNM2;RAB14;ARL1;ARL5C;RAC1;NOA1;TUBB4B;NUDT16;GNL2;GLUD1;ARF4;RAB32;RANBP17
prerank,monocarboxylic acid binding (GO:0033293),-0.35815413108098826,-1.1038390696832066,0.302491103202847,1.0,1.0,4/18,12.22%,NAPEPLD;RXRA;RARA;NR2F2
prerank,calcium-release channel activity (GO:0015278),0.4644700288698483,1.1032982726874545,0.3633841886269071,0.9135090687737067,1.0,3/17,12.44%,TRPM2;ITPR1;MCOLN2
prerank,single-stranded DNA binding (GO:0003697),0.36243688903186944,1.102907859703498,0.31347962382445144,0.9104872814018439,1.0,16/93,13.61%,SAMHD1;MSH2;POLR2G;MCM2;MCM7;DHX36;MCM4;MCM9;DHX9;ERCC4;HMGB1;TWNK;LONP1;HNRNPA1;DDX11;STN1
prerank,endopeptidase activator activity (GO:0061133),0.5149936162560143,1.102805127357831,0.3475609756097561,0.9064365407227016,1.0,7/10,27.43%,PSME2;PSME3;APH1A;APH1B;ADRM1;PSENEN;VSIR
prerank,DNA secondary structure binding (GO:0000217),0.4116712075232411,1.1008027249932257,0.3473423980222497,0.9093017885871647,1.0,8/31,15.01%,MSH2;KMT2A;RAD51C;XRCC3;HMGB1;MEN1;HMGB3;GEN1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.41942548357963594,1.0992284998084134,0.35775335775335776,0.9106389268992731,1.0,10/30,23.21%,NOL3;BIRC2;MT3;CST7;BIRC3;CD27;BIRC6;PTTG1;PRDX3;XIAP
prerank,metal ion:proton antiporter activity (GO:0051139),-0.41577280719854176,-1.0984109282946983,0.325,1.0,1.0,4/13,23.88%,SLC9A9;LETM1;SLC9A8;SLC9B2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3389079923094036,1.0945352682042835,0.125,0.9224524219944767,1.0,131/830,16.03%,STAT1;STAT2;NLRC5;IRF7;PITX2;SIM1;LHX2;LMX1A;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;TCF24;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;NFX1;BBX;TEAD2;ZBTB2;NFKB2;STAT3;ZFP37;BATF3;RBL1;ZNF471;ELK3;RUNX1;BHLHE40;NACC1;NKX6-2;RBMX;KLF15;CIC;DHX36;MZF1;NFXL1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;TCF7L2;TCF4;ZBTB43;NFKB1;BCL6;CREBRF;ZBTB38;BACH1;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;ETV6;TBPL1;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;TFDP1;DNMT3A;AEBP1;ATF1;HOXA9;NFIB;POU3F1;SCX;DACH2;ELF4;IRF9;BPTF;ZSCAN20;NR2C1;RORA;PROX1;FOXK1;MAX;CTCF;ZBTB5;MITF;XBP1;SKIL;TFDP2;KLF10;ZNF423;CUX1;RELB;TEF;REL;HOXB6;NR3C1;RB1;PRDM4;E2F4;ZNF35;PGBD1;ST18;BCL11B;IKZF1;ZNF418;CASZ1;MYPOP;SOX2;RREB1;CREB5;MYB;POU6F1;ZBTB24;ZBTB34;KLF16;SOX5;GTF2IRD1;MEF2A;CARF;PROX2;PPARD
prerank,N-acyltransferase activity (GO:0016410),0.4042511464128188,1.0896410774107783,0.38156209987195905,0.9354698290807376,1.0,5/32,6.22%,SATL1;SAT1;NAA50;CERS6;SMARCE1
prerank,cation channel activity (GO:0005261),0.3563050609718964,1.0868273102552954,0.33544973544973544,0.9409720075092577,1.0,15/94,15.80%,TRPM5;TRPM2;TRPM6;CUL5;TMEM38A;CALHM6;TRPM3;PANX1;ANO10;KCNK3;PSEN1;TRPV4;TMEM38B;TRPM7;SLC24A3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4047665084854092,1.0827578573874146,0.3564476885644769,0.9506227936462222,1.0,17/33,27.94%,ESRRB;AGO2;UVSSA;DHX9;ELP2;WAC;WDR43;PCF11;RECQL5;ELOF1;SMYD2;RPRD2;ZNF326;SCAF8;AGO1;CDC73;HNRNPU
prerank,endopeptidase inhibitor activity (GO:0004866),0.36213754294058126,1.0816698264875364,0.35163674762407604,0.9503853016677012,1.0,10/82,11.74%,AGT;BST2;SERPINC1;SLPI;UCHL5;CST7;APP;PRNP;TIMP2;USP14
prerank,transcription coregulator binding (GO:0001221),0.37847008729220494,1.0796214148973045,0.36280137772675086,0.9532828756834467,1.0,16/50,20.04%,THAP7;PER2;ZBTB17;TEAD2;CTNNB1;CCNT2;LMO2;RORA;CTCF;NEK6;LCOR;EZH2;PPARD;ZBTB49;CTBP1;PER1
prerank,GTPase activity (GO:0003924),0.34508115092849506,1.0783476988151082,0.3477822580645161,0.9532685488646174,1.0,57/192,23.13%,GBP4;IRGM;GBP5;RAB8B;ATL1;GBP3;RAB21;GBP2;RHOF;GPN2;SRPRA;GSPT1;RHEBL1;GBP7;RRAGC;RHOJ;GNA15;GNA14;LSG1;RAB22A;AGAP2;GFM1;RAB43;RAB11B;RAB5C;RAP1GAP;GCH1;DNM2;RAB14;ARL1;RAB24;SEPTIN9;RAC1;EFTUD2;TBCC;GPN3;GNL2;GPN1;RAB11A;RAB32;HBS1L;RHOT2;RAP2A;RAB5B;RAB1A;RND2;DDX3X;MTG2;RIT1;MMUT;RHOH;RHEB;RRAGA;ENTPD7;RAB2A;OPA1;RAB29
prerank,R-SMAD binding (GO:0070412),0.4497325879695645,1.0780157059644726,0.3953488372093023,0.9500887658198016,1.0,5/18,12.20%,DDX5;PMEPA1;SMAD2;MEN1;SMURF1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.43589981856855387,1.0776711864342978,0.3766404199475066,0.9469287207634941,1.0,6/22,13.34%,DUSP3;SBF1;DUSP29;PPM1F;DUSP10;DUSP16
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.4891436476734297,1.0766319894702068,0.3818722139673105,0.9458823929225619,1.0,5/11,18.02%,DCP2;NUDT5;NUDT16;NUDT4;DCPS
prerank,lysophospholipase activity (GO:0004622),-0.3423616343513175,-1.0766281211874449,0.34934497816593885,1.0,1.0,5/20,13.47%,ABHD16A;LYPLA1;LYPLAL1;MGLL;ABHD12
prerank,ligand-gated channel activity (GO:0022834),0.414001489931339,1.0765361787823435,0.37758830694275275,0.9419334987379436,1.0,7/29,16.24%,CNGB1;GRIN2D;GRIK3;GRIA2;CHRNB2;GRID1;GRIA4
prerank,ligand-gated ion channel activity (GO:0015276),0.4139912914855411,1.075667257696155,0.3717791411042945,0.9407191580414381,1.0,7/30,16.24%,CNGB1;GRIN2D;GRIK3;GRIA2;CHRNB2;GRID1;GRIA4
prerank,voltage-gated calcium channel activity (GO:0005245),0.399618080543461,1.075212156774792,0.3799019607843137,0.9380288299752082,1.0,3/37,2.42%,CATSPER4;CACNA2D4;TMC1
prerank,kinase binding (GO:0019900),0.33528045009878815,1.072885546436629,0.264,0.9419892128395854,1.0,94/435,17.56%,SP100;IRGM;TRIM14;NOD2;MSH2;TPRKB;IL15RA;TRIB3;SPRY2;SOCS1;DAXX;CENPJ;ZFP36;UTRN;CHEK2;SASH1;STAT3;FBXO7;CDC25B;TRIM21;THY1;RHOF;CCND2;HSP90AB1;CDKN2D;CACUL1;DUSP3;CTNNB1;CCND1;FAM83H;PFKM;AP2A1;ARHGEF7;CAB39;TCF7L2;PIP5K1A;USF1;DOK7;MAP2K3;CYLD;MAPRE1;AGAP2;MTCP1;CNTLN;CDK5RAP2;BCAR1;CSPG4;BARD1;CNKSR2;SIKE1;NEK9;PRKAG1;UBQLN1;MOB1B;NPM1;CEP152;SIK1;IRAK4;GSN;NEK6;RELB;STAP1;PTPN11;NR3C1;RB1;TRPV4;RPS6;LIMS1;BAD;TELO2;LYST;RAC1;ACTB;SNAP91;JAK2;IFNAR2;DLG1;RB1CC1;TNIP2;USP37;CALM3;ERCC6L2;CRK;OXSR1;NBEA;IRAK1;CCNK;BLNK;LLGL1;ZBTB4;TRIP4;SPRED3;PTPRC;CDC37
prerank,GTPase regulator activity (GO:0030695),0.3386735256186489,1.071822479428807,0.33434343434343433,0.9414978722403595,1.0,66/212,20.41%,WNT11;RASA4;RGPD1;TBC1D1;TAGAP;THY1;SYDE1;TBC1D8;AGAP2;RAPGEF2;CCDC88A;ABR;SEC23A;CDC42SE1;RAP1GAP;SYDE2;SIPA1L2;TBC1D8B;STARD8;ARHGAP25;SRGAP2;HACD3;RIN2;SOS1;ARHGAP10;RGS16;CHN1;ARHGAP11A;SIPA1L1;ALDH1A1;NRP1;RANBP1;ARHGAP39;ARHGAP30;SMAP1;ASAP3;RANBP3L;TBCD;SH3BP1;OPHN1;ARL2BP;TBCK;STXBP5L;LLGL1;OCRL;BCR;RUNDC3A;TBC1D2;RALGAPB;ARHGAP29;NF1;CPEB2;NPRL2;ARAP1;SIPA1L3;NPRL3;ARHGAP24;ARHGAP42;EIF5;ARHGAP18;SGSM1;SGSM3;SIRPA;TBC1D4;RGS10;ARHGAP31
prerank,magnesium ion binding (GO:0000287),0.34786177550684133,1.0711392856497062,0.3635427394438723,0.9396580576907427,1.0,43/135,22.28%,XYLT2;MSH2;STK38L;DHX36;RRAGC;PDXP;NT5C3A;HMGCL;IDH1;NUDT5;FEN1;PGM1;UBA2;SRPK1;NUAK2;XXYLT1;HPRT1;SIK1;NEK6;DYRK2;EPHX2;PAPOLA;DIS3L2;GEN1;NUDT16;TDG;OXSR1;GCLC;EYA2;SNRK;ENDOV;MARK1;PPA1;BRSK1;STK3;RAP2A;ERN1;TKT;MTPAP;STK11;ABL2;RHEB;IDH3A
prerank,I-SMAD binding (GO:0070411),0.4773881143768144,1.0675356282104578,0.40778097982708933,0.9469530997478934,1.0,3/13,12.20%,CTNNB1;SMAD2;SMURF1
prerank,calcium channel activity (GO:0005262),0.3549804585805867,1.0643152375852403,0.3789020452099031,0.9537308540788049,1.0,13/84,15.80%,TRPM5;CATSPER4;TRPM2;CACNA2D4;TMC1;CUL5;CACNA1A;P2RX4;PANX1;PSEN1;TRPV4;TRPM7;SLC24A3
prerank,NADPH binding (GO:0070402),0.474710682407025,1.0640637151273216,0.39185393258426965,0.9504002656583382,1.0,2/13,1.99%,DHFR;GRHPR
prerank,transcription cis-regulatory region binding (GO:0000976),0.33271590415555263,1.063474496835326,0.297,0.9483067307524875,1.0,78/406,18.52%,PITX2;SIM1;LHX2;LMX1A;TCF24;TFAP2C;PER2;ZBTB17;ESRRB;NFX1;XRN2;BBX;AGO2;STAT3;ARID5B;ZFP37;RBBP5;RBL1;ELK3;RUNX1;KLF15;CIC;DHX36;MZF1;NFXL1;SOX9;TCF7L2;ZBTB43;NFKB1;CREBRF;TFAP2B;SNAI2;ETV6;SMAD2;ATF6B;TFDP1;CDK5RAP2;NONO;AEBP1;ATF1;TAF2;SCX;HMGB1;MEN1;HNRNPL;RORA;PROX1;NPM1;FOXK1;MAX;CTCF;ZBTB5;XBP1;TFDP2;LONP1;KLF10;CUX1;NR3C1;RB1;ZNF35;CASZ1;SOX2;RREB1;SOX5;MEF2A;TIPARP;SREBF1;ZBED4;ZBTB4;BRD7;POU2F2;DACH1;ZNF513;FOSL2;HDAC1;HINFP;GABPB1;GABPB2
prerank,carboxypeptidase activity (GO:0004180),-0.29039758970818363,-1.0628689545779149,0.3081761006289308,1.0,1.0,9/35,15.93%,AGBL4;BLMH;CTSA;AGTPBP1;AGBL5;AGBL3;CTSZ;CPE;CPA6
prerank,cholesterol transfer activity (GO:0120020),0.45871971793769656,1.0626151037404483,0.3955026455026455,0.9471658506726042,1.0,6/16,19.17%,ABCA1;ABCG1;NPC2;GRAMD1C;MTTP;OSBPL2
prerank,endopeptidase activity (GO:0004175),0.3351873022187893,1.0617531786297636,0.32630522088353414,0.9457944566364397,1.0,38/257,15.97%,USP18;CASP4;CASP7;ADAM33;PSMB10;CTSS;PSMA5;PRSS12;ADAMTS3;USP25;MMP14;CASP6;USP15;USP40;PSMA3;ADAMTS19;CTSC;NLN;CTSH;PSMB9;USP34;PCSK7;KLK1;USP14;RHBDF2;PSEN1;ADAMTS2;PITRM1;PREP;MASP1;NAPSA;KDM8;PSMA4;USP37;ADAMTS6;HTRA3;ADAMTS12;SPRTN
prerank,Hsp90 protein binding (GO:0051879),0.40747678134998505,1.060585543957018,0.40389294403892945,0.9454720922798815,1.0,14/33,25.03%,NOD2;KDR;CHORDC1;NR3C1;HDAC8;TELO2;UNC45A;PTGES3;AHSA1;TSC1;ERN1;STUB1;HDAC6;STIP1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3796015242690043,1.057829739320076,0.3958333333333333,0.950536948230473,1.0,16/44,22.77%,RBBP5;KMT2A;NSD3;SETD3;ASH1L;MEN1;WDR5;SETD5;SETDB2;EZH2;SMYD1;SMYD2;SMYD5;SETD7;KMT5C;KMT2D
prerank,vinculin binding (GO:0017166),-0.40713556174569193,-1.0568033696414307,0.35873015873015873,1.0,1.0,5/11,5.89%,SORBS3;CTNNA1;PXN;DMD;CORO2B
prerank,GTPase activator activity (GO:0005096),0.33116911152089273,1.0561411330911055,0.3299899699097292,0.9518802135193468,1.0,94/313,20.51%,WNT11;RASA4;DOCK8;RGPD1;RGP1;TBC1D1;RINL;TAGAP;SPATA13;THY1;SYDE1;SBF1;RCC1L;ARHGEF7;HERC2;TBC1D8;GAPVD1;DENND1A;RAPGEF6;AGAP2;RAPGEF2;CCDC88A;ABR;EIF2B2;SEC23A;RAP1GAP;SYDE2;VAV1;SIPA1L2;TBC1D8B;STARD8;ARHGAP25;ANKRD27;ARHGEF11;SRGAP2;HACD3;RIN2;ARHGEF10;SOS1;ARHGAP10;LAMTOR3;ARFGEF2;RGS16;CHN1;ARHGAP11A;SIPA1L1;RIC1;FGD6;ALDH1A1;IQSEC2;AKAP13;RAPGEF1;NRP1;RANBP1;ARHGAP39;ARHGAP30;SMAP1;ASAP3;RANBP3L;DENND10;MYCBP2;DENND6B;TBCD;SH3BP1;DENND4A;OPHN1;TBCK;STXBP5L;LLGL1;OCRL;BCR;TBC1D2;WDR41;PLCE1;RALGAPB;ARHGAP29;NF1;EIF2B5;EIF2B3;NPRL2;ARAP1;SIPA1L3;DENND1B;NPRL3;ARHGAP24;ARHGAP42;ARHGAP18;SGSM1;SGSM3;TBC1D4;RGS10;LAMTOR4;ARHGAP31;DOCK10
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4075210263373921,1.0559442985933825,0.40801001251564456,0.9484466647977166,1.0,11/30,25.60%,SLC30A1;SLC30A5;SLC11A2;TTYH1;SLC39A10;SLC39A3;SLC31A1;SLC25A28;TMEM165;SLC39A13;ATP7B
prerank,protein kinase binding (GO:0019901),0.3297295107065431,1.0557594947952444,0.304,0.9451642206598619,1.0,108/480,17.40%,IRGM;TRIM14;NOD2;MSH2;TPRKB;IL15RA;TRIB3;SPRY2;IRS1;SOCS1;DAXX;CENPJ;ZFP36;UTRN;CHEK2;NELL2;ACVR1;SASH1;STAT3;FBXO7;CDC25B;TRIM21;THY1;MAD2L2;RHOF;CCND2;CDKN2D;CACUL1;DUSP3;SOX9;CCND1;FAM83H;AP2A1;EPHA4;ARHGEF7;TCF7L2;USF1;DOK7;MAP2K3;NBR1;CYLD;MAPRE1;AGAP2;MTCP1;CNTLN;MAPK8IP3;CDK5RAP2;CCDC88A;DACT1;BCAR1;CSPG4;PRKAR2B;CNKSR2;SIKE1;BMPR2;NEK9;PRKAG1;ROR2;TNIP1;GCH1;PRR7;NPM1;CEP152;SIK1;IRAK4;NEK6;RELB;STAP1;PTPN11;TJP2;NR3C1;DUSP10;TRPV4;RACK1;RPS6;LIMS1;BAD;DUSP16;TELO2;NELL1;LYST;RAC1;ACTB;SNAP91;JAK2;IFNAR2;DLG1;RB1CC1;TNIP2;HSP90AA1;USP37;CALM3;ERCC6L2;CRK;SPAG9;TAOK2;OXSR1;NBEA;IRAK1;CCNK;BLNK;LLGL1;ZBTB4;CSK;TRIP4;PRKAR2A;SPRED3;PTPRC
prerank,hormone activity (GO:0005179),0.3697977763555498,1.054882295185743,0.4049493813273341,0.9440963309784441,1.0,2/54,0.65%,GAL;AGT
prerank,protein serine/threonine kinase activity (GO:0004674),0.3303787864957987,1.052868592442086,0.354,0.9465069902221999,1.0,93/335,22.45%,EIF2AK2;PKMYT1;TAOK3;DAPK3;SRPK3;CAMK2D;TP53RK;ALPK1;SGK3;SGK2;FASTK;CPNE3;BRD2;CAMK2B;CHEK2;ACVR1;MAPK6;MAP3K8;STK38L;PKN2;PNCK;CHEK1;IKBKE;CDK12;MKNK1;PAK3;NRBP2;CSNK2B;CSNK2A2;HTATIP2;VRK3;CLK3;SRPK1;PLK3;PIK3R4;BMPR2;MAST3;MAPK14;CDK19;TNIK;CDK10;NUAK2;CDK20;RIOK3;BCKDK;SIK1;PIM1;IRAK4;NEK6;DYRK2;PRKDC;PRKCE;CLK2;MAP3K4;PRKCH;FAM20C;MASTL;MINK1;BMPR1A;NRBP1;TAOK2;OXSR1;MTOR;IRAK1;CCNK;PHKG2;STK39;BCR;SNRK;ACVR2A;MARK1;BRSK1;TESK1;MAP3K15;NEK7;STK16;STK3;STK24;AAK1;ERN1;RIPK2;ACVRL1;TLK2;MAP4K2;STK11;SBK1;PRKCD;CDK9;AKT3;MAPK9;PIM3;CDK8;CDK16
prerank,calcium ion binding (GO:0005509),0.3279084717011605,1.0505344815119744,0.363,0.9502184016283846,1.0,53/323,17.26%,NOL3;CABP4;LOXL2;AOAH;ASPH;COMP;TRPM2;CDH13;CANT1;RCN1;ASAH2;LRP2;ADAM8;SLC8A1;ENPP3;CABYR;ITPR1;TNNC1;PITPNM1;SYT7;RET;AIF1L;FBN1;CDH9;CETN3;BAIAP3;RAPGEF2;SMOC2;SYT3;PRNP;AGRN;CIB1;CRACR2A;ADGRV1;NOTCH4;SLIT3;SLIT1;GSN;ENPP1;CAPN1;MICU2;MASP1;DNER;SLC25A12;PAM;CALM3;ACER3;RPH3A;AIF1;PCDHA4;PCP4;SPARCL1;ANXA4
prerank,iron ion binding (GO:0005506),0.37265891332551526,1.0501843429391406,0.42427745664739885,0.9474031890941464,1.0,11/48,16.98%,ETHE1;FXN;EGLN2;NFU1;ALKBH1;ABCE1;SCD5;ALKBH2;TET2;KDM7A;FBXL5
prerank,SH2 domain binding (GO:0042169),0.39972836588552274,1.0499072436370553,0.42565947242206237,0.9444107912366289,1.0,11/31,20.61%,SLAMF1;IRS1;CCDC88A;TRPV4;RACK1;JAK2;CRK;BLNK;SH3PXD2B;PAG1;LCK
prerank,pyrophosphatase activity (GO:0016462),0.37084420003981367,1.0493974517635698,0.40348837209302324,0.9420890248870575,1.0,17/50,22.65%,TRPM2;ENTPD3;ENPP3;ENTPD6;DCP2;DHX9;NUDT5;ENTPD5;ENPP1;NUDT16;NUDT4;DCPS;PPA1;DDX3X;LHPP;ENTPD7;DOLPP1
prerank,carbohydrate kinase activity (GO:0019200),0.4926834487511964,1.0479074137421356,0.4289855072463768,0.9427232794720902,1.0,4/11,14.24%,HK1;FGGY;GNE;GALK2
prerank,fatty acid synthase activity (GO:0004312),0.4974398193921013,1.0474613993346413,0.4246987951807229,0.9402462357687261,1.0,1/10,0.51%,MCAT
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.4889156351329448,1.0473158612456575,0.4166666666666667,0.9368660034203592,1.0,3/11,26.96%,SLC25A47;SLC25A45;SLC22A4
prerank,"DNA binding, bending (GO:0008301)",0.45562232598455576,1.0449518957794453,0.41944847605224966,0.9405277175751138,1.0,3/14,11.77%,SAP30L;HMGB1;HMGB3
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.37437510808203983,-1.0442593293928366,0.39087947882736157,1.0,1.0,4/12,16.57%,ARSB;SULF1;ARSK;SGSH
prerank,Toll-like receptor binding (GO:0035325),0.48693929184436013,1.0439104808310213,0.42415316642120765,0.940088046324255,1.0,3/11,15.46%,UNC93B1;MYD88;TLR2
prerank,death receptor activity (GO:0005035),-0.40052966982112953,-1.0413783925548448,0.3961661341853035,1.0,1.0,9/11,51.11%,TNFRSF1B;TNFRSF19;FAS;TNFRSF25;TNFRSF4;NGFR;TNFRSF1A;EDA2R;TNFRSF11A
prerank,glycerophospholipid flippase activity (GO:0140333),0.4814563591555935,1.041166442960696,0.4273255813953488,0.9454529323983668,1.0,2/11,4.37%,ATP10A;ATP8A1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.34962958777210507,1.0378019127939409,0.41971207087486156,0.9524886308471017,1.0,26/69,27.30%,LIPT1;MCAT;ZDHHC21;ZDHHC20;CERS6;HHAT;LPGAT1;SOAT2;KAT8;ZDHHC13;SOAT1;ZDHHC8;CERS2;PLA2G4E;ZDHHC3;DBT;NMT1;ZDHHC18;KAT6A;AWAT2;KAT2B;ZDHHC17;ZDHHC16;PLA2G4A;ZDHHC7;EP300
prerank,phosphatase activator activity (GO:0019211),0.44892762246514645,1.0373134706344054,0.43448275862068964,0.9502006229238954,1.0,6/14,24.43%,PPP2R5C;PPP2R5D;CALM3;PHACTR4;PPP2R5A;CALM2
prerank,lipoprotein particle binding (GO:0071813),0.42446395317598606,1.0361908791317285,0.4281984334203655,0.9499711428093012,1.0,6/20,20.83%,STAB2;CDH13;LIPC;SORL1;LDLR;MSR1
prerank,proton transmembrane transporter activity (GO:0015078),0.38321612301254643,1.0354932795703113,0.4393063583815029,0.9484784597106949,1.0,7/39,14.18%,UQCRQ;MFSD3;SLC46A1;SLC11A2;DMAC2L;UQCR10;CTNS
prerank,sequence-specific DNA binding (GO:0043565),0.3203274304117202,1.0340010086137952,0.368,0.9494607204794162,1.0,96/590,17.10%,IRF7;PITX2;LMX1A;USF2;ETV3;MEF2B;MYBBP1A;TFAP2C;GMEB2;LRWD1;ESRRB;RARG;BBX;TEAD2;ZBTB2;NFKB2;MECP2;BATF3;ELK3;SMG7;BHLHE40;NKX6-2;KLF15;JUNB;ZNF23;SOX9;KMT2A;ZNF76;MBD2;TCF7L2;TCF4;ZBTB43;BCL6;ZBTB38;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;SRF;MEIS3;ATF6B;SLTM;HOXA9;NFIB;POU3F1;SCX;ELF4;IRF9;BPTF;NR2C1;RORA;PROX1;FOXK1;MAX;CTCF;XBP1;LONP1;SMG5;KLF10;ZNF423;CUX1;TEF;PPARGC1A;UPF2;HOXB6;NR3C1;UPF3A;FBXL19;PRDM4;E2F4;ZNF35;CXXC4;CHTOP;TELO2;STN1;ZBTB21;BCL11B;SOX2;CREB5;POU6F1;MBNL2;ERF;KLF16;ZCWPW1;MEF2A;PRMT1;PPARD;SREBF1;UPF1;ZBTB4;RBPJ;CHCHD2;ELF1;HMBOX1
prerank,protein phosphatase 1 binding (GO:0008157),0.43050808117181755,1.030861607319137,0.444015444015444,0.9555283752978118,1.0,5/21,15.61%,PPP1R3E;PPP1R3D;AKAP11;PPP1R11;PHACTR4
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.48508488713557507,1.0307366570891878,0.4508426966292135,0.9521804439728973,1.0,5/11,25.42%,PRMT2;PRMT1;PRMT3;FBXO11;PRMT9
prerank,myosin binding (GO:0017022),0.3588645665579322,1.0303777436685138,0.4377104377104377,0.9496660777434174,1.0,13/55,16.51%,CXCR4;TRAK1;MYOC;RAB11B;SPATA6;RAB14;GSN;MYRIP;MOBP;NCKIPSD;RAB11A;STXBP5L;LLGL1
prerank,insulin-like growth factor binding (GO:0005520),-0.3629936062179803,-1.0297517608810158,0.4110032362459547,1.0,1.0,9/15,23.35%,ITGAV;IGF2R;IGFBP5;IGFBP4;IGF1R;ITGB3;ITGB4;IGFBP6;IGFBP3
prerank,1-phosphatidylinositol binding (GO:0005545),0.44840667027288045,1.0252957311379902,0.453015427769986,0.9620202212345041,1.0,7/15,24.26%,SNX10;WDFY1;SNX9;SNAP91;ZFYVE1;EEA1;WDFY3
prerank,adenylate cyclase binding (GO:0008179),0.4826164652442595,1.023982602267903,0.4581430745814307,0.9625961493739591,1.0,3/10,15.21%,ADCY5;AKAP12;CALM3
prerank,triglyceride lipase activity (GO:0004806),0.41927303846565755,1.0233482759364723,0.45897079276773295,0.9608766900157678,1.0,2/20,7.72%,PNPLA2;LIPC
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.35068369841999514,-1.0231282861023603,0.3917525773195876,1.0,1.0,5/18,10.45%,AKR1B1;ALDH2;ALDH18A1;ALDH3B1;FAR1
prerank,phospholipase activity (GO:0004620),-0.24638239871879597,-1.0213567089386117,0.39285714285714285,1.0,1.0,21/67,21.59%,PLCB2;ABHD16A;LYPLA1;PLAAT3;NAPEPLD;LIPH;SMPDL3A;SMPD3;LYPLAL1;PDIA3;PLBD1;PITPNM3;MGLL;ABHD12;PLD4;LPL;SEC23IP;PLA2G15;SMPD1;ABHD6;SMPD2
prerank,U6 snRNA binding (GO:0017070),-0.3611928951514187,-1.021030172021965,0.4110032362459547,1.0,1.0,6/14,22.88%,METTL16;LARP7;LSM3;LSM2;TUT1;RBM22
prerank,transaminase activity (GO:0008483),0.48304334377212527,1.0197271395888274,0.460431654676259,0.9682752417628757,1.0,1/11,0.65%,AGXT
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.31600133735134756,1.0193905287766512,0.437,0.9656409973392468,1.0,78/597,12.97%,IRF7;PITX2;LMX1A;USF2;ETV3;MEF2B;TFAP2C;PER2;GMEB2;MCM2;ESRRB;RARG;BBX;DHX33;TEAD2;ZBTB2;NFKB2;STAT3;ARID5B;BATF3;RBBP5;ELK3;RUNX1;MCM7;BHLHE40;NKX6-2;KLF15;DHX36;MZF1;JUNB;MCM4;ZNF23;SOX9;KIF2C;ZNF76;MBD2;TCF7L2;TCF4;ZBTB43;NFKB1;BCL6;MCM9;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;MEIS3;ATF6B;CDK5RAP2;NONO;HOXA9;NFIB;TAF2;POU3F1;HMGB1;ELF4;IRF9;MEN1;HNRNPL;NR2C1;PROX1;FOXK1;MAX;CTCF;XBP1;KLF10;CUX1;TEF;HOXB6;ORC3;NR3C1;DDX11;PRDM4;E2F4
prerank,retinoic acid receptor binding (GO:0042974),0.4451891542341927,1.0170700146698863,0.46629986244841815,0.96906739140637,1.0,3/17,10.97%,PRMT2;RARG;SNW1
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.4740057058496567,1.0142515496027464,0.46589259796806964,0.9739339967791905,1.0,3/11,11.02%,RDH14;RDH11;AKR1B10
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3136098886629602,1.012280059006975,0.455,0.976512287535895,1.0,110/730,16.03%,STAT1;STAT2;NLRC5;IRF7;PITX2;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;TEAD2;ZBTB2;NFKB2;STAT3;BATF3;ZNF471;ELK3;RUNX1;BHLHE40;NACC1;NKX6-2;RBMX;KLF15;DHX36;MZF1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;TCF7L2;TCF4;NFKB1;BCL6;ZBTB38;BACH1;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;DNMT3A;ATF1;HOXA9;NFIB;POU3F1;SCX;DACH2;ELF4;IRF9;BPTF;ZSCAN20;NR2C1;RORA;PROX1;FOXK1;MAX;CTCF;ZBTB5;MITF;XBP1;SKIL;KLF10;ZNF423;RELB;TEF;REL;HOXB6;NR3C1;PRDM4;E2F4;PGBD1;ST18;BCL11B;IKZF1;ZNF418;MYPOP;SOX2;RREB1;CREB5;MYB;POU6F1;ZBTB24;ZBTB34;KLF16;SOX5;GTF2IRD1;MEF2A;CARF;PROX2;PPARD
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31305742012368226,1.0108586446990884,0.467,0.9771424926196515,1.0,109/731,16.03%,STAT1;STAT2;NLRC5;IRF7;PITX2;CIART;NR1H2;CC2D1B;ESR2;USF2;MEF2B;ZNF483;TFAP2C;GMEB2;RBPJL;ZBTB17;ESRRB;RARG;TEAD2;ZBTB2;NFKB2;STAT3;BATF3;ZNF471;ELK3;RUNX1;BHLHE40;NACC1;NKX6-2;RBMX;KLF15;DHX36;MZF1;JUNB;ZSCAN12;ZNF23;SOX9;ZNF2;ZNF76;ZSCAN22;ZSCAN26;TCF7L2;TCF4;NFKB1;BCL6;ZBTB38;BACH1;USF1;ZSCAN29;NFATC2;TFAP2B;SNAI2;UBP1;DHX9;SRF;IKZF2;SMAD2;GLIS3;MEIS3;ATF6B;DNMT3A;ATF1;HOXA9;NFIB;POU3F1;DACH2;ELF4;IRF9;BPTF;ZSCAN20;NR2C1;RORA;PROX1;FOXK1;CTCF;ZBTB5;MITF;XBP1;SKIL;KLF10;ZNF423;RELB;TEF;REL;HOXB6;NR3C1;PRDM4;E2F4;PGBD1;ST18;BCL11B;IKZF1;ZNF418;MYPOP;SOX2;RREB1;CREB5;MYB;POU6F1;ZBTB24;ZBTB34;KLF16;SOX5;GTF2IRD1;MEF2A;TIPARP;CARF;PROX2;PPARD
prerank,androgen receptor binding (GO:0050681),0.40465731341599537,1.0104784065541073,0.4800514800514801,0.9747177259634374,1.0,3/25,3.61%,DAXX;PRMT2;DDX5
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.39848266780245395,1.0099203961991254,0.4621309370988447,0.9729235059686552,1.0,8/22,21.28%,PARP10;IKBKE;ZRANB3;ZRANB1;SPRTN;TAB3;ATRIP;OPTN
prerank,C-C chemokine binding (GO:0019957),0.4045226847897898,1.009547865493958,0.4503311258278146,0.9703790931485107,1.0,3/22,8.48%,CXCR4;ZFP36;ACKR3
prerank,heme binding (GO:0020037),0.34763592048987074,1.0093689352937263,0.47345132743362833,0.967371920834557,1.0,13/65,18.29%,PXDNL;CYBB;THAP4;BACH1;CYB5B;CYP26B1;CYP27A1;CYB561D1;JAK2;PTGES2;PGRMC1;HMOX2;FLVCR1
prerank,potassium:proton antiporter activity (GO:0015386),-0.41183194469520035,-1.008196179016888,0.4472934472934473,1.0,1.0,1/10,1.02%,SLC9A9
prerank,metal ion binding (GO:0046872),0.31365417831352094,1.0076218863770137,0.476,0.9691554851909667,1.0,109/477,21.87%,NOL3;CABP4;LOXL2;AOAH;XYLT2;ASPH;MSH2;COMP;TRPM2;CDH13;CANT1;RCN1;ASAH2;LRP2;ADAM8;SLC8A1;STK38L;ENPP3;CABYR;ITPR1;DHX36;TNNC1;RRAGC;PITPNM1;PDXP;MT3;NT5C3A;HMGCL;SYT7;RET;IDH1;AIF1L;FBN1;NUDT5;CDH9;FEN1;PGM1;CETN3;BAIAP3;RAPGEF2;SMOC2;SYT3;UBA2;SRPK1;PRNP;AGRN;CIB1;CRACR2A;NUAK2;ADGRV1;XXYLT1;NOTCH4;HPRT1;SLIT3;SLIT1;SIK1;GSN;NEK6;TRIM26;DYRK2;EPHX2;APOE;ENPP1;CAPN1;PAPOLA;MICU2;MASP1;DIS3L2;DNER;SLC25A12;GEN1;PAM;CALM3;NUDT16;TDG;OXSR1;ACER3;RPH3A;AIF1;GCLC;PCDHA4;PCP4;SPARCL1;EYA2;ANXA4;SNRK;MAN1C1;ENDOV;MARK1;PPA1;BRSK1;STK3;CAMKK2;RAP2A;PLA2G4E;ERN1;TGM2;RPE;EFHD2;TKT;SPARC;TPD52;MTPAP;STK11;MCTP1;ABL2;RHEB;ARSA;S100A13
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.447768082767256,1.006549040993213,0.4714881780250348,0.9688729967369807,1.0,3/13,13.06%,PIK3CD;PIP5K1A;PIK3CB
prerank,endodeoxyribonuclease activity (GO:0004520),0.40722373562022757,1.0064641100560245,0.47831978319783197,0.9655037778415082,1.0,6/20,19.66%,APLF;FEN1;ERCC4;ZRANB3;ENDOV;DCLRE1C
prerank,protein tyrosine kinase binding (GO:1990782),0.3479756502898264,1.006205294395339,0.4733405875952122,0.9627807674327217,1.0,16/71,16.50%,CPNE3;ACVR1;ELMO2;DUSP3;PITPNM1;EPHA4;NCK1;SOCS5;BMPR2;PRR7;PTPN11;TJP2;RACK1;HSP90AA1;CRK;BLNK
prerank,amino acid:sodium symporter activity (GO:0005283),0.4655435592450201,1.005391920210133,0.4801762114537445,0.9616914548659362,1.0,2/11,3.41%,SLC38A2;SLC38A1
prerank,chemokine binding (GO:0019956),0.38140588813078335,1.0036262899059083,0.45879458794587946,0.9631416563372855,1.0,5/30,9.14%,CXCR4;ZFP36;ACKR3;PDPN;HMGB1
prerank,peptidase activator activity (GO:0016504),0.3971556180952771,1.0033778995127358,0.4682230869001297,0.9603785588432987,1.0,11/22,27.43%,PSME2;PSME4;PSME3;APH1A;APH1B;PCOLCE;TANK;ADRM1;VCP;PSENEN;VSIR
prerank,endopeptidase regulator activity (GO:0061135),0.3635136121697228,1.0029905973065392,0.464075382803298,0.9581922755716984,1.0,8/40,15.32%,PSME2;SLPI;UCHL5;CST7;USP14;PSME3;APH1A;APH1B
prerank,acid-thiol ligase activity (GO:0016878),-0.3781869544983928,-1.0018609556364324,0.45871559633027525,1.0,1.0,5/13,21.70%,ACSS3;AACS;ACSL1;ACSS1;SLC27A2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.3544389705188609,-1.0009340248068863,0.4379310344827586,1.0,1.0,5/14,15.09%,MICAL1;NOX1;AIFM1;NCF2;KMO
prerank,cholesterol binding (GO:0015485),0.3628295890141519,0.9996080711979065,0.47113163972286376,0.9645665796151485,1.0,18/47,21.64%,ABCA1;ABCG1;OSBPL8;OSBPL7;OSBPL3;STARD3;TSPO;PTCH1;NPC1;ERLIN2;OSBP2;NPC2;GRAMD1C;SOAT2;SOAT1;OSBPL2;OSBPL10;VDAC2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3449169548422571,0.9985888379845757,0.4983425414364641,0.9641243481444483,1.0,12/75,12.64%,SORD;GRHPR;HSD17B7;PHGDH;PGD;PTGR1;DHRS4;RDH11;LDHD;AKR1B10;DHRS11;LDHB
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.3838590279895302,-0.9980377986996782,0.43548387096774194,1.0,1.0,3/11,11.96%,MAP3K20;EGFR;MAP3K13
prerank,protein phosphorylated amino acid binding (GO:0045309),0.3594522125400079,0.9925120003197223,0.485414235705951,0.9782583548848374,1.0,17/42,25.65%,IRS1;HCK;FBXW7;SH3BP2;NCK2;LDLRAP1;VAV1;STAP1;PTPN11;CRK;PIN1;LCK;YES1;ABL2;PTPN6;YWHAE;SHC1
prerank,hormone receptor binding (GO:0051427),0.4378605636433381,0.9921149591451263,0.492816091954023,0.9758309677915,1.0,5/14,24.35%,NPPC;SOCS2;JAK2;CCK;JAK1
prerank,hyaluronic acid binding (GO:0005540),0.4748451228779188,0.9919685194678662,0.4880382775119617,0.9728300463790299,1.0,2/10,8.21%,STAB2;IMPG2
prerank,neuropeptide hormone activity (GO:0005184),0.3939846120871573,0.9911563737179189,0.48620236530880423,0.9718016396539789,1.0,1/22,0.59%,GAL
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4019877355815607,-0.990791493068976,0.4550898203592814,1.0,1.0,5/10,17.61%,DPP8;DPP4;DPP7;DPP9;FAP
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.36912877130272714,0.990313099394648,0.5036496350364964,0.9709434167910197,1.0,8/33,12.91%,AUP1;RNF5;SIAH1;DCUN1D4;RNF19B;UBA2;ARIH1;RNF185
prerank,estrogen receptor binding (GO:0030331),0.37324867610659457,0.9886925806899947,0.49813664596273294,0.9720865614234967,1.0,9/32,23.86%,PRMT2;NCOA1;CTNNB1;DDX54;LCOR;TRIP4;CCDC62;NRIP1;TACC1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.45574012358723526,0.9851149450657534,0.5029673590504451,0.9791113088318807,1.0,5/12,21.82%,PDE7B;PDE8B;PDE3A;PDE4B;PDE4A
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.38099931818703753,0.9824980519026508,0.5024813895781638,0.9831489824468804,1.0,9/28,25.15%,CHRNA9;GRIK3;CHRNB2;GRID1;GABRG1;GRIK4;GABRA3;GRIK5;GRIK2
prerank,actin monomer binding (GO:0003785),-0.31204749810379684,-0.9805338269775473,0.46494464944649444,1.0,1.0,4/22,9.52%,MTSS1;COBL;CORO1A;TMSB10
prerank,phosphatidic acid binding (GO:0070300),0.40458753082581456,0.9797325976531813,0.4905149051490515,0.9881048344007215,1.0,4/19,8.10%,PLEKHN1;PITPNM1;RAPGEF6;RAPGEF2
prerank,sodium:proton antiporter activity (GO:0015385),-0.390627243779043,-0.9778709459980829,0.46745562130177515,1.0,1.0,3/11,23.88%,SLC9A9;SLC9A8;SLC9B2
prerank,carboxylic acid binding (GO:0031406),-0.2619369482770513,-0.9775037032313044,0.47651006711409394,1.0,1.0,8/38,11.69%,GRIN2B;SRR;GRIN1;GLRB;CASTOR2;HIF1AN;EPDR1;GLRA3
prerank,retinoic acid binding (GO:0001972),-0.36446163221646727,-0.9764525707759183,0.496875,1.0,1.0,3/12,12.22%,RXRA;RARA;NR2F2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.372032788505866,-0.9760920989669709,0.46726190476190477,1.0,1.0,5/12,20.95%,GABRG3;GABRB1;GABRA2;GABRB3;GABRA5
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.33981413700723373,-0.9750527549282006,0.4842105263157895,1.0,1.0,6/16,16.27%,INPP5F;MTMR1;MTMR4;MTMR9;MTMR10;MTM1
prerank,copper ion binding (GO:0005507),0.3539890619651109,0.9745112927889709,0.52,0.9995060137583501,1.0,13/42,25.60%,LOXL2;MT3;P2RX4;PRNP;PAM;LACC1;SUMF1;COX17;S100A13;CUTA;ANG;COMMD1;ATP7B
prerank,transcription corepressor binding (GO:0001222),0.3821591363776743,0.9743080552909684,0.507537688442211,0.9965877964775132,1.0,8/27,20.04%,THAP7;PER2;RORA;NEK6;LCOR;EZH2;CTBP1;PER1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3628400392455888,0.9737847388889174,0.5067817509247842,0.9944847456966116,1.0,9/32,21.96%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;SFXN2;SLC36A4;SFXN1;MFSD12;SLC6A6
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2217960136243972,-0.9706728459521242,0.5507246376811594,1.0,1.0,37/80,40.49%,KCNC2;KCNH1;KCNJ10;KCNQ5;KCND2;KCND1;KCND3;KCNK6;KCNA2;KCNC3;KCNG2;KCNC1;KCNT2;KCNT1;KCNJ6;HCN3;KCNJ13;KCNB2;KCNH5;KCNC4;KCNH2;KCNQ4;KCNJ12;HCN4;LRRC55;KCNJ16;KCNH4;KCNN1;KCNQ1;KCNIP2;KCNG1;KCNE3;KCNJ15;KCNG4;KCNA6;KCNE4;KCNG3
prerank,metalloexopeptidase activity (GO:0008235),0.3410855647486328,0.9703770388849511,0.5382022471910113,1.0,1.0,14/51,24.10%,LAP3;MMP14;AGBL2;ERAP1;CPQ;AEBP1;NPEPPS;NUDT16;METAP2;FOLH1;MMP15;TRHDE;VASH1;RNPEP
prerank,SUMO transferase activity (GO:0019789),0.412399780886137,0.9702315358003143,0.5097222222222222,0.9975411643070914,1.0,8/16,27.82%,CBX4;NSMCE2;PIAS1;PIAS2;HDAC4;TRIM28;PIAS4;RANBP2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3751993067048016,0.9698073258753352,0.49878345498783455,0.9953059266749112,1.0,11/28,22.98%,AGO2;RNASEH2A;FEN1;DBR1;NUDT16;DICER1;RPP30;ENDOV;RPP14;RNASEH1;RPP21
prerank,semaphorin receptor binding (GO:0030215),-0.3052831296877715,-0.9695389965103641,0.4854771784232365,1.0,1.0,13/23,29.01%,SEMA4C;SEMA4G;SEMA4A;SEMA6A;SEMA4B;SEMA3E;SEMA5B;SEMA6D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,rRNA binding (GO:0019843),0.34934628112887783,0.9674016261669756,0.538638985005767,0.9986249479778672,1.0,8/42,7.16%,SBDS;ERAL1;NOP53;NGRN;RCC1L;MRPL16;RRS1;PPAN
prerank,tRNA binding (GO:0000049),-0.25618864624329296,-0.9662535051327021,0.5035460992907801,1.0,1.0,12/43,13.79%,FARS2;EEF1A1;EIF2A;TYW5;PSTK;TRNT1;MRPS27;TRMT10B;RPUSD4;YRDC;TRMT10A;NEMF
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.2687825090734589,-0.9656278466656951,0.5307262569832403,1.0,1.0,10/35,16.15%,APEX2;PLCB2;MPPED2;NAPEPLD;SMPDL3A;SMPD3;PDIA3;PLD4;GPCPD1;SMPDL3B
prerank,glucuronosyltransferase activity (GO:0015020),0.3965873811879147,0.9630123367751741,0.5092348284960422,1.0,1.0,1/19,0.70%,EXT1
prerank,steroid hydroxylase activity (GO:0008395),0.4064507672665899,0.9629395042817115,0.5236111111111111,1.0,1.0,3/16,20.66%,CH25H;CYP27A1;CYP39A1
prerank,transmitter-gated ion channel activity (GO:0022824),0.37162688693485424,0.9623586595035929,0.5455680399500624,1.0,1.0,12/29,25.15%,GRIN2D;GRIK3;GRIA2;GLRA2;GRID1;GRIA4;GABRG1;GABRB2;GRIK4;GABRA3;GRIK5;GRIK2
prerank,nuclear localization sequence binding (GO:0008139),0.4009945635810368,0.9603935401880919,0.5256064690026954,1.0,1.0,3/18,4.98%,RANBP6;NUP153;KPNB1
prerank,protein kinase inhibitor activity (GO:0004860),0.34535969086096885,0.9591100119314434,0.5313953488372093,1.0,1.0,9/42,13.88%,TAOK3;SPRY2;SOCS1;GMFB;NCK1;CIB1;NPM1;RACK1;DUS2
prerank,kinesin binding (GO:0019894),0.3679718279396771,0.958341310319597,0.5256570713391739,1.0,1.0,8/27,16.49%,CLSTN1;MAPK8IP3;ARHGEF10;NEK6;PLEKHM2;ACTB;SPAG9;KLC2
prerank,ligand-gated anion channel activity (GO:0099095),-0.3256628595443762,-0.9558600892250947,0.49504950495049505,1.0,1.0,6/17,15.73%,GABRG3;GABRB1;GLRB;GABRA2;GLRA3;GABRB3
prerank,ion gated channel activity (GO:0022839),0.3742858465199643,0.9555138135137144,0.5291073738680466,1.0,1.0,4/24,16.25%,TRPM5;TTYH1;ANO10;ANO5
prerank,protease binding (GO:0002020),0.31709704757562746,0.9552197292071207,0.5609243697478992,1.0,1.0,32/99,25.70%,NOL3;COMP;SERPINC1;BFAR;LONP2;CFLAR;ITGA3;AMFR;PRNP;TWNK;TIMP2;RIOK3;COL3A1;CHMP3;LCOR;TRIP4;CRADD;LDLR;RFFL;NFRKB;RIPK2;F3;ADRM1;SART3;SUMO1;INSL3;VCP;POLG;TNF;ANXA2;DERL2;RAD23A
prerank,endonuclease activity (GO:0004519),0.33606721399241146,0.9543972081853546,0.554176072234763,1.0,1.0,8/49,12.49%,AGO2;APLF;NOB1;ZC3H12C;FEN1;ERCC4;ZC3H12A;ZRANB3
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3269101108357791,0.9522436385704284,0.5749167591564928,1.0,1.0,27/71,27.27%,EYA4;CDC25B;PTPN18;DUSP3;TIMM50;PTPN7;DUSP26;PTPN11;DUSP11;PTPN9;PTPRU;EYA2;PTPRC;PTPRB;PTPRF;PTP4A2;PTPRM;PTPN6;PTPRS;PTPN23;EYA3;PTPN1;PTEN;EYA1;CDC14A;PTPRN;PTPRE
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3527546822427644,0.9508123891628271,0.5562273276904474,1.0,1.0,11/38,16.50%,IRS1;MAGI2;MAPK8IP3;NCK1;NCK2;LDLRAP1;G3BP2;STAP1;PTPN11;SPAG9;BLNK
prerank,carboxy-lyase activity (GO:0016831),0.3879304890156656,0.9493795742663003,0.5279255319148937,1.0,1.0,6/23,18.08%,AZIN2;DDC;AZIN1;GGCX;ACOD1;GAD1
prerank,nucleosomal DNA binding (GO:0031492),0.3885033073165589,0.9472850398407157,0.5473411154345007,1.0,1.0,9/21,23.98%,MBD2;SMARCE1;SMARCC2;MTA2;ACTB;SMARCD2;HDAC1;HDAC2;ACTL6A
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.35026513738396564,0.9469777578615086,0.561091340450771,1.0,1.0,10/37,18.29%,VARS1;RARS1;HARS2;IARS2;AARS1;IARS1;NARS1;PARS2;YARS2;TARS2
prerank,cadherin binding (GO:0045296),0.29673488804763865,0.9466260991175258,0.658,1.0,1.0,92/315,22.92%,STAT1;CHMP4B;ZC3HAV1;FMNL2;KDR;TRIM25;RARS1;CDH13;ACVR1;SH3GL1;FLNB;PKN2;LARP1;RSL1D1;HSP90AB1;GOLGA3;HNRNPK;CTNNB1;TNKS1BP1;SH3GLB1;IDH1;GAPVD1;ARGLU1;CDH9;MAPRE1;LASP1;RAB11B;NCK1;P2RX4;PLCB3;VAPB;BMPR2;HSPA8;FNBP1L;EIF4H;LYPLA2;SNX9;ATIC;HDLBP;FXYD5;CAPZB;TMOD3;PTPN11;PSEN1;TJP2;CTNNA3;KTN1;RACK1;RANBP1;CORO1B;SEPTIN9;UNC45A;CTNND2;DLG1;DBNL;BZW1;RPL23A;BAIAP2;BAIAP2L1;PPME1;KLC2;SNX1;IST1;TBC1D2;LRRFIP1;EPN2;AHSA1;CHMP5;MYH9;RPL24;CNN3;STK24;PTPRB;EIF5;ARHGAP18;RAB1A;PI4KA;TRPC4;EFHD2;DDX3X;CD46;RPL29;PSMB6;LDHA;USP8;RPL6;SNX2;CLIC1;ESYT2;RAB10;TWF1;EEF1G
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.2688166077438253,-0.9458789370256289,0.5444444444444444,1.0,1.0,7/35,11.69%,SYK;SLA;DYRK1A;FES;FGR;SRC;TNK2
prerank,sulfate transmembrane transporter activity (GO:0015116),0.4156060498739871,0.9440691132155912,0.5433526011560693,1.0,1.0,3/14,11.35%,SLC26A1;SLC25A10;SLC26A2
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.42848892242174097,0.9419869516087612,0.5451936872309899,1.0,1.0,7/12,28.73%,IRS1;STAP1;BLNK;GAB2;SHC1;SH2B1;PIK3R1
prerank,FAD binding (GO:0071949),0.3788288014748245,0.9416184956558497,0.567741935483871,1.0,1.0,3/24,8.06%,MTHFR;CYB5R2;CYB5R3
prerank,phosphotyrosine residue binding (GO:0001784),0.3480284258521673,0.9411313278515963,0.5632458233890215,1.0,1.0,12/37,21.67%,IRS1;HCK;SH3BP2;NCK2;LDLRAP1;VAV1;STAP1;PTPN11;CRK;LCK;YES1;ABL2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.2520225424211939,-0.9403640916380582,0.5329341317365269,1.0,1.0,8/34,15.57%,MYO10;FCHSD2;MYO1G;IQGAP1;RACGAP1;AKT1;MYO1B;ARAP3
prerank,protein tyrosine kinase activity (GO:0004713),0.30728666818478056,0.939742167015487,0.6084656084656085,1.0,1.0,30/108,23.19%,AXL;FLT1;KDR;HCK;PEAK1;EPHA4;FGFR2;RET;EPHA6;LTK;MET;LYN;INSR;ROR2;DYRK2;JAK2;FYN;FGFR3;CSK;CAMKK2;WEE1;DDR2;LCK;YES1;ROR1;ABL2;ERBB3;TWF1;PKDCC;AATK
prerank,nuclear import signal receptor activity (GO:0061608),0.4084659731244707,0.9380349075746997,0.5520110957004161,1.0,1.0,3/15,13.46%,RANBP6;KPNB1;TNPO2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.348319390836783,0.9380256026295405,0.5602409638554217,1.0,1.0,11/34,20.89%,METTL21A;NSD3;SETD3;EEF2KMT;MEN1;CAMKMT;EZH2;SMYD1;ATPSCKMT;SMYD2;SETD7
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.30213877777458176,0.937316835242459,0.6363636363636364,1.0,1.0,42/147,21.15%,DOCK8;RGP1;RINL;SPATA13;SBF1;RCC1L;ARHGEF7;HERC2;GAPVD1;DENND1A;RAPGEF6;RAPGEF2;CCDC88A;ABR;EIF2B2;VAV1;ANKRD27;ARHGEF11;RIN2;ARHGEF10;SOS1;LAMTOR3;ARFGEF2;RIC1;FGD6;IQSEC2;AKAP13;RAPGEF1;DENND10;MYCBP2;DENND6B;DENND4A;BCR;WDR41;PLCE1;EIF2B5;EIF2B3;DENND1B;LAMTOR4;DOCK10;DENND2D;DENND4B
prerank,sterol binding (GO:0032934),0.33148569690609164,0.9360938768169016,0.5736782902137233,1.0,1.0,18/56,17.01%,ABCA1;ABCG1;OSBPL8;OSBPL7;OSBPL3;RORA;STARD3;TSPO;PTCH1;NPC1;OSBPL9;ERLIN2;OSBP2;NPC2;GRAMD1C;SOAT2;OSBP;SOAT1
prerank,retinoid binding (GO:0005501),-0.29099736468567133,-0.9350903493745839,0.5358649789029536,1.0,1.0,4/22,12.22%,PTGDS;RXRA;RARA;NR2F2
prerank,voltage-gated chloride channel activity (GO:0005247),0.4375027825158782,0.9345505762362107,0.5586510263929618,1.0,1.0,2/10,5.82%,CLCN2;CLCN6
prerank,GABA-A receptor activity (GO:0004890),-0.3064914894234284,-0.9333569551176599,0.5475285171102662,1.0,1.0,9/18,36.74%,GABRG3;GABRB1;GABRA2;GABRB3;GABRA5;GABRR2;GABRE;GABRA4;GABRQ
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.3592712076499629,-0.9322830835052418,0.5311475409836065,1.0,1.0,2/11,3.48%,PPP1R14C;PPP1R8
prerank,5'-nucleotidase activity (GO:0008253),0.41426269583108344,0.9321567354681081,0.5519203413940256,1.0,1.0,3/13,16.19%,NT5DC1;NT5C3A;NT5C3B
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2937288597343332,0.929545449402407,0.6823647294589178,1.0,1.0,46/254,18.64%,NR1H2;MEF2B;TFAP2C;ZBTB17;ESRRB;NFKB2;STAT3;ELK3;RUNX1;KLF15;MZF1;SOX9;ZNF76;TCF4;NFKB1;CREBRF;TFAP2B;UBP1;SRF;SMAD2;MEIS3;ATF6B;TFDP1;ATF1;NFIB;SCX;ELF4;MITF;TFDP2;KLF10;REL;NR3C1;PRDM4;E2F4;CASZ1;RREB1;MYB;SMARCD2;MEF2A;RBPJ;ELF1;ZNF445;FOSL2;HINFP;HOXA5;PRRX1
prerank,protein heterodimerization activity (GO:0046982),0.2962224724869075,0.928159400530118,0.6478304742684158,1.0,1.0,50/178,25.44%,SIM1;EXT1;USF2;ABCG1;TUBB2B;FBXO7;PAFAH1B3;CYBB;BHLHE40;ZHX3;TCOF1;RRAGC;TCF4;ITGA3;USF1;TFAP2B;NOLC1;BARD1;VAPB;UBA2;XBP1;GABBR2;MICU2;MEF2A;MIGA2;IRAK1;SNX1;MTTP;BAX;RALGAPB;LSM5;PAFAH1B1;BUD23;PSMF1;MCL1;GADD45A;TENM4;SNX2;RRAGA;ERBB3;BCL2L2;TAF7;CYBA;TENM1;YWHAE;EXT2;ATF6;GCA;EPAS1;KCNB1
prerank,insulin-like growth factor I binding (GO:0031994),-0.3420953627400372,-0.927950103633225,0.5335365853658537,1.0,1.0,8/13,23.35%,ITGAV;IGFBP5;IGFBP4;IGF1R;ITGB3;ITGB4;IGFBP6;IGFBP3
prerank,protein phosphatase inhibitor activity (GO:0004864),0.3620254745195499,0.9277614192324747,0.5810126582278481,1.0,1.0,13/26,30.59%,ARPP19;PPP1R11;PPP1R1A;MGAT5;PPME1;SET;CABIN1;ENSA;BOD1;PPP1R14A;PPP1R2;PABIR1;LGALS3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4343322699940489,0.9265095121930432,0.5787831513260531,1.0,1.0,1/10,0.80%,APOBEC1
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4356417711692954,0.9245133622061446,0.5707692307692308,1.0,1.0,3/10,16.41%,AUH;ECHDC3;HADHA
prerank,methyltransferase activity (GO:0008168),0.33077734040837514,0.9235812613877551,0.5892448512585813,1.0,1.0,12/46,18.74%,COMTD1;BCDIN3D;MRM2;NTMT1;MEPCE;COQ3;DNMT1;COMT;GCSH;PRMT1;PRMT3;BUD23
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.40535374466857227,0.9227290378458799,0.5630372492836676,1.0,1.0,2/14,10.23%,BST2;TIMP2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.25862675769121474,-0.9216174894041232,0.5945945945945946,1.0,1.0,18/32,40.49%,KCNC2;KCNH1;KCNQ5;KCNA2;KCNC3;KCNG2;KCNC1;KCNB2;KCNC4;KCNH2;KCNQ4;KCNQ1;KCNG1;KCNE3;KCNG4;KCNA6;KCNE4;KCNG3
prerank,telomeric DNA binding (GO:0042162),0.3519569639562105,0.9194074943413979,0.5804878048780487,1.0,1.0,10/32,19.00%,SMG7;HNRNPA2B1;SMG5;UPF2;UPF3A;TELO2;STN1;UPF1;HMBOX1;TERF2
prerank,protein kinase C activity (GO:0004697),-0.32765144458835793,-0.9166894007304215,0.5755395683453237,1.0,1.0,4/14,12.82%,PRKCQ;PRKCZ;CCL3;PRKCI
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.4090865064340673,0.9157768243960078,0.5818431911966988,1.0,1.0,4/13,17.08%,SOX9;PRKAR2B;CSK;PRKAR2A
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.39433762444522047,0.9155011640109378,0.57991513437058,1.0,1.0,3/15,9.05%,AGPAT5;ABHD8;LPCAT2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.4209689075947567,0.9153952055082983,0.5793871866295265,1.0,1.0,2/11,25.51%,SLC2A9;SLC17A5
prerank,histone demethylase activity (GO:0032452),0.3566676148964164,0.9126453497203648,0.6110397946084724,1.0,1.0,7/27,15.96%,KDM4D;HR;KDM3B;RIOX2;FBXL19;KDM8;KDM7A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2888317005955443,0.9114232290982612,0.6859169199594731,1.0,1.0,43/173,22.22%,TFAP2C;ZBTB17;NFX1;ZBTB2;ZFP37;BATF3;ELK3;BHLHE40;NACC1;MZF1;NFKB1;BCL6;BACH1;SNAI2;ETV6;AEBP1;PROX1;FOXK1;MAX;CTCF;ZBTB5;MITF;SKIL;NR3C1;ZBTB21;MYPOP;POU6F1;ZBTB34;ERF;GTF2IRD1;PPARD;ZBTB4;LRRFIP1;ZBTB49;DACH1;ZKSCAN3;ZEB1;ZFP90;SCRT1;ZBTB20;E2F6;ZNF692;PRDM1
prerank,deoxyribonuclease activity (GO:0004536),0.4010915983401963,0.9099172801063621,0.6017191977077364,1.0,1.0,3/14,12.49%,APLF;ERCC4;ZRANB3
prerank,UDP-galactosyltransferase activity (GO:0035250),0.42325896227935333,0.9098536185606484,0.5697151424287856,1.0,1.0,2/10,8.93%,B4GALT1;B4GALT5
prerank,phospholipase activator activity (GO:0016004),0.4248197121111605,0.9098376179260873,0.5794251134644478,1.0,1.0,5/10,23.43%,CCL5;STX4;FYN;LCK;PDPK1
prerank,Wnt-activated receptor activity (GO:0042813),-0.3330645759668384,-0.9093558354804233,0.5698529411764706,1.0,1.0,10/15,41.55%,RYK;TSPAN12;FZD7;FZD4;FZD6;FZD2;FZD5;FZD8;FZD1;FZD10
prerank,protein phosphatase activator activity (GO:0072542),0.40227225290023394,0.9079780866264154,0.5885634588563459,1.0,1.0,6/13,24.43%,PPP2R5C;PPP2R5D;CALM3;PHACTR4;PPP2R5A;CALM2
prerank,receptor tyrosine kinase binding (GO:0030971),0.320493712465441,0.9066712451962412,0.6218961625282167,1.0,1.0,9/56,12.94%,IRS1;CPNE3;ELMO2;DUSP3;PITPNM1;NCK1;SOCS5;STAP1;RACK1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3596165910707652,0.9063444076289175,0.6036036036036037,1.0,1.0,5/24,12.15%,ITPKC;PPIP5K1;CMPK2;AK4;AK3
prerank,aspartic-type peptidase activity (GO:0070001),0.42843288476538055,0.9031693626982517,0.5963302752293578,1.0,1.0,3/10,18.95%,PSEN1;NAPSA;DDI2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.32792434837650636,-0.9026428418129308,0.5663716814159292,1.0,1.0,4/13,11.69%,GABRG3;GLRB;GABRA2;GLRA3
prerank,GTPase inhibitor activity (GO:0005095),-0.3302941321465964,-0.9019516328396322,0.5709876543209876,1.0,1.0,6/13,20.65%,PDE6D;IQGAP1;ARL2;TNK2;GPS1;RTKN
prerank,palmitoyltransferase activity (GO:0016409),0.34583594178124255,0.9009693881168069,0.5928659286592866,1.0,1.0,12/28,27.23%,GOLGA7;ZDHHC21;ZDHHC20;HHAT;ZDHHC13;ZDHHC8;ZDHHC3;ZDHHC18;ZDHHC22;ZDHHC17;ZDHHC16;ZDHHC7
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.3039863556368832,0.9003675642795808,0.6324503311258278,1.0,1.0,10/73,19.40%,RXFP2;GPR37L1;FPR3;S1PR2;GPR37;GALR1;INPP5K;HCRTR1;NLRP6;ADCYAP1R1
prerank,metallopeptidase activity (GO:0008237),0.2945702751201739,0.8973095737753132,0.666323377960865,1.0,1.0,23/113,22.31%,ADAM33;LAP3;ADAMTS3;MMP14;ADAM8;ERAP1;ADAMTS19;NLN;PAPPA;ADAMTS2;PITRM1;ADAMTS6;NUDT16;ADAMTS12;SPRTN;METAP2;MPND;MIPEP;PSMD7;ADAMTS18;CHMP1A;IDE;MMP15
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.36218676906263275,0.8970968435038701,0.6093959731543624,1.0,1.0,7/21,21.82%,PDE7B;PDE8B;PDE3A;PDE1C;PDE4B;PDE9A;PDE4A
prerank,hydro-lyase activity (GO:0016836),0.3223391250063907,0.8966518945168358,0.6284023668639053,1.0,1.0,9/41,16.41%,CA4;AUH;ECHDC3;HACD3;CDYL;CA2;UROS;TGDS;HADHA
prerank,lysine N-methyltransferase activity (GO:0016278),0.3669396738710695,0.891838694493484,0.6084099868593955,1.0,1.0,8/20,26.45%,METTL21A;SETD3;EEF2KMT;ATPSCKMT;SMYD2;SETD7;EEF1AKMT1;EHMT2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.33484635068365287,0.8913912878430036,0.6325301204819277,1.0,1.0,7/33,14.05%,PNPT1;XRN2;CNOT7;XRN1;DCP2;DIS3L2;EXOSC9
prerank,MAP kinase kinase activity (GO:0004708),0.38856434089092645,0.8912515558962872,0.6049723756906077,1.0,1.0,4/15,11.82%,PAK3;MAP2K3;MAPK14;MAP2K2
prerank,RNA stem-loop binding (GO:0035613),0.40554219332206043,0.8910119844065448,0.6149341142020498,1.0,1.0,5/12,20.51%,DHX9;ZC3H12A;RC3H2;CSDE1;DDX3X
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.2609171186006561,-0.89020827771594,0.6124401913875598,1.0,1.0,9/27,23.88%,SLC9A9;SLC8A3;SLC4A8;SLC3A2;PKD2L1;SLC9A8;CNNM4;SLC8A2;SLC9B2
prerank,myosin II binding (GO:0045159),0.42149584604976725,0.8894585045414262,0.616793893129771,1.0,1.0,3/10,16.51%,GSN;STXBP5L;LLGL1
prerank,cardiolipin binding (GO:1901612),0.4242142787247537,0.8884908018380474,0.6110260336906586,1.0,1.0,1/10,3.62%,PLEKHN1
prerank,CoA hydrolase activity (GO:0016289),0.3787054458055881,0.8874654392151163,0.6104815864022662,1.0,1.0,3/16,12.85%,ACOT9;ABCD1;ACOT13
prerank,MHC class II protein complex binding (GO:0023026),-0.3483941468723688,-0.8869190197465826,0.5904761904761905,1.0,1.0,4/11,10.56%,CD81;ATP1B1;PKM;ANXA11
prerank,TBP-class protein binding (GO:0017025),-0.28524167155856683,-0.8859098550243648,0.6401673640167364,1.0,1.0,6/21,17.49%,TAF12;ESR1;THRA;TAF1;PSMC1;AHR
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.3964408087970104,0.8858574442642161,0.6204268292682927,1.0,1.0,4/12,15.96%,KDM4D;HR;KDM3B;KDM7A
prerank,metalloaminopeptidase activity (GO:0070006),0.37938627531639396,0.8837069695249342,0.6256906077348067,1.0,1.0,6/16,24.10%,MMP14;ERAP1;NPEPPS;MMP15;TRHDE;RNPEP
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3066576065455569,0.8834454453139888,0.6429378531073446,1.0,1.0,13/53,22.21%,SLC25A22;SLC38A2;SLC38A1;SLC38A3;SLC38A6;SLC7A6;CTNS;SLC25A12;SLC36A4;SFXN1;SLC25A15;SLC7A7;SLC1A3
prerank,ionotropic glutamate receptor activity (GO:0004970),0.3743032237419097,0.8830641531070627,0.635116598079561,1.0,1.0,3/17,6.56%,GRIN2D;GRIK3;GRIA2
prerank,ATPase regulator activity (GO:0060590),0.3220327858096884,0.8821496154345183,0.6405307599517491,1.0,1.0,10/38,20.79%,TOR1AIP2;TOR1AIP1;ATP1B3;DNAJB4;DNAJB6;BAG1;AHSA1;FNIP2;TSC1;HSPBP1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.3307618334850053,0.8799433310151474,0.6372670807453417,1.0,1.0,9/31,17.96%,UBE2L6;UBE2W;UBE2B;UBE2E3;UBE2E1;UBE2L3;UBE2Q1;UBE2K;BIRC6
prerank,dynactin binding (GO:0034452),-0.3238413674658549,-0.879654574856454,0.5782747603833865,1.0,1.0,3/12,8.69%,BICDL1;HTT;GSK3B
prerank,acetylcholine receptor activity (GO:0015464),-0.27336281806310864,-0.8791055894417602,0.6533333333333333,1.0,1.0,4/22,21.25%,CHRFAM7A;CHRNA7;CHRM2;CHRNA4
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.33742647721930547,0.8785597277252475,0.6335877862595419,1.0,1.0,8/26,24.58%,SLC27A1;SLC16A13;SLC16A14;SLC16A6;ABCG2;SLC5A6;SLC6A6;SLC16A4
prerank,anion channel activity (GO:0005253),-0.21445165744438255,-0.8765292310630404,0.7272727272727273,1.0,1.0,17/61,22.28%,GABRG3;VDAC1;CLCN5;GABRB1;GLRB;GABRA2;GPR89B;GPR89A;GLRA3;SLC1A4;GABRB3;SLC26A8;GABRA5;LRRC8A;CLCN4;ANO6;FXYD1
prerank,Notch binding (GO:0005112),0.3503237560646833,0.8761612289280152,0.6339869281045751,1.0,1.0,8/22,23.82%,DLK2;MEGF10;SNW1;NOTCH4;DNER;AAK1;CUL3;NCOR2
prerank,gap junction channel activity (GO:0005243),0.35263619626251025,0.8742692682232259,0.6307692307692307,1.0,1.0,2/22,11.21%,PANX2;PANX1
prerank,phosphatase binding (GO:0019902),0.2889822050223528,0.8739808571170649,0.708768267223382,1.0,1.0,21/105,14.69%,FCRL6;STAT3;ANAPC5;IKBKE;CTNNB1;ANK1;NFATC2;MAGI2;CTSC;PPP6R3;SMAD2;ANAPC4;VRK3;MET;MAPK14;TRAF3;CDC27;RACK1;BAD;DLG1;DZIP3
prerank,lipase activity (GO:0016298),-0.23072933153049302,-0.873774857462777,0.6981132075471698,1.0,1.0,14/43,21.59%,ABHD16A;LYPLA1;LIPH;SMPD3;PLBD1;PITPNM3;MGLL;ABHD12;LPL;FAAH;SEC23IP;PLA2G15;ABHD6;SMPD2
prerank,ferrous iron binding (GO:0008198),0.35243275491269666,0.8737133821477531,0.6372155287817939,1.0,1.0,5/21,14.85%,FXN;EGLN2;ALKBH1;ALKBH2;TET2
prerank,NADP binding (GO:0050661),0.33004339313978776,0.8727657508118414,0.6457073760580411,1.0,1.0,4/32,8.33%,DHFR;GRHPR;PGD;HSD11B1
prerank,thioesterase binding (GO:0031996),0.40306411497259004,0.8723256842293883,0.6330827067669172,1.0,1.0,4/11,13.91%,TRAF4;TRAF3;TRAF5;RAC1
prerank,cell adhesion mediator activity (GO:0098631),0.347745230732714,0.8722524727157739,0.6561712846347607,1.0,1.0,7/24,19.96%,CD47;PLXNB3;NPTN;DSCAM;DSCAML1;JAM3;SIRPA
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.34639945327507876,0.8703470448262827,0.650200267022697,1.0,1.0,7/23,21.82%,PDE7B;PDE8B;PDE3A;PDE1C;PDE4B;PDE9A;PDE4A
prerank,sodium channel activity (GO:0005272),0.3185857184343355,0.870201291315906,0.6513317191283293,1.0,1.0,11/37,26.99%,GRIK3;ASIC4;SCN2A;SCN1B;SCN8A;HCN2;GRIK4;GRIK5;GRIK2;SHROOM2;SCN4B
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3059186459325491,-0.8672116384108273,0.631578947368421,1.0,1.0,6/15,19.75%,NDST3;HS6ST3;HS2ST1;HS3ST2;HS3ST3A1;HS3ST5
prerank,peptidase inhibitor activity (GO:0030414),0.32351158962723836,0.8643877224325697,0.6662636033857315,1.0,1.0,5/33,11.74%,SLPI;UCHL5;CST7;TIMP2;USP14
prerank,poly-purine tract binding (GO:0070717),0.33544401661360934,0.8643171680999511,0.6695979899497487,1.0,1.0,13/27,29.64%,PNPT1;RBMS2;HNRNPDL;ATXN1;DAZAP1;RBPMS;DDX3X;ZC3H14;KHDRBS2;HNRNPU;KHDRBS1;PABPC1;PABPC4
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.31575210188670344,-0.8630170543023351,0.6521739130434783,1.0,1.0,4/13,11.27%,DNASE1L1;ZGRF1;SLX4;DNA2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3639376145291705,0.8619298939123816,0.6585034013605442,1.0,1.0,3/17,12.85%,ACOT9;ABCD1;ACOT13
prerank,exonuclease activity (GO:0004527),0.31096220662603513,0.8586365375195644,0.6965116279069767,1.0,1.0,10/46,14.13%,XRN2;APLF;ENPP3;AEN;CNOT7;FEN1;ZC3H12A;ENPP1;EXOSC9;REXO1
prerank,GDP binding (GO:0019003),0.2973177166285483,0.857715737987302,0.6980306345733042,1.0,1.0,9/63,10.99%,RAB8B;RAB21;RHEBL1;RAB12;RRAGC;RAB22A;RAB11B;RAB5C;RAB14
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.33735265110254187,0.8524363748281857,0.6675224646983312,1.0,1.0,3/24,5.22%,GOLGA7;ZDHHC21;ZDHHC20
prerank,sialyltransferase activity (GO:0008373),0.3487950340866691,0.850319855039727,0.6657997399219766,1.0,1.0,4/20,9.71%,ST6GALNAC4;ST6GALNAC6;ST6GAL1;ST3GAL1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.2634189431685545,-0.8496700407370483,0.6796116504854369,1.0,1.0,9/24,33.79%,KCNJ10;KCNK6;KCNJ6;KCNJ13;ABCC8;KCNH2;KCNJ12;KCNJ16;KCNN1
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2888965023228733,0.8495058406955864,0.7163355408388521,1.0,1.0,16/72,19.67%,CGAS;ACTN2;GRAMD2A;SYT7;ADAP2;LDLRAP1;GSN;PLEKHA4;SNAP91;RPH3A;KCNJ2;PHLDA3;TULP3;MARK1;OSBPL2;PLA2G4E
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.27844760721058304,-0.8478903588412533,0.6877323420074349,1.0,1.0,6/18,21.76%,PDLIM5;PDLIM1;S100A11;CDC42EP1;ANXA1;STXBP6
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.33530698814118826,0.8473441397097065,0.682741116751269,1.0,1.0,10/25,26.74%,ADAP2;KIF16B;PLEKHA1;PLEKHA4;PHLDA3;PLA2G4E;ZFYVE1;COMMD1;GAB2;PLEKHA2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.36549510227662263,0.8441082605484382,0.6704707560627675,1.0,1.0,3/16,14.80%,SLC25A22;SLC25A10;SLC25A12
prerank,endoribonuclease activity (GO:0004521),0.31601395499849844,0.8414667960880369,0.6791767554479419,1.0,1.0,7/32,19.75%,AGO2;NOB1;ZC3H12C;ZC3H12A;DICER1;ENDOV;ERN1
prerank,wide pore channel activity (GO:0022829),0.33640996627623443,0.8412658617217277,0.6780735107731305,1.0,1.0,2/23,11.21%,PANX2;PANX1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.30885354995386727,0.8411113959945588,0.6726835138387485,1.0,1.0,9/34,17.96%,UBE2L6;UBE2W;UBE2B;UBE2E3;UBE2E1;UBE2L3;UBE2Q1;UBE2K;BIRC6
prerank,cytokine receptor activity (GO:0004896),0.2796900384744659,0.8398319046091023,0.755939524838013,1.0,1.0,17/83,21.46%,CRLF1;IL15RA;IL21R;IL17RC;IL10RA;IL12RB2;LEPR;GFRA2;IL10RB;IFNAR2;IL1RAP;CSF2RA;IFNGR2;IFNGR1;EBI3;IL4R;F3
prerank,transcription coactivator binding (GO:0001223),0.3383147556202002,0.8395202093903963,0.6790450928381963,1.0,1.0,6/20,17.69%,ZBTB17;TEAD2;CCNT2;RORA;PPARD;ZBTB49
prerank,amino acid transmembrane transporter activity (GO:0015171),0.2944058794740259,0.8392916245983875,0.7063583815028902,1.0,1.0,6/47,9.34%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;PDPN;SLC7A6
prerank,translation elongation factor activity (GO:0003746),-0.30145932784711804,-0.8366077249049798,0.6551724137931034,1.0,1.0,6/14,24.66%,EEF1A1;EEF1B2;TSFM;EIF5A2;GTPBP1;EEF1A2
prerank,death receptor binding (GO:0005123),0.36157723426004373,0.8365092013709184,0.666191155492154,1.0,1.0,2/15,3.91%,BDNF;FEM1B
prerank,cation:chloride symporter activity (GO:0015377),-0.3430353465765865,-0.836469460498302,0.6564245810055865,1.0,1.0,2/10,2.43%,SLC12A6;SLC12A2
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.38154472214705926,0.8345688296612939,0.6762481089258698,1.0,1.0,4/11,22.37%,ITPR1;RPH3A;TRPC4;TRPC1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.31844418141784414,-0.8333806246265436,0.6842105263157895,1.0,1.0,4/12,9.22%,PIK3C2A;IPMK;PIK3C3;PIK3CG
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.3004858004230628,-0.8323521324758607,0.6964856230031949,1.0,1.0,5/14,16.27%,MTMR1;MTMR4;MTMR9;MTMR10;MTM1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.3824370044243723,0.8297988214937232,0.7018284106891702,1.0,1.0,4/12,20.17%,ACVR1;BMPR2;BMPR1A;ACVRL1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.3494060866079584,0.8285903337262076,0.695137976346912,1.0,1.0,5/18,20.17%,ACVR1;BMPR2;BMPR1A;ACVR2A;ACVRL1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.31507298852154186,0.8284015522289025,0.7120291616038882,1.0,1.0,11/29,28.12%,SPRY2;CDKN2D;PRKAR2B;CIB1;PRKAR2A;SPRED1;YWHAG;KAT2B;CDKN2A;PKIB;PRKAR1A
prerank,solute:anion antiporter activity (GO:0140323),0.3665398147269322,0.8282974494862235,0.6815642458100558,1.0,1.0,3/14,16.45%,SLC26A1;SLC26A2;SLC4A2
prerank,phosphatase activity (GO:0016791),0.28182358743209546,0.8281111272287603,0.7628755364806867,1.0,1.0,27/73,26.65%,DUSP3;PDXP;SBF1;LPIN2;DUSP28;DUSP26;EPHX2;DUSP10;DUSP16;DUSP11;INPP5K;NUDT16;OCRL;DUSP8;MINPP1;SACM1L;LHPP;PGAM5;PLPP2;PLPPR2;PLPPR1;FRA10AC1;MDP1;PLPP6;PLPP1;NT5C;NOCT
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.3192411094237961,0.8267059911732095,0.7117346938775511,1.0,1.0,5/27,10.14%,AUP1;SIAH1;DCUN1D4;RNF19B;ARIH1
prerank,general transcription initiation factor binding (GO:0140296),-0.24598417640012712,-0.8253218501910361,0.7477477477477478,1.0,1.0,7/25,13.07%,AR;TAF12;ESR1;THRA;TBP;TAF1;PSMC1
prerank,active ion transmembrane transporter activity (GO:0022853),0.3073379790620843,0.8249326815805,0.7345029239766082,1.0,1.0,3/37,6.50%,UQCRQ;SLCO1C1;SLCO1B1
prerank,metalloendopeptidase activity (GO:0004222),0.2800424247612131,0.8244758126958249,0.7569002123142251,1.0,1.0,11/76,17.51%,ADAM33;ADAMTS3;MMP14;ADAMTS19;NLN;ADAMTS2;PITRM1;ADAMTS6;ADAMTS12;SPRTN;MIPEP
prerank,retinoid X receptor binding (GO:0046965),0.3900354475113687,0.8238727292822141,0.7167630057803468,1.0,1.0,1/11,2.12%,RARG
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.31735915919221513,0.8231453814806062,0.7180124223602484,1.0,1.0,8/29,19.34%,HEXD;NEU1;GANC;HPSE;HPSE2;ACER3;GBA2;ABHD10
prerank,tropomyosin binding (GO:0005523),-0.2859914518302114,-0.8226803344300373,0.6877192982456141,1.0,1.0,12/16,50.24%,CALD1;NEBL;TMOD1;TNNT3;SMTNL2;LMOD3;TMOD2;PYCARD;LMOD1;TNNT2;TMOD4;TNNT1
prerank,voltage-gated cation channel activity (GO:0022843),0.2704730805526658,0.8219051262932073,0.7910922587486744,1.0,1.0,8/97,9.70%,CATSPER4;CACNA2D4;GRIN2D;TMC1;KCNH8;KCNS3;CACNA1A;KCNA4
prerank,protein kinase C binding (GO:0005080),0.29195461492750563,0.8214194487587657,0.7425287356321839,1.0,1.0,7/43,13.47%,IRS1;NELL2;CCDC88A;DACT1;TRPV4;RACK1;NELL1
prerank,motor activity (GO:0003774),0.2812899669422364,0.8207744885303339,0.7406181015452539,1.0,1.0,14/60,20.63%,KIF26A;KIF3C;KIF7;KIF2C;KIF3B;KIF16B;MYO6;KIF2A;APPBP2;DYNC2H1;MYH9;KIF19;PIN1;STARD9
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.24239901015816767,-0.8201579053909013,0.8,1.0,1.0,10/28,21.89%,MAP2K6;SGK1;MAP3K9;RPS6KA2;TNK2;AKT1;MAP2K5;MAPKAPK5;PRKCG;RPS6KA1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.34976042524529777,0.8197499105294097,0.7087912087912088,1.0,1.0,4/17,12.15%,NOL9;CMPK2;AK4;AK3
prerank,microtubule binding (GO:0008017),0.2589516403925087,0.8195900097102884,0.8825301204819277,1.0,1.0,52/222,19.36%,SBDS;KIF26A;KIF3C;KIF7;REEP2;POLB;KIF2C;KIF3B;HOOK2;SAXO2;MAPRE1;CETN3;CEP57L1;RAE1;CDK5RAP2;CCDC88A;NEFM;VAPB;KIF16B;PRNP;HOOK1;SPEF1;CCDC88B;DNM2;CCDC181;SUN2;UXT;MAP1LC3B;TOGARAM2;TRPV4;FGF13;CLIP2;WHAMM;REEP3;HOOK3;CCDC61;CEP295;MAP4;KIF2A;GAS2L3;CCDC66;RAB11A;CLIP4;RMDN1;CAMSAP2;PAFAH1B1;KIF19;SVBP;FNTA;NUMA1;MAP1B;CCDC69
prerank,fibroblast growth factor binding (GO:0017134),0.33086364811593577,0.8180528263740092,0.7019354838709677,1.0,1.0,7/21,26.16%,FGFR2;FGFR3;FIBP;FGFRL1;S100A13;GLG1;CEP57
prerank,calcium channel regulator activity (GO:0005246),0.2992540513341379,0.8169623638337121,0.7475961538461539,1.0,1.0,4/37,6.02%,SGK3;ITPR1;SLC30A1;INAFM1
prerank,pseudouridine synthase activity (GO:0009982),0.36426105885979837,0.816734075304498,0.6826086956521739,1.0,1.0,4/13,21.54%,PUS7L;PUS7;RPUSD1;PUS10
prerank,solute:sodium symporter activity (GO:0015370),-0.23562156005587465,-0.8160065249412614,0.7729468599033816,1.0,1.0,10/27,41.52%,SLC20A1;SLC4A8;SLC28A2;SLC4A9;SLC4A10;SLC4A7;SLC13A5;SLC5A3;SLC28A1;SLC4A5
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.31437295289604605,-0.8153500430442231,0.7064220183486238,1.0,1.0,4/11,9.13%,STK38;MAP3K11;TRAF6;DAB2IP
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.2758727749836328,-0.815243830984943,0.7318840579710145,1.0,1.0,2/16,1.17%,MACROD2;CD38
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.3258136712250794,-0.8138726717013586,0.7016574585635359,1.0,1.0,2/10,9.15%,GABRG3;GABRA2
prerank,histone methyltransferase activity (GO:0042054),0.30203287140789503,0.8132359890422354,0.7379807692307693,1.0,1.0,9/32,20.89%,PRMT2;NTMT1;NSD3;MEN1;EZH2;PRMT1;SMYD1;SMYD2;SETD7
prerank,platelet-derived growth factor binding (GO:0048407),-0.31432533936055396,-0.8130145093514503,0.7241379310344828,1.0,1.0,6/11,31.89%,COL1A2;COL4A1;PDGFRA;COL6A1;PDGFRB;COL5A1
prerank,exopeptidase activity (GO:0008238),0.2872017632374823,0.8086071143782635,0.7585034013605442,1.0,1.0,16/50,26.06%,LAP3;DPEP2;ERAP1;CTSH;DPP3;NPEPPS;KDM8;NUDT16;METAP2;FOLH1;CNDP2;TRHDE;RNPEP;DPP10;DPP6;CPM
prerank,pre-mRNA binding (GO:0036002),0.31401465976314374,0.8068112738501213,0.7444717444717445,1.0,1.0,6/28,12.68%,DDX5;TARBP2;RNPC3;HNRNPL;HNRNPA1;RBM41
prerank,diacylglycerol kinase activity (GO:0004143),-0.3131003123941726,-0.8048174054297733,0.7166123778501629,1.0,1.0,4/11,12.32%,DGKH;DGKZ;DGKD;DGKE
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.3556978021160641,0.8047424228238476,0.7186588921282799,1.0,1.0,6/13,20.92%,TRMT1;WDR4;TRMT10C;THUMPD3;METTL1;TARBP1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.306251864527261,0.8028839356443942,0.7297297297297297,1.0,1.0,8/29,18.46%,NBR1;MAPK14;TNIP1;GCH1;DUSP10;DUSP16;PRMT1;DUSP8
prerank,Tat protein binding (GO:0030957),0.3808636055890331,0.8017585284444206,0.7144992526158446,1.0,1.0,3/10,14.00%,MDFIC;NPM1;ACTB
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.28826892534003157,0.8007313260639413,0.758703481392557,1.0,1.0,5/40,9.13%,COMTD1;MEPCE;SETD3;DNMT3A;DNMT1
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.254170805073372,0.8006349750290178,0.8713272543059777,1.0,1.0,22/188,11.05%,PITX2;PER2;STAT3;ARID5B;RBBP5;RUNX1;KLF15;DHX36;MZF1;TCF7L2;NFKB1;DHX9;ATF6B;CDK5RAP2;NONO;TAF2;HMGB1;MEN1;HNRNPL;PROX1;FOXK1;CTCF
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.3272607195031786,-0.7997926379274397,0.7183908045977011,1.0,1.0,2/10,11.57%,DPYSL3;CRMP1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3720963997682433,0.7982964952117304,0.7255192878338279,1.0,1.0,7/11,27.70%,AMFR;RBX1;UBE4B;UBE2K;STUB1;PRPF19;ANAPC11
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.29699829148016577,-0.7981562576405695,0.7651006711409396,1.0,1.0,6/12,33.77%,B3GNT2;B3GALT5;B3GALT2;B3GNT7;B3GNT8;B3GNT6
prerank,potassium ion leak channel activity (GO:0022841),-0.27670929550982576,-0.7973509411488083,0.7491289198606271,1.0,1.0,7/15,36.15%,KCNK6;KCNK12;KCNK9;KCNK5;KCNK4;KCNK13;KCNK7
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.30639536887967334,0.7940903239966144,0.7531328320802005,1.0,1.0,4/27,11.35%,SLC26A1;ANKH;SLC25A10;SLC26A2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.3461340977263888,0.7939725391871469,0.7219101123595506,1.0,1.0,1/15,4.58%,PLA2G12A
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3301185614194022,0.7934455413013068,0.7251700680272108,1.0,1.0,3/18,8.51%,USP15;SMAD2;BAMBI
prerank,tubulin binding (GO:0015631),0.24926484742749735,0.7917589775800842,0.927,1.0,1.0,101/296,27.64%,GPAA1;CENPJ;SBDS;KIF26A;B9D2;KIF3C;KIF7;REEP2;POLB;KIF2C;ARHGEF7;KIF3B;HOOK2;SAXO2;EFHC2;DLEC1;CETN3;CEP57L1;STMN4;RAE1;CDK5RAP2;CCDC88A;NEFM;VAPB;KIF16B;PRNP;HOOK1;SPEF1;TPPP3;GIT1;STMN3;CCDC88B;DNM2;CCDC181;SUN2;TTLL7;UXT;MAP1LC3B;TOGARAM2;TRPV4;FGF13;CLIP2;WHAMM;REEP3;HOOK3;CCDC61;CEP295;FYN;MAP4;KIF2A;GAS2L3;TBCD;CCDC66;RAB11A;DNAL1;STMN2;RMDN1;PAFAH1B1;KIF19;SVBP;FNTA;BRSK1;NUMA1;MAP1B;CCDC69;DDX3X;STARD9;TRAPPC14;CRIPT;DIXDC1;MAP6D1;RAB11FIP5;MAPRE3;OPA1;KIF21A;MDM1;DNM3;HDAC6;ARL4C;BBS4;HAUS6;DCTN1;RAD51D;EML5;CHP1;MAPRE2;ABRAXAS2;CEP57;CDK5R1;KIF13B;MAST2;TUBGCP5;KIF1A;DNM1;SNPH;LRPPRC;ATF5;MAP1S;CDK5;CCDC170;IRAG2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.34914688620386725,0.7916845955867935,0.7354196301564723,1.0,1.0,3/13,13.22%,ALDH7A1;ALDH1A2;ALDH1A1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.37416386825014214,0.7916080207480578,0.7301349325337332,1.0,1.0,1/10,3.68%,CYBB
prerank,myosin V binding (GO:0031489),0.34517804024342175,0.7867032728066278,0.7455295735900963,1.0,1.0,6/15,26.50%,RAB11B;RAB14;RAB11A;RAB10;RAB3A;RAB3D
prerank,cell-cell adhesion mediator activity (GO:0098632),0.2840386017334217,0.7857713274876569,0.798154555940023,1.0,1.0,14/42,25.46%,CD47;PLXNB3;TMOD3;NPTN;DSCAM;BAIAP2;DSCAML1;BAIAP2L1;JAM3;CNN3;SIRPA;RAB10;CNTN2;ANXA2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.3657018223717069,0.7850676217609857,0.7526555386949925,1.0,1.0,1/10,4.00%,CD47
prerank,NF-kappaB binding (GO:0051059),0.30730366676300724,0.7850117522402437,0.7440100882723834,1.0,1.0,6/24,18.24%,TAF4B;COMMD7;NPM1;RNF25;ANXA4;HDAC1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.29470373395566896,0.7844476531820864,0.7620817843866171,1.0,1.0,5/31,14.30%,TMEM38A;SLC12A5;SLC12A8;KCNK3;TMEM38B
prerank,beta-tubulin binding (GO:0048487),0.2983241529546774,0.7834544603419379,0.7730582524271845,1.0,1.0,7/31,15.36%,DLEC1;VAPB;TTLL7;UXT;TRPV4;FGF13;TBCD
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3135513802220008,0.783372025331632,0.7630890052356021,1.0,1.0,3/23,9.28%,PLCB4;CCL5;PLCB3
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.2957257778159391,0.7816244777509912,0.7747524752475248,1.0,1.0,9/32,18.74%,EGLN2;ALKBH1;RIOX2;ALKBH2;KDM8;TET2;KDM7A;JMJD4;P4HTM
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.3103118482123269,0.7813495466967446,0.7542043984476067,1.0,1.0,6/23,19.67%,KIF16B;PLEKHA4;SH3PXD2B;PHLDA3;GBF1;PLA2G4E
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3465724487516144,0.7803157954633239,0.7334273624823695,1.0,1.0,1/14,0.81%,SLC25A22
prerank,tau protein binding (GO:0048156),0.2844583195142221,0.779632217979711,0.7795823665893271,1.0,1.0,11/40,19.47%,CLU;HSP90AB1;SMAD2;APOE;ACTB;FYN;HSP90AA1;TAOK2;MARK1;BRSK1;PIN1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.30697677971128917,-0.77951289012264,0.7401812688821753,1.0,1.0,6/11,24.60%,SAMD8;AASDHPPT;SGMS2;SGMS1;PIGO;PTDSS2
prerank,potassium ion antiporter activity (GO:0022821),-0.2745903245338937,-0.7754144718196256,0.7818791946308725,1.0,1.0,1/15,1.02%,SLC9A9
prerank,gamma-tubulin binding (GO:0043015),0.30742455176534444,0.7714240356089364,0.764629388816645,1.0,1.0,5/22,10.43%,CENPJ;B9D2;ARHGEF7;CDK5RAP2;GIT1
prerank,anion:anion antiporter activity (GO:0015301),0.3267136850655875,0.7703931963892691,0.760053619302949,1.0,1.0,4/17,16.45%,SLC26A1;SLC19A1;SLC26A2;SLC4A2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.33374595390036776,0.7691365286389149,0.7618403247631935,1.0,1.0,3/15,13.06%,PIK3CD;PI4KB;PIK3CB
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.35121468759102725,0.7678338116570576,0.7535816618911175,1.0,1.0,2/11,16.21%,NAA50;NAA25
prerank,small GTPase binding (GO:0031267),0.24253967450446848,0.7664567701722965,0.9044715447154471,1.0,1.0,52/170,25.21%,ABCA1;DAPK3;RGP1;MYO1C;GOLGA5;TNFAIP1;RILP;CYFIP1;GGA3;KIF3B;RAPGEF6;UNC13D;RAP1GAP;SIKE1;SPHK2;CIB1;ANKFY1;ANKRD27;SRGAP2;SORL1;RIC1;FGD6;AKAP13;WHAMM;RANBP1;DENND10;MYCBP2;LZTR1;PEX5;OCRL;PLCE1;RANBP9;SGSM1;NCKAP1;SGSM3;STRN3;GCC1;RHOH;OPTN;USP33;BRK1;CCDC186;IQGAP2;RAB29;ARHGAP1;BICD2;EXOC2;RAF1;FLNA;RIN3;EVI5L;TBC1D20
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.252127442412736,0.7654768295180652,0.8602941176470589,1.0,1.0,30/100,24.99%,SAP30L;PLEKHN1;GAP43;OSBPL8;DENND1A;RUBCNL;ADAP2;ZFYVE26;KIF16B;ANKFY1;RUBCN;PLEKHA4;PLEKHA3;RPH3A;OSBP;SH3PXD2B;SNX24;PHLDA3;GBF1;GOLPH3L;ARAP1;DENND1B;PLA2G4E;CERT1;IQGAP2;ZFYVE1;SNX12;ARAP2;COMMD1;GAB2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.32989188081631554,0.7646933557993324,0.7672176308539945,1.0,1.0,2/15,11.35%,SLC26A1;SLC26A2
prerank,kinase inhibitor activity (GO:0019210),0.2866645777401512,0.7625401241078902,0.7930204572803851,1.0,1.0,6/33,13.88%,TAOK3;SOCS1;GMFB;NCK1;NPM1;DUS2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.33349586663068614,0.7600666587527113,0.7573632538569425,1.0,1.0,1/15,0.81%,SLC25A22
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.28210977335651377,0.7599724048395383,0.8097502972651606,1.0,1.0,9/34,19.65%,NDUFA5;NDUFB9;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.28210977335651377,0.7599724048395383,0.8097502972651606,1.0,1.0,9/34,19.65%,NDUFA5;NDUFB9;NDUFS1;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,BMP binding (GO:0036122),0.3540147175742507,0.7597543417175283,0.7470588235294118,1.0,1.0,1/11,9.54%,BMPR2
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.2517028855883997,0.7588729688864577,0.8493589743589743,1.0,1.0,19/91,19.67%,CGAS;ACTN2;GRAMD2A;SYT7;ADAP2;KIF16B;LDLRAP1;GSN;PLEKHA4;SNAP91;RPH3A;KCNJ2;SH3PXD2B;PHLDA3;TULP3;GBF1;MARK1;OSBPL2;PLA2G4E
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.22234902130420764,-0.7585287184811271,0.8681818181818182,1.0,1.0,6/26,16.62%,CHSY1;CSGALNACT1;B3GNT2;B3GALT5;B3GALT2;B4GALNT1
prerank,mechanosensitive ion channel activity (GO:0008381),0.33974679961741544,0.7539865997454145,0.7848664688427299,1.0,1.0,1/12,2.42%,TMC1
prerank,G protein-coupled receptor activity (GO:0004930),-0.14659709495890472,-0.7536918721232493,1.0,1.0,1.0,110/239,42.34%,GRM3;GPR183;CNR2;CALCRL;LPAR1;PTAFR;ADGRL1;OPRM1;C5AR2;CX3CR1;GPR45;GPR34;HRH1;ADGRL3;GPR149;P2RY14;XPR1;GPR173;ADGRB3;ADGRA1;CMKLR1;GRM8;TAPT1;S1PR1;GLP2R;ADGRG3;HCRTR2;NTSR2;F2R;QRFPR;PDGFRL;S1PR5;GPR135;ADGRB2;NPR3;ADRA2A;PAX8;P2RY1;DRD2;OPRL1;OPRK1;GPR85;OPN3;GPR75;LPAR6;PDGFRB;GPR26;CRHR1;GPR61;GPR101;TSHR;PTH2R;GPR18;ADRB2;GRPR;F2RL2;ADGRB1;NPR1;OPRD1;MRGPRE;NPFFR2;GPR65;GPR161;GPR27;GPR88;LANCL1;MC5R;HCAR2;SSTR2;FFAR1;NMUR2;BDKRB2;ADGRE5;NPY;GPR171;ADGRG5;S1PR3;DRD3;GPR174;LTB4R;LPAR4;CXCR5;LPAR2;KISS1R;FFAR4;VIPR2;APLNR;CXCR6;CYSLTR1;PTH1R;NTSR1;NMBR;GLP1R;GPR17;RRH;SCTR;S1PR4;ADORA2A;AVPR2;LGR5;ADGRL2;ADGRG6;MC4R;GPR52;LPAR3;ADGRG7;P2RY10;FPR2;GPR62;GPR4
prerank,alpha-tubulin binding (GO:0043014),0.2858714375380515,0.753613021088322,0.8103241296518607,1.0,1.0,12/31,26.37%,EFHC2;DLEC1;TTLL7;TRPV4;FYN;DNAL1;FNTA;TRAPPC14;HDAC6;ARL4C;BBS4;CDK5R1
prerank,ribosome binding (GO:0043022),0.2700555240958051,0.7519082270295697,0.8321596244131455,1.0,1.0,10/46,18.42%,SBDS;YTHDF1;MTIF3;ZC3H12A;EIF6;RACK1;EIF2S1;ETF1;NOMO1;CPEB2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3548820936453253,0.7518525864425858,0.7764705882352941,1.0,1.0,2/10,16.21%,NAA50;NAA25
prerank,growth factor receptor binding (GO:0070851),0.24896824844648258,0.7499527000891887,0.8831725616291533,1.0,1.0,18/95,22.14%,TGFA;ERAP1;CCDC88A;TIMM50;VEGFD;FGF9;PSEN1;JAK2;FYN;IL1RAP;PIBF1;ARF4;SNX1;CD300LF;ERN1;TRIP6;FGF2;SNX2
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.2949539394266374,0.7496424739795033,0.8194622279129321,1.0,1.0,7/24,22.40%,OSBPL8;RUBCNL;PLEKHA3;OSBP;GOLPH3L;PLA2G4E;CERT1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3581262708675757,0.7485279608059053,0.7915451895043731,1.0,1.0,2/10,13.06%,PIK3CD;PIK3CB
prerank,epidermal growth factor receptor binding (GO:0005154),0.2946304695336285,0.7484045333243402,0.7933247753530167,1.0,1.0,8/25,27.02%,TGFA;CCDC88A;ARF4;SNX1;SNX2;LINGO1;SHC1;FER
prerank,nuclear export signal receptor activity (GO:0005049),0.34830577984555156,0.7482389871570708,0.7685459940652819,1.0,1.0,2/11,16.75%,CSE1L;RANBP17
prerank,GABA receptor activity (GO:0016917),-0.23311991110460925,-0.7480104910465081,0.8508064516129032,1.0,1.0,3/21,9.15%,GABRG3;GABRB1;GABRA2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.28131465669703015,-0.7473150852033871,0.7817589576547231,1.0,1.0,6/12,26.11%,CRYZL1;AIFM2;CBR1;NQO2;DCXR;CRYZ
prerank,snoRNA binding (GO:0030515),-0.21696524176646406,-0.7466873898764095,0.9144144144144144,1.0,1.0,11/30,22.82%,XRCC5;NOP56;NUDT7;NOP58;TBL3;IMP3;NUDT16L1;NOP14;NUDT1;BYSL;NUFIP1
prerank,GTPase binding (GO:0051020),0.23395584880426143,0.7466804563785232,0.9305835010060363,1.0,1.0,55/195,24.53%,ABCA1;DAPK3;RGP1;MYO1C;GOLGA5;TNFAIP1;RILP;RRAGC;CYFIP1;GGA3;KIF3B;RAPGEF6;UNC13D;RAP1GAP;SIKE1;SPHK2;FNBP1L;CIB1;ANKFY1;ANKRD27;SRGAP2;SORL1;IARS1;RIC1;FGD6;AKAP13;WHAMM;RANBP1;DENND10;HSP90AA1;MYCBP2;LZTR1;PEX5;OCRL;PLCE1;BECN1;RANBP9;SGSM1;NCKAP1;SGSM3;STRN3;GCC1;RHOH;OPTN;USP33;BRK1;CCDC186;IQGAP2;RAB29;ARHGAP1;BICD2;EXOC2;RAF1;FLNA;RIN3
prerank,cation transmembrane transporter activity (GO:0008324),0.2630680622764058,0.7455733505573666,0.83675799086758,1.0,1.0,10/48,21.96%,SLC38A2;SLC38A1;SLC38A3;SLC38A6;SFXN2;SLC36A4;SFXN1;SLC25A15;MFSD12;SLC6A6
prerank,potassium channel activity (GO:0005267),0.24699650130090803,0.7445776828269282,0.8641711229946524,1.0,1.0,8/89,11.77%,KCNMB3;GRIK3;TMEM38A;KCNH8;KCNS3;KCNA4;CCDC51;KCNK3
prerank,ankyrin binding (GO:0030506),-0.2453400447920404,-0.7444410183586315,0.8433734939759037,1.0,1.0,4/19,17.31%,SPTB;SPTBN4;PLEC;NRCAM
prerank,lipase activator activity (GO:0060229),0.35106849942658264,0.7404229359134504,0.7947932618683001,1.0,1.0,4/10,23.43%,CCL5;FYN;LCK;PDPK1
prerank,pyridoxal phosphate binding (GO:0030170),0.3052348629923937,0.7398604895454028,0.7932885906040269,1.0,1.0,1/20,0.65%,AGXT
prerank,metallocarboxypeptidase activity (GO:0004181),-0.22145909416067355,-0.7396884660350961,0.8955223880597015,1.0,1.0,6/26,15.93%,AGBL4;AGTPBP1;AGBL5;AGBL3;CPE;CPA6
prerank,ribonuclease P activity (GO:0004526),-0.2884220943320149,-0.7377496667713433,0.8184818481848185,1.0,1.0,7/11,29.60%,RPP38;RPP40;POP4;POP5;POP7;PRORP;POP1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.26439044330293165,-0.7374744192686854,0.8163265306122449,1.0,1.0,9/14,46.83%,KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.2546621263593468,-0.7340904932629103,0.8368055555555556,1.0,1.0,3/16,9.07%,PTPRK;PTPRA;PTPRG
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.2546621263593468,-0.7340904932629103,0.8368055555555556,1.0,1.0,3/16,9.07%,PTPRK;PTPRA;PTPRG
prerank,peptide hormone receptor binding (GO:0051428),-0.28569245686746014,-0.7337205780635675,0.830945558739255,1.0,1.0,5/11,40.34%,ADCYAP1;PTHLH;GNRH1;PSMC5;VIP
prerank,microtubule motor activity (GO:0003777),0.2582395605727156,0.7336749804449546,0.859075535512965,1.0,1.0,6/51,9.40%,KIF26A;KIF3C;KIF7;KIF2C;KIF3B;KIF16B
prerank,snRNA binding (GO:0017069),0.2652749579888843,0.7332570279917743,0.8307873090481787,1.0,1.0,12/42,23.57%,NCBP2;CCNT2;MEPCE;RNPC3;RBM41;EFTUD2;DDX39B;SNRPB2;CDK9;SART3;LSM4;SNRPD3
prerank,Hsp70 protein binding (GO:0030544),0.2780119210897655,0.730573867933939,0.8292682926829268,1.0,1.0,3/31,6.59%,NOD2;METTL21A;GPR37
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2547137816828869,0.7299860548623786,0.8561721404303511,1.0,1.0,8/55,15.80%,TRPM2;CUL5;ITPR1;PANX1;PSEN1;TRPV4;TRPM7;SLC24A3
prerank,nucleotidase activity (GO:0008252),0.3134374363898943,0.7291968142483833,0.8146611341632088,1.0,1.0,2/15,6.72%,NT5DC1;NT5C3A
prerank,MAP-kinase scaffold activity (GO:0005078),0.3360050670044039,0.7290714860422249,0.8028571428571428,1.0,1.0,4/11,15.57%,MAPK8IP3;MAP2K2;AKAP13;SPAG9
prerank,mRNA methyltransferase activity (GO:0008174),0.3336412450193106,0.7264325113540223,0.7904191616766467,1.0,1.0,4/12,16.71%,TRMT61B;RNMT;TRMT10C;METTL14
prerank,glucose transmembrane transporter activity (GO:0005355),0.3074891955547676,0.7263617760026267,0.8147651006711409,1.0,1.0,1/17,4.15%,SLC2A6
prerank,phospholipase A2 activity (GO:0004623),0.28445581133760584,0.7259838087998524,0.8281053952321205,1.0,1.0,6/26,21.55%,PLA2G12A;ABHD3;PLA2G4E;PNPLA3;PLA2G6;PNPLA8
prerank,high voltage-gated calcium channel activity (GO:0008331),0.3387501033989361,0.7259251538481738,0.802773497688752,1.0,1.0,1/10,8.44%,CACNA1A
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3029080484008041,0.7252099678501561,0.8146666666666667,0.9995333647000003,1.0,5/20,23.76%,SLC30A1;SLC30A5;SLC39A10;SLC39A3;SLC39A13
prerank,phospholipase C activity (GO:0004629),0.28532553131024424,0.723479087784023,0.8337595907928389,0.9994327510887474,1.0,3/25,9.28%,PLCB4;CCL5;PLCB3
prerank,actin binding (GO:0003779),0.22490861211636476,0.7134686938810124,0.9421319796954315,1.0,1.0,42/170,23.84%,MYOZ2;NOD2;CXCR4;UTRN;FLNB;PARVB;BCL7B;MRTFA;CCDC88A;SSH3;SPEF1;FXYD5;CORO7;GSN;CAPZB;MYRIP;SYNPO;PRKCE;TRPV4;MOBP;PLEKHH2;MYO6;RUSC1;GAS2L3;DBNL;PHACTR4;PDLIM3;TNNI2;MYH9;ABITRAM;MAP1B;KLHL1;MSRB1;ABL2;NRAP;IQGAP2;TWF1;FHL3;VASH1;PARVG;MAEA;ANG
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.3077378329252963,0.7120150275589949,0.8393632416787264,1.0,1.0,3/15,13.22%,ALDH7A1;ALDH1A2;ALDH1A1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.3341939680502732,0.7097162149670163,0.8166431593794076,1.0,1.0,4/11,20.09%,APLF;ALKBH1;NEIL2;HMCES
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.2349119652017456,-0.7079841598560445,0.9146341463414634,1.0,1.0,8/19,30.01%,PAK2;AFAP1L2;CD24;EGF;NRG3;ABI1;DGKQ;GREM1
prerank,phosphatase inhibitor activity (GO:0019212),0.2889223325560456,0.7063927492831692,0.8463576158940397,1.0,1.0,9/20,30.59%,ARPP19;MGAT5;PPME1;SET;CABIN1;ENSA;BOD1;PPP1R2;LGALS3
prerank,signal sequence binding (GO:0005048),0.2657624595006286,0.7057466175866626,0.8683574879227053,1.0,1.0,7/35,18.04%,RANBP6;NUP153;KPNB1;KDELR1;TNPO2;PEX5;BABAM2
prerank,hexose transmembrane transporter activity (GO:0015149),0.32058059007196305,0.7052702296569832,0.84,1.0,1.0,1/12,4.15%,SLC2A6
prerank,gated channel activity (GO:0022836),0.30936520838646153,0.7047280579101841,0.8270348837209303,1.0,1.0,2/14,9.44%,TMC1;TMEM266
prerank,C-C chemokine receptor activity (GO:0016493),0.2867860859164941,0.7046565727512514,0.8300132802124834,1.0,1.0,2/21,8.48%,CXCR4;ACKR3
prerank,sulfotransferase activity (GO:0008146),0.2658186615151663,0.7035483460374706,0.8596273291925466,1.0,1.0,1/33,0.26%,TPST1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2484163979485768,0.7026450259757153,0.8721461187214612,1.0,1.0,5/46,11.71%,EXT1;GCNT4;B3GLCT;MGAT4C;B3GALNT1
prerank,calcium:sodium antiporter activity (GO:0005432),0.32803359982056085,0.7016602504528434,0.8120411160058737,1.0,1.0,2/10,15.80%,SLC8A1;SLC24A3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.2533431717078824,-0.7009298720945762,0.8737201365187713,1.0,1.0,3/14,16.16%,FHIT;NUDT6;ENPP4
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.2751580769827491,0.7005537539809954,0.8607594936708861,1.0,1.0,3/25,12.23%,CH25H;CYP26B1;CYP27A1
prerank,poly(A) binding (GO:0008143),0.2863998415163868,0.6996703481247615,0.8623853211009175,1.0,1.0,10/21,29.64%,RBMS2;HNRNPDL;RBPMS;DDX3X;ZC3H14;KHDRBS2;HNRNPU;KHDRBS1;PABPC1;PABPC4
prerank,MAP kinase activity (GO:0004707),0.31099161195393243,0.698944006554624,0.8335625859697386,0.9989665523704058,1.0,2/14,9.64%,MAPK6;MAPK14
prerank,SH3 domain binding (GO:0017124),0.24163240445233336,0.6983701869146497,0.8912319644839067,0.9974983893778487,1.0,7/62,10.62%,ZNF106;CNTNAP1;SYNJ1;CABYR;EVL;SH3BP2;DNM2
prerank,AMP binding (GO:0016208),0.32851120128629185,0.6982875132914639,0.8131386861313868,0.9955453722967806,1.0,3/11,17.99%,PFKM;PRKAG1;ACSS2
prerank,syntaxin-1 binding (GO:0017075),-0.21679198576954092,-0.6980297128094124,0.9255813953488372,1.0,1.0,6/22,20.44%,DAPK1;NSF;VAMP3;STXBP5;UNC13A;SYT1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.21697831700089487,-0.695527937386928,0.9094827586206896,1.0,1.0,3/21,21.25%,CHRFAM7A;CHRNA7;CHRNA4
prerank,neuropeptide binding (GO:0042923),0.29382483014582494,0.6954822839442915,0.8396846254927727,0.9965967161072966,1.0,2/18,11.65%,GPR37;SORL1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.22333416665083974,-0.6928078397143482,0.8914728682170543,1.0,1.0,9/20,26.13%,MOGAT3;DGAT1;AGPAT4;AGPAT2;PLA2G15;GPAT4;GPAT3;LCLAT1;DGAT2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.24415787264435504,0.6919351663417782,0.8895216400911162,0.9983833989726765,1.0,17/49,27.14%,CPNE3;SYT7;SYT3;RPH3A;ANXA4;PLA2G4E;MCTP1;CPNE9;ESYT2;C2CD5;PCLO;SYT12;SYT11;ANXA2;SYT4;PLA2G4A;ANXA9
prerank,chemokine receptor activity (GO:0004950),0.2719640989613164,0.6912364245300341,0.8628205128205129,0.9971408359339179,1.0,3/24,12.50%,CXCR4;ACKR3;GPR35
prerank,chloride channel activity (GO:0005254),0.2382009724218192,0.6907617611477274,0.9029345372460497,0.9956221244425535,1.0,18/59,27.24%,CLIC4;CLCN2;CLCN6;TTYH1;GLRA2;CLCN7;ANO5;CLCN1;GABRG1;GLRA1;GABRB2;CLIC1;GABRA3;SLC26A7;CFTR;ANO4;ANO3;GABRG2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.2679740222519674,0.6906751126917126,0.8718905472636815,0.9936865336821542,1.0,3/27,6.94%,ITPR1;ASIC4;SLC11A2
prerank,cAMP response element binding (GO:0035497),-0.28115114774867667,-0.6899731508833578,0.8833819241982507,1.0,1.0,5/10,30.21%,ATF7;HMGA2;CREB1;ATF2;CREB3L1
prerank,GABA receptor binding (GO:0050811),0.3202433764634596,0.6881162521844855,0.8381924198250729,0.9944467140111923,1.0,2/11,12.81%,TRAK1;ARFGEF2
prerank,purinergic nucleotide receptor activity (GO:0001614),0.29434121312481787,0.6878888964194907,0.8535564853556485,0.9926485988534193,1.0,2/15,8.96%,P2RY13;P2RX4
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.28742201097996717,0.6861912604571048,0.8553888130968622,0.9924252569350654,1.0,8/19,27.24%,GRIK3;GRID1;GABRG1;GRIK4;GABRA3;GRIK5;GRIK2;GABRG2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3047954176375759,0.6854991998192769,0.8363095238095238,0.9911807074884408,1.0,2/13,9.05%,AGPAT5;LPCAT2
prerank,3'-5' exonuclease activity (GO:0008408),0.2465034137305237,0.6826540003596452,0.9076212471131639,0.9920870116239193,1.0,4/45,4.81%,PNPT1;XRN2;APLF;CNOT7
prerank,phospholipase binding (GO:0043274),-0.26299109828838485,-0.6826421546699335,0.8543046357615894,1.0,1.0,7/13,29.78%,SYK;SRC;WAS;BTK;ARHGAP6;PRKN;DGKQ
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.28084217514320736,0.6806144675711249,0.8817345597897503,0.9901718006977491,1.0,10/21,27.47%,CDK12;CDK19;CDK10;CDK20;CCNK;CDK9;CDK8;CDKL4;CDK7;CDK5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.28084217514320736,0.6806144675711249,0.8817345597897503,0.9901718006977491,1.0,10/21,27.47%,CDK12;CDK19;CDK10;CDK20;CCNK;CDK9;CDK8;CDKL4;CDK7;CDK5
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.32468293564066714,0.6796850427503368,0.850381679389313,0.9891704930327626,1.0,3/10,15.96%,RIOX2;KDM8;KDM7A
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.31409782799875685,0.6770552559322774,0.8338414634146342,0.9897691778440324,1.0,2/11,11.08%,SLC19A1;SLC25A25
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.24680103181442192,-0.6759511208862456,0.9049079754601227,0.9996797162032449,1.0,2/13,2.69%,SLC66A1;SLC7A2
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.30493952332619095,0.6737522011868716,0.8764367816091954,0.9910202455360496,1.0,5/12,22.39%,CDK12;CDK19;CCNK;CDK9;CDK8
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.28043510109606773,0.6722396174177553,0.8775235531628532,0.9905455967634907,1.0,5/20,14.43%,CMPK2;AK4;AK3;TJP2;DLG1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.23706855253334952,0.670999030052567,0.9051918735891648,0.9897539060409274,1.0,6/51,10.44%,SLCO1C1;SLC25A16;SLCO1B1;ANKH;SLC25A10;TMEM241
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2511670739019348,0.6695454649783461,0.9137115839243499,0.9891632720332347,1.0,3/34,4.81%,PNPT1;XRN2;CNOT7
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.30873794979611524,0.6694111605600047,0.8735955056179775,0.9873430027346037,1.0,4/12,26.65%,CNOT7;PAN3;CNOT2;NOCT
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.3001319605528702,0.6662315002300674,0.8663793103448276,0.988438145226893,1.0,2/12,11.22%,CCDC88A;VEGFD
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2320178980332559,0.6644374892599781,0.9357696566998892,0.9882470892636513,1.0,11/57,19.65%,UQCRQ;NDUFA5;NDUFB9;NDUFS1;UQCR10;NDUFB5;NDUFS4;NDUFA10;NDUFB6;NDUFS8;NDUFS7
prerank,ubiquitin-dependent protein binding (GO:0140036),0.31728548030886183,0.6629858785917744,0.8827160493827161,0.9876013189205022,1.0,4/10,24.13%,USP15;IDE;DNAJB2;DNAJC2
prerank,H4 histone acetyltransferase activity (GO:0010485),0.31014686709243033,0.6621836059305075,0.8562874251497006,0.9864146202132669,1.0,2/10,16.70%,NAA50;KAT8
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.24150777138492396,0.6597061784469033,0.9176470588235294,0.9867065325194213,1.0,10/38,23.74%,DENND1A;RUBCNL;ZFYVE26;KIF16B;PLEKHA4;SH3PXD2B;PHLDA3;PLA2G4E;ZFYVE1;SNX12
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.31544460640540206,0.6581241463540217,0.8748091603053435,0.9842782316720179,1.0,3/10,18.46%,DUSP10;DUSP16;DUSP8
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.31544460640540206,0.6581241463540217,0.8748091603053435,0.9842782316720179,1.0,3/10,18.46%,DUSP10;DUSP16;DUSP8
prerank,vitamin D receptor binding (GO:0042809),0.2885116242295538,0.656497009342673,0.8757062146892656,0.9837828024312701,1.0,6/14,24.81%,MED12;SNW1;MED16;MED24;TAF7;TAF11
prerank,FMN binding (GO:0010181),0.3017741989118038,0.6562647821363444,0.8661764705882353,0.9821129093531651,1.0,3/11,23.73%,DUS2;PPCDC;NDOR1
prerank,actinin binding (GO:0042805),0.2673467570939021,0.6559644877181473,0.8988173455978975,0.9804514980778827,1.0,2/21,6.30%,CSRP1;NFKB1
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.31235799885652127,0.6528981175201201,0.8746268656716418,0.9812119350332666,1.0,3/10,11.24%,ASH1L;SETD5;SETDB2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.25704510573236294,-0.6490373879220847,0.8835820895522388,1.0,1.0,3/10,17.88%,GALM;DSEL;GFUS
prerank,intracellular chloride channel activity (GO:0061778),0.27432314883940184,0.6482132046525106,0.8969359331476323,0.9814991220343039,1.0,3/16,16.25%,TTYH1;ANO10;ANO5
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.27432314883940184,0.6482132046525106,0.8969359331476323,0.9814991220343039,1.0,3/16,16.25%,TTYH1;ANO10;ANO5
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.23354038322470672,-0.6472949742882972,0.9032258064516129,1.0,1.0,6/13,30.38%,IL1R1;ITGB3;PDGFRA;PDGFC;PDGFRB;PDGFD
prerank,ephrin receptor activity (GO:0005003),0.26612833181370227,0.6456391719686032,0.8934426229508197,0.9799073752117721,1.0,2/17,7.50%,EPHA4;EPHA6
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.26612833181370227,0.6456391719686032,0.8934426229508197,0.9799073752117721,1.0,2/17,7.50%,EPHA4;EPHA6
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.2814729531565837,0.6438699487447448,0.9065550906555091,0.9794397854032137,1.0,5/14,22.98%,TSEN2;RPP30;TSEN34;RPP14;RPP21
prerank,ribonuclease P RNA binding (GO:0033204),-0.25821965026851906,-0.6426397190216716,0.8966565349544073,1.0,1.0,6/10,29.60%,RPP38;RPP40;POP4;POP5;POP7;POP1
prerank,leak channel activity (GO:0022840),-0.21203380755133894,-0.6381716681568192,0.9230769230769231,0.99864293126846,1.0,8/18,36.15%,NALCN;KCNK6;KCNK12;KCNK9;KCNK5;KCNK4;KCNK13;KCNK7
prerank,alanine transmembrane transporter activity (GO:0022858),0.28440837672109875,0.6378502566602511,0.9001426533523538,0.9823367846393173,1.0,4/12,25.52%,SLC38A3;SLC36A4;SLC6A6;SLC36A1
prerank,exoribonuclease activity (GO:0004532),0.28542915923252943,0.6307002483301417,0.8953323903818954,0.9859384159935638,1.0,3/12,14.05%,CNOT7;ZC3H12A;EXOSC9
prerank,5'-3' RNA polymerase activity (GO:0034062),0.24089094395344934,0.6290030403318658,0.9215189873417722,0.9853403195174556,1.0,2/27,6.35%,POLR2G;POLR3B
prerank,acylglycerol lipase activity (GO:0047372),0.29035739381415593,0.6277009927642476,0.8959537572254336,0.9844937818582663,1.0,2/11,14.84%,ABHD2;ABHD3
prerank,histone deacetylase activity (GO:0004407),0.25829291986794173,0.6247692743958384,0.9319148936170213,0.9847570062060318,1.0,11/19,30.45%,SIRT6;MIER1;HDAC8;HDAC1;HDAC2;HDAC4;HDAC6;SIRT2;HDAC5;SIRT3;HDAC11
prerank,phospholipid transfer activity (GO:0120014),0.25186211801563546,0.6236231195146061,0.9241830065359478,0.9836747764900059,1.0,8/21,23.37%,PITPNM1;PLEKHA3;MTTP;OSBPL2;GLTP;TNFAIP8L3;CERT1;PITPNA
prerank,phosphatidylglycerol binding (GO:1901611),0.27814374030222033,0.6187842185526458,0.9101449275362319,0.9852181399401916,1.0,1/13,3.62%,PLEKHN1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.21474609446208856,0.6185811733063491,0.9606299212598425,0.9835209583812891,1.0,18/54,28.62%,ASAH2;SIRT6;NGLY1;MIER1;HDAC8;HINT3;ACER3;HDAC1;TGM2;NIT1;HDAC2;HDAC4;HDAC6;SIRT2;NTAN1;GLS2;KLK3;HDAC5
prerank,amino acid binding (GO:0016597),0.23603469991004256,0.6150917364027152,0.9267080745341615,0.9840304457438815,1.0,5/31,16.14%,AGXT;AARS1;GLRA2;SHMT1;GCLC
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.2796107732717187,0.6148347990639313,0.9156441717791411,0.9823535129817749,1.0,2/12,11.08%,SLC19A1;SLC25A25
prerank,voltage-gated anion channel activity (GO:0008308),0.267276912780918,0.6130727642522319,0.9183381088825215,0.9816745002649704,1.0,2/15,5.82%,CLCN2;CLCN6
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2336161939826204,0.6117239122347048,0.9269521410579346,0.9807144213337435,1.0,2/27,6.35%,POLR2G;POLR3B
prerank,antiporter activity (GO:0015297),0.2543572716362002,0.6108392520300999,0.9058355437665783,0.9794247861111474,1.0,6/20,22.93%,SLC25A16;SLC25A10;TMEM241;SLC35D1;SLC35C2;SLC25A30
prerank,single-stranded telomeric DNA binding (GO:0043047),0.28407634486939715,0.6069301857936877,0.9074626865671642,0.9800351971982736,1.0,4/11,19.00%,HNRNPA2B1;HNRNPA1;STN1;TERF2
prerank,ephrin receptor binding (GO:0046875),0.24775516830506925,0.6055362830267226,0.9305373525557011,0.9791219212256453,1.0,4/21,15.44%,LYN;CHN1;FYN;CRK
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.19482176793762318,-0.6043661762161653,0.9665271966527197,0.9964737705018698,1.0,6/22,28.03%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,serotonin receptor activity (GO:0099589),-0.19482176793762318,-0.6043661762161653,0.9665271966527197,0.9964737705018698,1.0,6/22,28.03%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.19482176793762318,-0.6043661762161653,0.9665271966527197,0.9964737705018698,1.0,6/22,28.03%,HRH2;HRH1;CHRM2;HTR7;HTR1D;HTR1B
prerank,adrenergic receptor binding (GO:0031690),0.2542809015161574,0.6025198057586911,0.9305949008498584,0.9790661261032865,1.0,2/16,8.10%,MAGI2;RAPGEF2
prerank,histone acetyltransferase activity (GO:0004402),0.22797870838420053,0.5952915914860337,0.9496221662468514,0.9815852169751094,1.0,12/30,28.46%,NAA50;KAT14;TADA2A;KAT8;KAT7;MCM3AP;KAT6A;KAT5;KAT2B;EP300;SRCAP;USP22
prerank,store-operated calcium channel activity (GO:0015279),0.2743165566424642,0.5889195303615947,0.9244372990353698,0.9836237165125975,1.0,6/10,31.82%,TRPC4;TRPC1;ORAI1;TRPC7;STIM2;TRPC3
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.2730850434272282,0.5857299663294022,0.9323308270676691,0.9835351383165601,1.0,1/10,5.08%,CDKN2D
prerank,voltage-gated sodium channel activity (GO:0005248),-0.1831982853651941,-0.5831462831704208,0.9795918367346939,0.9992256420787587,1.0,9/22,31.85%,SCN3A;SCN3B;SCN9A;HCN3;SCN7A;SCN2B;CACNA1G;HCN4;CACNA1H
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.24884711997600134,0.5813941892340033,0.9290586630286494,0.9823818475813207,1.0,4/16,22.42%,ATP6V0D1;TCIRG1;ATP6V1B2;ATP5F1B
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.24884711997600134,0.5813941892340033,0.9290586630286494,0.9823818475813207,1.0,4/16,22.42%,ATP6V0D1;TCIRG1;ATP6V1B2;ATP5F1B
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.21347441456310298,-0.5813695432749673,0.9585987261146497,0.992485776178001,1.0,4/13,17.31%,ARHGDIB;RGS14;GDI1;ITGB1BP1
prerank,cAMP binding (GO:0030552),0.269324925579586,0.5759958372143673,0.9356814701378254,0.9833887778735539,1.0,4/11,21.82%,RAPGEF2;PDE4B;CNBD2;PDE4A
prerank,O-acyltransferase activity (GO:0008374),0.21824761383785612,0.573577977186587,0.9651307596513076,0.98271905964777,1.0,4/30,17.01%,PIGW;LPCAT2;SOAT2;SOAT1
prerank,serine-type peptidase activity (GO:0008236),0.18768545869447226,0.5702770315574167,0.9871794871794872,0.9825027602211326,1.0,8/96,15.81%,PRSS12;CTSH;PCSK7;KLK1;RHBDF2;PREP;MASP1;HTRA3
prerank,serine-type endopeptidase activity (GO:0004252),0.18944101092208038,0.5674441960767355,0.9868995633187773,0.9820932617875704,1.0,6/80,13.76%,PRSS12;CTSH;PCSK7;KLK1;RHBDF2;MASP1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.25682717056940174,0.5671825957055674,0.950965824665676,0.9804350821274682,1.0,12/12,74.34%,ELOVL4;GNAT2;OPN1SW;RHO;OPN4;OPN5;OPN1MW;OPN1MW3;GPR52;RRH;GPR88;OPN3
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.24775581753619833,0.5583459095859165,0.9679144385026738,0.9826655093518236,1.0,2/14,13.85%,USP15;MINDY3
prerank,phosphate ion binding (GO:0042301),-0.2218553759702231,-0.5573161301466718,0.9682539682539683,0.9941053639927231,1.0,1/10,5.60%,PNP
prerank,symporter activity (GO:0015293),0.2566066160316368,0.5454953925003528,0.9614197530864198,0.9860697492086443,1.0,10/10,74.36%,SLC5A6;SLC4A4;SLC28A3;SLC5A8;SLC5A12;SLC5A5;SLC28A1;MFSD2A;SLC46A2;SLC28A2
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.19553411747164146,-0.5451250163913691,0.9701986754966887,0.9905134759665392,1.0,8/14,36.18%,CMPK1;DTYMK;NME1;NME2;AK7;AK9;NME4;AK1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.2532443347984372,0.532946074897158,0.9643916913946587,0.9885510596499063,1.0,4/10,29.16%,CYLD;OTUD5;STAMBPL1;ATXN3
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.2505452790949976,0.5307935661319886,0.9538690476190477,0.9874418955183334,1.0,3/10,19.66%,FEN1;DCLRE1A;DCLRE1C
prerank,phospholipase inhibitor activity (GO:0004859),-0.20845464075928816,-0.527184685534112,0.9777777777777777,0.9881522577898406,1.0,4/10,32.21%,SNCA;ANXA1;APOC1;SNCB
prerank,organic cation transmembrane transporter activity (GO:0015101),0.22323101162475817,0.5185018342480272,0.9833564493758669,0.9892373460341273,1.0,15/16,62.44%,SLC44A1;SLC25A26;SLC22A4;SLC5A7;SLC22A5;SLC44A4;SLC22A16;SLC22A1;SLC7A8;SLC29A4;SLC22A2;SLC44A2;SLC22A3;SLC18A3;SLC25A17
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.22387325172910735,0.5087817320064136,0.9784791965566715,0.9899570502171035,1.0,3/14,15.81%,CAPNS1;CAPN1;CAPN5
prerank,phosphatidate phosphatase activity (GO:0008195),0.21327422127057988,0.4756203040167917,0.9885550786838341,0.9950696698367677,1.0,5/13,25.46%,LPIN2;PLPP2;PLPPR2;PLPPR1;PLPP1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.19454343261987966,0.47300447037585214,0.9896238651102465,0.9937733204059063,1.0,3/21,21.96%,FGF9;NPTN;FGF2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.20522041920897002,0.45337745811631786,0.9879154078549849,0.9945475663798652,1.0,2/13,17.75%,IDI1;EBP
